TW381178B - Compositions and methods for protein structural determinations - Google Patents

Compositions and methods for protein structural determinations Download PDF

Info

Publication number
TW381178B
TW381178B TW083102456A TW83102456A TW381178B TW 381178 B TW381178 B TW 381178B TW 083102456 A TW083102456 A TW 083102456A TW 83102456 A TW83102456 A TW 83102456A TW 381178 B TW381178 B TW 381178B
Authority
TW
Taiwan
Prior art keywords
labeled
patent application
protein
scope
amino acid
Prior art date
Application number
TW083102456A
Other languages
Chinese (zh)
Inventor
Jonathan Miles Brown
Original Assignee
Martek Biosciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/014,243 external-priority patent/US5393669A/en
Application filed by Martek Biosciences Corp filed Critical Martek Biosciences Corp
Application granted granted Critical
Publication of TW381178B publication Critical patent/TW381178B/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

A method for determining three-dimensional structural information of a protein involves producing the protein in a form substantially labeled with C13 or N15 or both or substantially labeled with N15 and C13 and partially labeled with H2 and subjecting the protein to nuclear magnetic resonance spectroscopic analysis. The isotopically labeled protein is produced by a method which involves producing a substantially labeled microbial protein hydrolysate, subjecting the protein hydrolysate to cation exchange chromatography to produce a partially purified labeled amino acid mixture, subjecting the partially purified labeled amino acid mixture to anion exchange chromatography to produce a purified labeled amino acid mixture and supplementing the purified labeled amino acid mixture with isotopically labeled cysteine and optionally with isotopically labeled glutamine and asparagine.

Description

A7A7

五、發明説明(/ ) 發明簕園 (請先閱讀背面之注意事項再填寫本頁) 本發明乃關於生物性大分子三維结構的測定,尤其是對 於蛋白質。特別是,其乃關於利用N光譜分析,對由培 養的哺乳動物細胞,或昆蟲細胞所表現的蛋白質之三維结 構測定,所使用的新穎姐合物及方法。 發明背暑 多年來.*對於生物性大分子,尤其是蛋白質,之k維結 構的測定均抱持ά大興趣。所謂”結構-功能”研討已藉著 訂定某一種分子,或某一類分子中,其結構型態對生物活 性的性來探討由於諸位諾貝爾得主對結構探討的先驅 工程,如Perutz及其同伴對血紅素結構的探討(perutz, M . F · e t a 1 .,LaJLU.C-.e....,LSi. 416-422 (1960))及 Watson 及 Crick 對 DNA 结構的研究(Watson, J.D.,及 Crick, F · H . C · , N_a..t.nr e , 111, 737 (1953)),使得結構研究於生 物科學上佔有極大重要性。 經濟部中央標準局員工消費合作社印製 最近又衍生了 ”理性化藥物設計”的概念。此藥物設計策 略乃關於訂定特殊生物分子,其三維结構中的”活性部份 a *如蛋白質。此生物分子可為受體,酵素,激素,或其 他具生物活性分子。了解該活性區域的三維结構有肋於科 學家設計分子,使其可抑制,模擬或加強該分子的天然生 物活性。(Appelt, K., et al.,,J . MpH . Π h p. m . . 3 4 . 1925 (1991))。因此,生物分子三維結構的測定具有極大 的實用性及商業意義。 首先發展用K測定三維結構的技術為X -射線结晶學。血 紅素及DNA的结構均Μ此技術測定。X -射線结晶學乃是將 本紙張尺度適用中國國家標準(CNS )/4規格(210X297公釐) 83. 3. 10,000 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(>) 受檢物的结晶KX -射線撞擊後,經由結晶中規律分子的原 子折射而造成。此散射的X-射線為照相板所捕獲。後再K 標進技術展開呈像。此繞射X-射線於板上為一糸列的點像 >由其型態,可訂定分子结晶的結構。對大分子而言,必 須K重金屬離子,如釕來使其結晶,κ避免由於相差造成 的不確定性。 最近,另一種技術,核磁共振(” N MR ”)光譜學已被發展 用來測定生物分子的三維结構,尤其是蛋白質。NMR光譜 學原於1 950年代發展,且被做為分析小化合物结構的有效 步驟「妞同於分析分子量$ 1000 daltons者。簡言之,此 技術乃將物質(通常存於合適的涪劑中)置於強力磁場中 ,虽Μ強大電訊激發不同原子的原子核將根據磁場作排列 ,直至Κ電訊添加能量。其吸收此能量並於某頻率下放射 再度被激發(共振),其根據i )原子核態及Π )原子核的化 學環境(大部份由鍵結所決定)。更甚者,共振可經由鍵结 ,或三維空間,由一個原子核傳導至另一個,而提供了特 定原子核,其周邊環境及其鄰近原子核的資訊。 ——,不過,很重要的是並非所有原子核均具有N M R活性。事 實上,同一個元素的所有同位素並不全具有活性。例如, 雖然”正常”氫,1 Η具N M R活性,但,重氫(氘),2 Η,並不 具活性。因此,任何於正常情況下含有1Η氫的物質,可藉 著將所有1Η氫Κ 2Η取代,使其於氫N MR光譜中為”不可見 的”。因此,水溶性物質的N M R光譜乃於2 Η 2 0溶液中測定 * Μ避除水的訊號。 相反的,”正常”碳1 2 C不具N M R活性,而其穩定同位素 λ -4 - (請先閱讀背面之注意事項再填寫本頁)V. Description of the Invention (/) Invention Gion (Please read the notes on the back before filling this page) The present invention relates to the determination of the three-dimensional structure of biological macromolecules, especially for proteins. In particular, it relates to novel novel compounds and methods for measuring the three-dimensional structure of proteins expressed by cultured mammalian cells or insect cells using N-spectroscopy. Invented over the years. * For the determination of k-dimensional structure of biological macromolecules, especially proteins, there is great interest. The so-called "structure-function" research has discussed the structure and biological activity of certain molecules, or certain types of molecules, due to the pioneering projects of structure exploration by Nobel laureates, such as Perutz and his companions. Discussion on the structure of heme (perutz, M.F · eta 1., LaJLU.C-.e ...., LSi. 416-422 (1960)) and the study of DNA structure by Watson and Crick (Watson, JD , And Crick, F · H. C ·, N_a..t.nre, 111, 737 (1953)), make structural studies of great importance in biological sciences. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, the concept of “rational drug design” has recently been derived. This drug design strategy is about specifying a specific biomolecule, the "active part a *" of its three-dimensional structure, such as a protein. This biomolecule can be a receptor, enzyme, hormone, or other biologically active molecule. Knowing the active area The three-dimensional structure allows scientists to design molecules that can inhibit, mimic or enhance the natural biological activity of the molecule. (Appelt, K., et al., J. MpH. Π h p. M.. 3 4. 1925 (1991)). Therefore, the determination of the three-dimensional structure of biomolecules has great practicality and commercial significance. Firstly, the technique of measuring the three-dimensional structure using K was developed as X-ray crystallography. The structures of heme and DNA were determined by this technique. X-ray crystallography is to apply this paper size to the Chinese National Standard (CNS) / 4 specification (210X297 mm) 83. 3. 10,000 printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Α7 Β7 V. Description of the invention (> ) The crystalline KX-rays of the test object are caused by the atomic refraction of regular molecules in the crystal. The scattered X-rays are captured by the photographic plate. Then the K-scaling technique is used to develop the image. This diffraction X- Rays A series of dot images on the plate can be used to define the crystal structure of the molecule. For large molecules, K heavy metal ions, such as ruthenium, must be used to crystallize them, and κ to avoid uncertainty caused by phase differences. Recently, another technique, nuclear magnetic resonance ("N MR") spectroscopy, has been developed to determine the three-dimensional structure of biomolecules, especially proteins. NMR spectroscopy was originally developed in the 1950s and is used to analyze small compounds An effective step in the structure is the same as analyzing a molecular weight of $ 1000 daltons. In short, this technology puts a substance (usually stored in a suitable tincture) in a strong magnetic field. Although M powerful telecommunications excite the nuclei of different atoms, Arrange according to the magnetic field until K Telecom adds energy. It absorbs this energy and radiates it again at a certain frequency (resonance). It is based on the chemical environment of the nucleus i) and nucleus nucleus (mostly determined by the bonding). What's more, resonance can be transmitted from one nucleus to another via a bond, or in a three-dimensional space, providing a specific nucleus, its surrounding environment and its neighboring atoms. Nuclear information. However, it is important to note that not all nuclei have NMR activity. In fact, not all isotopes of the same element are active. For example, although "normal" hydrogen, 1 has NMR activity, but , Deuterium (deuterium), 2 Η, is not active. Therefore, any substance containing 1 Η hydrogen under normal circumstances can be made invisible in the hydrogen N MR spectrum by replacing all 1 Η hydrogen K 2 Η ". Therefore, the NMR spectrum of water-soluble substances is determined in a 2 Η 20 solution. * Μ signal to avoid water. In contrast," normal "carbon 1 2 C does not have NMR activity, and its stable isotope λ -4- (Please read the notes on the back before filling this page)

本紙張尺度適用中國國家標準(CNS ),4規格(210Χ 297公釐) 83. 3. !〇,〇〇〇 經濟部中央標準局員工消費合作社印裝 A7 B7 五、發明説明(>) 13C ,其於天然碳中佔約1 %,卻具有NMR活性。類似的 ,”正常”氮,14N不具NMR活性,而其穩定同位素1SN , 同樣的,其於天然氮中佔有約1 %,為具活性者。已知對 小分子而言,若實驗於足量的物質與足夠的時間下進行, 此低天然存量已足K產生實驗所需的資料。 於硬體及軟體均進步的情況下,上述技術可分析的分子 大小已增至_約1 0,0 0 0 d a 11 ο n s,其為小蛋白質的大小。因 此,利用NMR光譜學測定蛋白質结構於幾年前才開始。其 快速被了解到大小限制的克服,可經由將蛋白質中不具 HMR活_性的14Κ及12C同位素,Κ具HMR活性之穩定同位 素1 5 N及1 3 C來取代。達到此取代目的的方法之一,乃將 可產生此蛋白質的微生物,於Μ此同位素標示的培養基中 生長。 . 於過去2年或3年中,經1SN-標示及13C-標示的蛋白質 ,已分別將可分析之大小限制提高至約15kd及25kd。此同 位素取代法的完成,乃將經由基因工程改造的*可產生選 定蛋白質的细菌或酵母菌,於含有經及/或1標示 ------受質的培養基中生長。實際上,此培養基通常含有1SC標 示之葡萄糖及/或1標示銨鹽。(Kay, L. et al., S P. i Ρ· η P. P. . 249 . 411 (1990)及其列出之參考文獻)°最 近,又有報告指出利用含有經標示之蛋白質水解物作為细 菌及酵母菌營養培養基。參見國際專利應用,發表Η〇· W0 90/15525 * 1990年 12月 27日發表。 當13C及15N標示使得NMR對蛋白質的结構測定較前述 為大時,利用此技術分析高於2 5 k d的蛋白質得到模糊的 本紙張尺度適用中國國家標準(CNS IA4規格(21 〇 X 297公釐) 83. 3. 10,000 (請先閱讀背面之注意事項再填寫本頁) 0^------1T------β 經濟部中央標準局員工消費合作社印褽 A7 B7 五、發明説明(仏) 结果。於此大小時*來自不同原子的共振,由於太過於廣 泛而無法解析。在最近的一篤報告中指出,利用三重-標 示,i . e .部份结合重氫,2 Η,Μ及1 3 C和1 5 N同位素,可 降低較大型分子中散佈的訊號。Bax, ,1. Am. Chem.This paper size applies Chinese National Standards (CNS), 4 specifications (210 × 297 mm) 83. 3.! 〇, 〇〇〇 Consumer Standards of the Central Standards Bureau of the Ministry of Economic Affairs printed A7 B7 V. Description of the invention (>) 13C , Which accounts for about 1% of natural carbon, but has NMR activity. Similarly, "normal" nitrogen, 14N, does not have NMR activity, and its stable isotope 1SN, similarly, it occupies about 1% of natural nitrogen and is active. It is known that for small molecules, if the experiment is performed with a sufficient amount of substance and sufficient time, this low natural inventory is sufficient to produce the data required for the experiment. With the advancement of both hardware and software, the size of molecules that can be analyzed by the above technology has increased to about 10,000, 0 0 0 d a 11 ο n s, which is the size of small proteins. Therefore, the determination of protein structure using NMR spectroscopy has only begun a few years ago. It is quickly understood that the size limitation can be overcome by replacing 14K and 12C isotopes without HMR activity in the protein, and stable isotopes 15K and 1C with HMR activity in the protein. One way to achieve this substitution is to grow microorganisms that can produce this protein in a medium labeled with this isotope. In the past 2 or 3 years, the 1SN-labeled and 13C-labeled proteins have increased the size limit that can be analyzed to about 15kd and 25kd, respectively. The completion of this isotope replacement method is to genetically engineer * bacteria or yeasts that can produce the selected protein to grow in a medium containing and / or 1-marked --- substance. In fact, this medium usually contains 1SC-labeled glucose and / or 1-labeled ammonium salts. (Kay, L. et al., S P. i P · η PP. 249. 411 (1990) and listed references) ° Recently, there have been reports of the use of labeled protein hydrolysates as bacteria and Yeast nutrient medium. See International Patent Applications, Publication Η〇 · 90/15525 * Published December 27, 1990. When the 13C and 15N labels make the NMR structure determination of the protein larger than the foregoing, the use of this technique to analyze proteins higher than 25 kd yields ambiguous paper standards applicable to Chinese national standards (CNS IA4 specifications (21 0X 297 mm) ) 83. 3. 10,000 (Please read the precautions on the back before filling out this page) 0 ^ ------ 1T ------ β Employees ’Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Invention Explain (仏) the result. At this size * resonances from different atoms are too broad to be resolved. It was pointed out in a recent Yidu report that using triple-labeling, i.e. partially bound heavy hydrogen, 2 Europium, M, and 1 3 C and 15 N isotopes can reduce the signal scattered in larger molecules. Bax,, 1. Am. Chem.

Soc. , LL5_:4369 (1993)。因此,利用NMR測定約高於25 kd的蛋白質结構,其較佳的使用三重標示培養基來製備 其經標示蛋白質。對细菌蛋白質而言,可將细菌於含H20 及2H2〇混合物中培養,而得部份2H-標示。但此方法並無 法滿足產生經適當標的哺乳動物细胞蛋白質。 因此有關MR結構測定的組合物及方法,有一定的限 制。許多欲探討其結構功能的蛋白質均來自哺乳類。更甚 者,實際上於理性人類藥物設計中欲探討的蛋白質均來自 哺乳類,丨.e.人類。因此,X -射線結晶學或NMR光譜學並 無法廣泛地被應用於檢测產自哺乳動物细胞的蛋白質。 X -射線结晶學,於定義上而言,需要晶體物,但哺乳動物 细胞卻極難结晶。至目前為止,僅有少數抗體及衍生自哺 乳動物细胞的受體曾生成適合於進行结晶學分析的型態。 ----這些曾生成晶體者*通常乃選自分子的某一部份。於檢視 衍生自分子Η段的資料卻必須留心,由於無法得知主要分 子的這部份於單獨存在時,其結構是否仍與存於完整分子 中相同。尤其是,X -射線结晶學無法應用於得不到晶體的 物質上。 N M R結構研討,其限制於必須於细菌或酵母菌中表現經 標示蛋白質。不過,多數哺乳動物蛋白質含有重要的轉譯 後修飾部份*其於細菌及酵母菌糸統中無法達成。也就是 -6 - 本紙張尺度適用中國國家標準(CNS ),4規格(210Χ297公釐) 83. 3. 10,000 (請先閱讀背面之注意事項再填寫本頁)Soc., LL5_: 4369 (1993). Therefore, NMR is used to determine the protein structure above 25 kd, and it is better to use triple labeling medium to prepare its labeled protein. For bacterial proteins, the bacteria can be cultured in a mixture containing H20 and 2H20 to obtain a portion of the 2H-label. However, this method is not sufficient to produce mammalian cell proteins that are appropriately labeled. Therefore, there are certain restrictions on the composition and method for MR structure measurement. Many proteins whose structure and function are to be explored come from mammals. What's more, the proteins to be explored in rational human drug design are actually from mammals, e. Humans. Therefore, X-ray crystallography or NMR spectroscopy cannot be widely used to detect proteins produced from mammalian cells. X-ray crystallography, by definition, requires crystals, but mammalian cells are extremely difficult to crystallize. To date, only a few antibodies and receptors derived from mammalian cells have produced patterns suitable for crystallographic analysis. ---- These crystals * are usually selected from a part of the molecule. When reviewing the data derived from the molecular segment, one must be careful, because it is not known whether this part of the main molecule, when it exists alone, will still have the same structure as that in the intact molecule. In particular, X-ray crystallography cannot be applied to substances where crystals cannot be obtained. NM structural studies are limited to the need to express labeled proteins in bacteria or yeast. However, most mammalian proteins contain important post-translational modifications * which cannot be achieved in bacterial and yeast systems. That is -6-This paper size applies to Chinese National Standards (CNS), 4 specifications (210 × 297 mm) 83. 3. 10,000 (Please read the precautions on the back before filling this page)

經濟部中央搮準局員工消費合作杜印製 A7 B7 五、發明説明(Γ) 說,於適當地摺®及與雙硫鍵交互鍵结後*其可接上寡糖 類支鏈或可由蛋白質水解切除後生成具活性態。由细菌或 酵母菌所產生的蛋白質通常不擁有由哺乳動物细胞產生的 蛋白質之生物活性。事實上,於某些情況下*哺乳動物蛋 白質無法由细菌產生。為了上述原因*生技工業於1980年 代中期,將生產重組性療效蛋白質,如組織胞漿素原活化 因子’因子vm:c*紅血球生成素等,由细菌表現糸轉至 哺乳動物表現糸某些哺乳動物细胞蛋白質,利用將欲 探討分子部份的基因選殖至細菌中,使其於同位素標示的 培養基Φ生長,而得其同位素標示片段後KHMR分析。同 樣的,只有可於细菌中表現的分子,可利甩此糸统作研討 。(e.q.見 Driscoll,P.C., et al·, Nature, 353, 1 〇 月24日,199 1)。由於在细菌表現糸統中缺乏了轉譯後修 飾,因此,所得的欲檢視分子缺少此轉譯後修飾,如糖基 化etc .,同樣的,使人懷疑所得结構的價偉。與X-射線結 晶學相同,其不斷地為人懷疑所得蛋白質片段之結構的價 值。 --------目前,已發展了利用哺乳動物细胞及昆蟲細胞作為寄主 -載體糸統。哺乳動物细胞株,如中國黃金鼠卵巢(CH0) 细胞,C0S細胞及昆蟲细胞株,如S D n d 〇 p t e ΓΑ· 胞株 SF9 及 SF 21 (Luckow, V.i\.及 Summers, M.D., B i o t r p. h η n 1 n g v . g_47-55 (1988)) ’ 均 已被發現,可對所產生的重姐哺乳類蛋白質作轉譯後修飾 ,使其與天然蛋白質相似。 利用NMR研討哺乳動物细胞及昆蟲细胞所生產的蛋白質 本紙張尺度適用中國國家標準(CNS )_A4規格(210X 297公釐) 83.3. !0,〇〇〇 nn n^n nflfl— m^i Km ^\\T/ · t^itf nnf ,^¾ i (請先閱讀背面之注意事項再填寫本頁) 經濟部中夬標準局員工消費合作社印裝 A7 ___:_--~~— 五、發明説明(& ) 只有一定的功效,其與用於細菌的方法相同,乃均句地攝 入穗定同位素,如13c或13C及15N作為相似物。不過, 細菌可於簡單的葡萄糖及鹽類混合物中生長’而哺乳類及 昆蟲细胞,除了葡萄糖之外,尚需所有的必須胺基酸以供 生長。例如,為了由哺乳動物細胞獲得完全由13c及/或 1 s N所標示的蛋白質,則所有的必須胺基酸都要存在,且 均需完全地Μ 13 C且/或1 5 N所標示。 —種產生經同&素標示培養基的理論方法是使用經同位 素槱示蛋白質的水解物。不幸的是,將蛋白質水解為組成 胺基酸~時,也同時生成副產物,其對哺乳動物细胞有毒性 。使用未經純化的水解物*將導致细胞的快速死亡。更甚 者,傳統的水解步驟將破壞某些必須胺基酸*而目前,避 此類破壞的方法常引發毒性。另一方面*已知分離及鈍化 單一胺基酸的技術。例如,LeMaster及其同事發表了一篇 報告(An^l. Biochem., 1_2_2_,218 (1982)),其敘述了純 化及胺基酸的方法。其只需少於5個管柱層析純化 步驟,而且雖無法分離出完全標示的半胱胺酸及麩醯胺, ---其獲得的色胺酸為”不穩定”的。上述三種胺基酸均為大部 份作為生產重姐蛋白質宿主之哺乳動物及昆蟲细胞生長所 需。更甚者,此步驟利用六氫吡啶作為引子,使胺基酸由 製備型層析管柱中沖提出。六氮%陡已知為具高毒性,且 為經管制的物質。因此,純化單一胺基酸的步驟為複雜, 費時*且低產率,因此,不夠經濟。因此,雖.然有些i3C 且/或1 5 N胺基酸可購得,但只有少量,大多數均非如此 - 8 - 本紙浪尺度適用中國國家標準(CNS )夕4規格(210X297公釐) 一 83. 3. 10,000 (請先閱讀背面之注意事項再填寫本頁)The consumer cooperation of the Central Economic and Technical Bureau of the Ministry of Economic Affairs of the People's Republic of China Du printed A7 B7 5. The invention description (Γ) states that, after being properly folded and interactively bonded with a disulfide bond *, it can be connected to oligosaccharide branches or can be hydrolyzed by proteins After excision, an active state is generated. Proteins produced by bacteria or yeasts generally do not possess the biological activity of proteins produced by mammalian cells. In fact, in some cases * mammalian proteins cannot be produced by bacteria. For the above reasons, in the mid-1980s, the biotechnology industry will produce recombinant therapeutic proteins, such as histone cytosinogen activating factor 'factor vm: c * erythropoietin, etc., from bacterial performance to mammalian performance. Some For mammalian cell proteins, the genes to be explored for the molecular part are cloned into bacteria and allowed to grow on the isotopically labeled medium Φ, and the isotopically labeled fragments are obtained for KHMR analysis. Similarly, only molecules that can be expressed in bacteria can be used for discussion. (E.q. See Driscoll, P.C., et al., Nature, 353, October 24, 199 1). Due to the lack of post-translational modifications in the bacterial expression system, the resulting molecule to be inspected lacks this post-translational modification, such as glycosylation etc., and, similarly, one suspects the value of the resulting structure. As with X-ray crystallography, it is constantly questioning the value of the structure of the resulting protein fragments. -------- At present, mammalian cells and insect cells have been developed as host-carrier systems. Mammalian cell lines, such as Chinese golden rat ovary (CH0) cells, COS cells, and insect cell lines, such as SD nd opp ΓΑ · cell lines SF9 and SF 21 (Luckow, Vi \. And Summers, MD, Biot p. h η n 1 ngv. g_47-55 (1988)) have all been found to post-translationally modify the produced mammalian proteins to make them similar to natural proteins. Use NMR to study proteins produced by mammalian cells and insect cells. This paper is sized to the Chinese National Standard (CNS) _A4 (210X 297 mm) 83.3.! 0, 〇〇〇〇nn n ^ n nflfl — m ^ i Km ^ \\ T / · t ^ itf nnf, ^ ¾ i (Please read the precautions on the back before filling this page) Printed by the Consumers' Cooperative of the China Standards Bureau, Ministry of Economic Affairs, printed A7 ___: _-- ~~ — V. Description of the invention (&Amp;) It has only a certain effect, which is the same as the method used for bacteria, but it takes the isotopes such as 13c or 13C and 15N as analogs. However, bacteria can grow in a simple mixture of glucose and salt, and mammalian and insect cells require all amino acids other than glucose for growth. For example, in order to obtain a protein completely labeled by 13c and / or 1 s N from mammalian cells, all necessary amino acids must be present, and all must be completely labeled by 13 C and / or 15 N. A theoretical method for producing isotope-labeled media is to use isotope-labeled protein hydrolysates. Unfortunately, when hydrolyzing proteins to form amino acids, by-products are also formed, which are toxic to mammalian cells. Use of unpurified hydrolysate * will result in rapid cell death. What's more, traditional hydrolysis steps will destroy certain essential amino acids *, and currently, methods to avoid such damage often cause toxicity. On the other hand * techniques are known for separating and deactivating a single amino acid. For example, LeMaster and colleagues published a report (An ^ l. Biochem., 1_2_2_, 218 (1982)), which describes methods of purification and amino acids. It only requires less than 5 column chromatography purification steps, and although fully labeled cysteine and glutamine cannot be separated, the tryptophan obtained is "unstable". The three amino acids mentioned above are all required for the growth of mammalian and insect cells that serve as hosts for the production of heavy protein. Furthermore, this step uses hexahydropyridine as a primer, so that the amino acid is extracted from the preparative chromatography column. Hexazine is known to be highly toxic and a regulated substance. Therefore, the steps for purifying a single amino acid are complicated, time consuming *, and low yields, and therefore, are not economical. Therefore, although some i3C and / or 1 5 N amino acids are commercially available, there are only a few, and most of them are not.-8-This paper applies the Chinese National Standard (CNS) Standard 4 (210X297 mm) I 83. 3. 10,000 (Please read the notes on the back before filling this page)

經濟部中央標準局員工消費合作社印装 A7 B7 五、發明説明(77) 最近,Fesik及其同僚發表一種方法,其可用以生產由 哺乳動物细朐所得的經同位素標示蛋白質,其用於N M R结 構研討(B i ο n h ρ. m ί s t. r V . 3 1 . Ho· 51,12713, (1992))。 其於色胺及眯唑存在下,K甲碩酸水解經同位素標示的藻 顆及細菌蛋白質。後面的試劑乃作為”自殺鹼”的目的, Μ分別減少色胺酸及織胺酸被破壞。將水解產物Μ LeMaster及其同僚所描述的步驟進行純化;即,將水解產 物加入為H +型態陽離子交換樹脂中,且Μ六氫吡啶將胺 基Κ 一群方式沖提出。將此含有胺基酸部份相混,揮發至 乾燿,再溶於水中,Μ氫氧化納調整出至11.5,將所得的 溶液揮發至出維持固定,”表示不再有氨或六氫吡啶被去 除”。將此胺基酸Κ分子量為500的濾膜過滹,去除不純 物後,將其冷凍乾燥。作者並未指出所得的胺基酸可直接 使用U . e .於高pH值)*或是Μ酸將溶液的出值中和。 Fesik等人的工作,雖然表現了技術的進步,但仍無法提 供可用於NMR結構訂定的經完全標示的哺乳動物细胞表現 蛋白質。首先,所使用的水解條件破壞了天門冬醯胺,麩 •-醸胺及半胱胺酸,且僅殘留”極少量”的色胺酸02715頁, 表1)。第二,此步驟採用六氫吡啶為沖提液,如上述,其 具有毒性且為經管制物質。第三,LeMaster於其原始報告 中指出,”自殺鹼”之一,眯唑將與胺基酸白胺酸一起共沖 提出。LeMaster利用對白胺酸行結晶反應來去除蹄哩。 I7 e s i k等人則未提及此一'結晶步驟,且事實上,由於於 Fes ik等人的工作中,單一的胺基酸並未被分離,因此, 不可能進行此一步驟。 本紙張尺度適用中國國家標準(CNS )..A4規格(210X297公釐) 83. 3. 10,000 (請先閱讀背面之注意事項再填寫本頁) 、-» 1& 經濟部中央標準局員工消費合作社印裝 A7 B7 五、發明説明(及). F e s i k等人描述利用提高溶液的出值至11 . 5後’以加熱 揮發至pH值趨於穩定後,來去除六氪吡啶沖提液。於此出 值,尤其在去除六氫吡啶的高溫下(沸點106 °c) ’極可能 產生消旋性反應且/或使胺基酸受六氫吡啶/氫氧化納混 合物侵犯生成親核性反應。這類反應將減少混合物中可用 胺基酸的量,且降低其作為生長培養基的效用。更甚者, 作者自己亦了解,加熱揮發步驟將於穩定的溶液pH值指出 ”氨或六氫吡啶d完全被去除”時停止。因此,胺基酸混 合物中可能含有少量的高毒性的六氫吡啶。 更重要的是,其缺乏天門冬醯胺,麩醯胺,半胱胺酸, 且僅含”極少量”色胺酸(1 27 1 5頁,表1 )。雖然,缺乏天 門冬_胺於Fesik等人所檢試的糸統中並非重要,但,麩 醱胺對细胞生長極具有重要性(12716頁,Fig 2)。作者 提供了利用麩醯胺酸來合成麩醯胺的酵素方法。因此,若 要使此反應具有價值,必須具有經適當標示的麩醯胺酸。 如作者所指*可購得13C ,1SN標示的麩醯胺酸。但是, 經三重標示的麩醯胺酸卻無法購得。 --------相對應的,Fesik並未提供任何製備經標示半胱胺酸的 方法。僅可購得1SN標示的半胱胺酸。無法取得雙重標示 的13C ,半胱胺酸或三重標示的2H, 13C ,15N-半胱 胺酸。因此,由Fes ik及其同僚所採用的方法,除了簡單 的15N -標示,無法獲得經完金標示的產物,此因半胱胺酸 及色胺酸無法被適當地標示。更甚者,經由细胞代謝,可 將不正確標示的半胱胺酸轉至其他胺基酸,而造成同位素 遺漏。 -10 - 本紙張尺度適用中國國家標準(CNS )„Α4規格(210X297公釐) 83. 3. 10,000. (請先閱讀背面之注意事項再填寫本頁) ,裝. 、\=° Α7 Β7 五、發明説明(^) 原則上,產生經標示的半胱胺酸,包括三重標示的最簡 單方法*乃將有有機體於富含經適當標示之半胱胺酸培養 基中培養*且再由此有機體之蛋白質分離半胱胺酸。此有 機體與已知技術相似,且又包括紫硫菌,如 Phodopseudomonas soRroiries 及 c 3 d s ij 〗只 t p » 及其他高半 胱胺酸有機體,如L a p t n t h r i x d i s f; n d h 〇 r a及 Sc..faJ.z〇p.hy_LljLiii commune ,及經重組用M生產高半胱肢酸 蛋白質的細菌,如ATCC 31448 *及用Μ表規人類胰島素A 鍵之大腸桿菌。 半晄胺酸Μ水解方式,由蛋白質中分離而得。已知用K 水解蛋白質且不伴隨對半胱胺酸有破壞的唯一方法為丨)於 鹼性條件下水解(見 Okuda,Pr. Acad. Tokyo. Z_, 2 7 7 ) 及ί i ) K酵素水解。不幸的是,上述二種方法均不適於產 生經標示的半胱胺酸,尤其是經三重標示的。於鹼性條件 下水解*將造成所需之L-半胱胺酸行消旋性反懕,且亦造 成其他多種有用的,經同位素標示的胺基酸被破壞。酵素 水解易造成由酵素分解產物帶來同位素污染,尤其是長時 —間的水解反應。 於Fesik等人所用的混合物中,與半胱胺酸相伴的之” 極少量”的色胺酸,若不經由額外的添加,則不足以供應 細胞生長。(12715頁,表1 ; 12716頁,Fig 1及2)。雖 可購得15H -標示之色胺酸,但,,15N及三重標示者 卻無法獲得。因此,除了 標示之外,欲蔣色胺酸作為 添加劑,加入標示實驗中,將與缺乏經合適的標示半胱胺 酸相同而造成問題,亦即不完全的同位素標示。 ^ 11 - 本紙張尺度適用中國國家標準(CNS Μ4規格(210X 297公釐)A7 B7 printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (77) Recently, Fesik and his colleagues published a method that can be used to produce isotopically labeled proteins obtained from mammalian cells, which are used in NMR structures Research (B i ο nh ρ. M ί s t. R V. 3 1. Ho. 51, 12713, (1992)). In the presence of tryptamine and oxazole, K-formamic acid hydrolyzes algae and bacterial proteins labeled with isotopes. The latter reagents are used for the purpose of "suicide base". M reduces tryptophan and weaving acid respectively. The hydrolysate M LeMaster and his colleagues were purified according to the procedure described; that is, the hydrolysate was added to the H + -type cation exchange resin, and M hexahydropyridine was used to pour out the amino group K in a group. The amino acid-containing portion was mixed, evaporated to dryness, and then dissolved in water. The sodium hydroxide was adjusted to 11.5, and the resulting solution was evaporated to maintain a fixed state. "Means that there is no more ammonia or hexahydropyridine. Removed. " This amino acid K molecular weight 500 membrane filter was passed through a filter to remove impurities, and then freeze-dried. The author did not indicate that the resulting amino acid can be directly used at U.e. at high pH) * or M acid to neutralize the output of the solution. The work of Fesik et al., Although showing technological advances, has not been able to provide fully labeled mammalian cell expression proteins that can be used for NMR structure determination. First, the hydrolysis conditions used destroyed asparagine, glutamine, and cysteine, leaving only "very small amounts" of tryptophan on page 27715 (Table 1). Second, this step uses hexahydropyridine as the eluent. As mentioned above, it is toxic and a regulated substance. Third, LeMaster stated in its original report that one of the "suicide bases", oxazole will be co-produced with the amino acid leucine. LeMaster uses a crystallization reaction with leucine to remove hoofs. I7 e s ik et al did not mention this' crystallization step, and in fact, it was not possible to perform this step because a single amino acid was not isolated in the work of Fes ik et al. This paper size applies to Chinese National Standards (CNS) .. A4 size (210X297 mm) 83. 3. 10,000 (Please read the notes on the back before filling out this page),-»1 & Employees' Cooperatives, Central Bureau of Standards, Ministry of Economic Affairs Printing A7 B7 V. Description of the invention (and). Fesik et al. Described the use of increasing the output value of the solution to 11.5 'after heating to volatilize until the pH value stabilized, to remove the hexapyridine eluate. Here, especially at the high temperature (boiling point 106 ° c) at which hexahydropyridine is removed, it is very likely that a racemic reaction will occur and / or the amino acid will be violated by the hexahydropyridine / sodium hydroxide mixture to form a nucleophilic reaction. . Such reactions will reduce the amount of available amino acids in the mixture and reduce their effectiveness as a growth medium. What's more, the author himself understands that the heating volatilization step will stop when the stable solution pH indicates that "ammonia or hexahydropyridine d is completely removed". Therefore, the amino acid mixture may contain a small amount of highly toxic hexahydropyridine. More importantly, it lacks asparagine, glutamine, and cysteine, and contains only "very small amounts" of tryptophan (page 1 27 1 5; Table 1). Although the lack of asparagine is not important in the system tested by Fesik et al., Glutamine is extremely important for cell growth (12716, Fig. 2). The authors provide an enzyme method for synthesizing glutamine with glutamic acid. Therefore, for this reaction to be valuable, it must have appropriately labeled glutamine. As the author points out, 13C, 1SN labeled glutamic acid is available. However, triple labeled glutamic acid is not available. -------- Correspondingly, Fesik does not provide any method for preparing labeled cysteine. Only 1SN labeled cysteine is commercially available. Cannot get double labeled 13C, cysteine or triple labeled 2H, 13C, 15N-cysteine. Therefore, the method adopted by Fesik and his colleagues, except for the simple 15N-labeling, cannot obtain the finished product, because cysteine and tryptophan cannot be properly labeled. What's more, through cell metabolism, incorrectly labeled cysteine can be transferred to other amino acids, resulting in missed isotopes. -10-This paper size applies Chinese National Standard (CNS), Α4 size (210X297mm) 83. 3. 10,000. (Please read the precautions on the back before filling this page), and install. 、 \ = ° Α7 Β7 5 2. Description of the invention (^) In principle, the easiest way to produce labeled cysteine, including triple labeling *, is to cultivate an organism in a suitably labeled cysteine-rich medium *, and from this organism The protein is isolated from cysteine. This organism is similar to the known technology and includes purple sulfur bacteria such as Phodopseudomonas soRroiries and c 3 ds ij only tp »and other homocysteine organisms such as L aptnthrixdisf; ndh 〇 ra and Sc..faJ.zop.hy_LljLiii commune, and bacteria that produce homocysteic acid protein by using recombinant M, such as ATCC 31448 * and E. coli that regulates the human insulin A bond by M. Hemicarbine Μ hydrolysis method, obtained from protein separation. The only method known to hydrolyze protein with K without concomitant damage to cysteine is hydrolysis under alkaline conditions (see Okuda, Pr. Acad. Tokyo. Z_ , 2 7 7) And ί i) K enzyme hydrolysis. Unfortunately, neither of the above two methods is suitable for producing labeled cysteine, especially triple labeling. Hydrolysis under alkaline conditions * will result in the required L-half Cysteine is a racemic reaction, and it also causes a variety of other useful, isotope-labeled amino acids to be destroyed. Enzymatic hydrolysis can easily cause isotope pollution caused by enzyme decomposition products, especially long-term hydrolysis reactions. In the mixture used by Fesik et al., The "very small amount" of tryptophan accompanying cysteine is not sufficient for cell growth without additional addition. (Page 12715, Table 1; Page 12716 (Fig 1 and 2). Although 15H-labeled tryptophan can be purchased, 15N and triple labeling are not available. Therefore, in addition to labeling, tryptophan is used as an additive in the labeling experiment. , Will cause the same problem as the lack of proper labeling of cysteine, that is, incomplete isotope labeling. ^ 11-This paper size applies to the Chinese national standard (CNS M4 specification (210X 297 mm))

經濟部中央標準局員工消費合作社印裝 83. 3. 10,000 (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 83. 3. 10,000 (Please read the precautions on the back before filling this page)

經濟部中央橾準局員工消費合作杜印製 A7 B7 五、發明説明(/ ο) 因此’由Fesik及其同僚所提供的方法,僅於標示 蛋白質中’可得完整的經同位素標示之蛋白質。雖然此法 為更高等的方法,但,如前述,已可購得15N -標示胺基酸 。於13c ’ 15卜標示實驗中,半胱胺酸及色胺酸無法被完 全標示*而於2H-標示實驗及三重標示賁驗中,半胱胺酸 *色胺酸及麩醯胺無法被正確的標示。 使用蛋白質水解步驟,製備哺乳動物細胞培養基的另一 個缺點為,於水I#條件下,於起始蛋白質中出現的胺基酸 •黎醯胺及天門冬醯胺均可分別被轉成麩醯胺酸及天門冬 酸。大部份哺乳動物细胞培養基含有少量的麩醯胺酸及一 部份的麩醯胺。此培養基乃發展來產生具適當表現的哺乳 動物細胞*即為其细胞存活性及生產性。事實上,幾乎所 有的用Μ生產作NMR分析用蛋白質的哺乳動物细胞,均於 含少量麩醯胺酸及高量麩醯胺的培養基中培養。 為了能適用於最廣範圍的细胞株,因此,用Κ作哺乳動 物細胞同位素標示蛋白質之培養基,其較佳含有少量的麩 醯胺酸及大部份的麩醯胺。相似地*培養基中較佳含有大 一——部份的天門冬醯胺*而幾乎不含天門冬酸。 因此,需要一種方法,用Μ專一性地由胺基酸混合物中 去除麩藤胺酸且/或天門冬酸,而不改變其他存在胺基酸 的比例,且將所得的麩醯胺酸及/或天門冬酸轉化為經適 當標示的麩醯胺及/或天門冬醯胺,再將所得的麩醯胺及 /或天門冬醯胺加入胺基酸混合物中。 目前,仍無特定的方法可具專一性地將麩醯胺酸由胺基 酸涓合物中去除。已發表利用酵素方法將麩醯胺酸轉為麩 -12 - l·—,---.—G裝— (請先閱讀背面之注意事項再填寫本頁) 訂 ..—@--- 本紙張尺度適用中國國家標準(CNS 規格(210X297公釐) 83. 3. 10,000 經濟部中央標隼局員工消費合作杜印裝 A7 I 1 ____‘ _B7__ 五、發明説明(//). 臨胺(Fesik, et al., Biochemistry. 31 (51), 12713 (1992))。不幸的是,此反應極慢(3-4天),且伴隨著酵 素的裂解,會產生天然胺基酸的污染。更甚者,於胺基酸 的三重標示,i . e . 2 Η的部份標示及完全地Μ 1 3 C及1 s N 標示,原子的出現可減緩經2H標示麩釀胺酸轉化為麩醯 胺的酵素反應,且又加上2H同位素效應。最後,目前並無 將天門冬規轉為天門冬醯胺的酵素方法。Printed by the staff of the Central Economic and Technical Bureau of the Ministry of Economic Affairs of the People's Republic of China Du printed A7 B7 V. Description of the invention (/ ο) Therefore, the method provided by Fesik and his colleagues can only obtain the complete isotope-labeled protein among the labeled proteins. Although this method is a more advanced method, as mentioned above, 15N-labeled amino acids are already commercially available. In the 13c '15b labeling experiment, cysteine and tryptophan cannot be fully labeled *, and in the 2H-labeling experiment and triple labeling test, the cysteine * tryptophan and glutamine cannot be correctly labeled Mark. Another disadvantage of using the proteolytic step to prepare mammalian cell culture media is that under the conditions of water I #, the amino acids • lipidamine and asparagine that appear in the starting protein can be converted into bran respectively. Amino acid and aspartic acid. Most mammalian cell culture media contain a small amount of glutamine and a portion of glutamine. This medium has been developed to produce mammalian cells with appropriate performance *, ie its cell viability and productivity. In fact, almost all mammalian cells produced by using M as a protein for NMR analysis are cultured in a medium containing a small amount of glutamic acid and a high amount of glutamine. In order to be applicable to the widest range of cell lines, K is used as a culture medium for mammalian cell isotope-labeled proteins, which preferably contains a small amount of glutamic acid and most of glutamine. Similarly, it is preferred that the culture medium contains a large part of aspartame * and almost no aspartic acid. Therefore, there is a need for a method to specifically remove glutamic acid and / or aspartic acid from an amino acid mixture without changing the proportion of other amino acids present, and to obtain the obtained glutamic acid and / Or aspartic acid is converted to appropriately labeled glutamine and / or aspartamine, and the resulting glutamine and / or aspartamine is added to the amino acid mixture. Currently, there is no specific method to specifically remove glutamic acid from amino acid trickle. Has been published to use enzyme method to convert glutamic acid to gluten-12-l · —, ---.— G Pack— (Please read the precautions on the back before filling this page) Order .. — @ --- 本Paper size applies to Chinese national standards (CNS specifications (210X297 mm) 83. 3. 10,000 Consumers 'cooperation with the Central Bureau of Standards of the Ministry of Economic Affairs Du printed A7 I 1 ____' _B7__ V. Description of the invention (//). Linamine (Fesik , Et al., Biochemistry. 31 (51), 12713 (1992)). Unfortunately, this reaction is extremely slow (3-4 days), and accompanied by enzyme cleavage, it will produce natural amino acid pollution. More In addition, the triple labeling of amino acids, the partial labeling of i.e. 2 及 and the complete M 1 3 C and 1 s N labeling, the occurrence of atoms can slow down the conversion of glutamic acid to gluten by the 2H label. The enzyme reaction of amines, coupled with the 2H isotope effect. Finally, there is currently no enzyme method to convert asparagus to asparagine.

目前,由Hsu及Armitage發表了一篇報告 (Biochemistry· 3丄(51 ) 12778 (1992)),其有關於 K NMR訂定免疫抑制藥物CyCI〇sP〇rin A與其受體 cyclophilin相结合之结構。其Μ不具NMR活性之同位素 2Η標示cyclophiHn *且以細菌來產生。他們因此可研討 cyclosporin A/cyclophilin複合體的结構*而不受來自 cyclophilin訊息的干擾。由於哺乳動物配合子/受體相 互反應之重要性,因此,需要將哺乳動物细胞蛋白質,尤 其是受體,Μ 2 Η作完全標示。而可達到此目標之經標示哺 乳動物细胞營養基仍無法取得。 一-根據上述理由,為了 一般結構-功能研究及理性藥物設 計,需要經完全標示組合物及方法,其用Κ訂定哺乳動物 细胞蛋白質,及蛋白質複合物之三維结構。因此,其需要 產生Κ穩定同位素經完全標示之哺乳動物綑胞蛋白質。 發阴摘酉 根據本發明,訂定蛋白質三維结構的步驟,包括⑻於蛋 白質-生產條件下,將可產生欲探討蛋白質之哺乳動物或 昆蟲细胞於營養性培養基中生長,此培養基中含有所有生 -13 - 本紙張尺度適用中國國家標隼(CNS )._Λ4規格(210X297公釐〉 83.3.10,000 (請先閱讀背面之注意事項再填寫本頁)At present, a report (Biochemistry · 3 丄 (51) 12778 (1992)) published by Hsu and Armitage on the structure of the binding of the immunosuppressive drug CyCI0Sporin A to cyclophilin by K NMR. The isotope 2Η, which has no NMR activity, is labeled cyclophiHn * and is produced by bacteria. They can therefore study the structure of the cyclosporin A / cyclophilin complex * without interference from cyclophilin messages. Due to the importance of mammalian partner / receptor interactions, mammalian cell proteins, especially the receptor, M 2 Η, need to be fully labeled. Nutrient bases of labeled mammalian cells that can achieve this goal are still not available. 1- For the above reasons, for general structure-function research and rational drug design, a fully labeled composition and method is required, which uses K to define the three-dimensional structure of mammalian cell proteins and protein complexes. Therefore, it is necessary to produce mammalian cell cytosolic proteins with fully stabilized K isotopes. Hair removal according to the present invention. The step of determining the three-dimensional structure of a protein according to the present invention includes growing mammalian or insect cells capable of producing a protein to be explored in a nutrient medium under protein-producing conditions. -13-This paper size applies to China National Standards (CNS). _Λ4 size (210X297 mm> 83.3.10,000 (Please read the precautions on the back before filling this page)

經濟部中央標隼局員工消費合作社印裝 A7 I l · _B7 五、發明説明((>). 長用之胺基酸及碳水化合物來源,必須礦物值及生長因子 ,其中,用於供细胞合成蛋白質之胺基酸及其他基質,均 Μ具HMR活性之同位素來標示;(b)由營養性培養基中分離 經標示蛋白質且Μ其經標示態及<c)將此蛋白質作NMR光譜 分析Κ訂定其三維结構。 本發明的其他方面,訂定蛋白質三維结構方法之步驟, 包括⑻於奪白質-生產條件下,將可產生欲探討蛋白質之 哺乳動物或昆蟲i胞於營養性培養基中生長,此培養基含 有所有生長用之胺基酸及碳水化合物來源*必須礦物值及 生長因子,其中營養性.培養基中之所有胺基酸及碳水化合 物來源之碳原子為13c ; (b>由營養性培養基中分離經標示 蛋白質且K其經標示態及⑵將此蛋白質作NMR光譜分析Μ 訂定其三維结構。 本發明的另一方面,訂定蛋白質三維结構方法之步驟, 包括⑻於蛋白質-生產條件下,將可產生欲探討蛋白質之 哺乳動物或昆蟲細胞於營養性培養基中生長,此培養基含 有所有生長用之胺基酸及碳水化合物來源,必須礦物質及 ------唑長因子,其中營養性培養基中之所有胺基酸及碳水化合 物來源之碳原子為13C ,且其胺基酸之氮原子為lsN ;<b) 由營養性培養基中分離經標示蛋白質*且Μ其經標示態且 將此蛋白質作NMR光譜分析Κ訂定其三維结構。 另一方面,本發明乃是訂定第一種分子的三維结構,且 將其與第二種分子生成複合體,其中這二種分子,至少有 一種為蛋白質。此方法乃將其中第一種分子K具NMR活性 之穗定同位素來標示,且Μ重氫標示第二種分子*且使第 .<〇» -14 - 本紙張尺度適用中國國家標準(CNS )/Α4規格(210Χ297公釐)_ ~~~83. 3. 10,000 (請先閔讀背面之注意事頊再填寫本頁)A7 I l · _B7 printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention ((>). Sources of amino acids and carbohydrates for long-term use must have mineral values and growth factors, of which are used for cells Synthetic amino acids and other substrates are labeled with HMR-active isotopes; (b) the labeled protein is separated from the nutrient medium and its labeled state and < c) the protein is analyzed by NMR spectroscopy K defines its three-dimensional structure. In another aspect of the present invention, the steps of the method for determining the three-dimensional structure of a protein include growing mammalian or insect cells capable of producing a protein to be explored in a nutrient medium under conditions of white matter-production, and the medium contains all growth Sources of amino acids and carbohydrates * must have mineral values and growth factors, which are nutritional. The carbon atoms of all amino acids and carbohydrate sources in the medium are 13c; (b > Isolate the labeled protein from the nutrient medium Moreover, the three-dimensional structure of the protein is determined by the labeled state and the NMR spectrum analysis of the protein. In another aspect of the present invention, the steps of the method for determining the three-dimensional structure of the protein, including the step of protein-production conditions, can produce To explore the growth of protein mammalian or insect cells in a nutrient medium, this medium contains all amino acids and carbohydrate sources for growth, must be minerals and azole growth factor, in which the nutrient medium The carbon atom of all amino acids and carbohydrate sources is 13C, and the nitrogen atom of its amino acid is lsN; < b) by The labeled protein * is isolated from the nutrient medium and its labeled state is analyzed. This protein is subjected to NMR spectral analysis to determine its three-dimensional structure. On the other hand, the present invention is to define the three-dimensional structure of the first molecule and form a complex with the second molecule, at least one of which is a protein. This method is to label the first molecule K with NMR-active isotopes, and M deuterium to label the second molecule *, and make the first. ≪ 〇 »-14-This paper size applies Chinese National Standard (CNS ) / Α4 specifications (210 × 297 mm) _ ~~~ 83. 3. 10,000 (Please read the notes on the back first, and then fill out this page)

A7 B7 五、發明説明(1^7) 〜種及第二種分子生成複合物,再將此複合物作NMR光譜 分析* K訂定第一種分子之三維结構。 本發明之另一方面乃是一種新穎的營養培養基,其可供 應哺乳動物或昆蟲细胞生長*其含有细胞生長所需的所有 胺基酸,碳水化合物來源,及必須礦物質及生長因子,其 中*凡用於细胞合成蛋白質用之胺基酸及其他基質,均Μ 13C或Μ Ύ及來標示。 本發明尚包括生產經完全同位素標示之胺基酸混合物的 方法,其包括⑻將微生物置於營養性培養基中生長*其中 凡作為蛋白質生合成受質之碳源均為13 C ; (b>由此微生物 培養液中回收蛋白質分液;(〇於硫氫基選原劑存在下,K • _性,非氧化性條件水解蛋白質* K產生胺基酸混合物; @將此未經純化的胺基酸混合物加入陽離子交換樹脂,使 產生部份純化的胺基酸混合物;®再將此部份鈍化的胺基 酸混合物加入陰離子交換樹脂中,使產生經純化的胺基酸 混合物;(f>加人足.量的經1 3C-標示的半胱胺酸至經純化的 胺基酸混合物中,使足κ供應哺乳動物及昆蟲细胞行蛋白 質生產。上述方法也可用生產經,15M-雙重標示的胺 基酸混合物,或經2H,13C ,15N-三重標示的胺基酸,或 經濟部中央標準局員工消費合作社印製 產生經2H-標示的胺基酸混合物。 本發明更提供了分別將麩醯胺酸及天門冬酸轉成麩醯胺 及天門冬醯胺的方法,且提供經同位素標示的哺乳動物细 胞培養基,其含有少量的麩醯肢酸及高量的麩醯胺,且其 中具選擇性地含有極少量或不含天門冬酸及高量的夭門冬 藤胺。尤其,本發明更提供了具專一性的方法,可將麩醯 -15 - 83. 3. 10,000 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS LA4規格(210X297公釐) A7A7 B7 V. Description of the invention (1 ^ 7) ~ The first and second molecules form a complex, and this complex is then subjected to NMR spectral analysis * K defines the three-dimensional structure of the first molecule. Another aspect of the invention is a novel nutrient medium that can supply mammalian or insect cell growth * which contains all the amino acids, carbohydrate sources, and essential minerals and growth factors required for cell growth, of which * All amino acids and other matrices used in the synthesis of proteins by cells are marked with M 13C or M Ύ. The present invention also includes a method for producing a fully isotopically labeled amino acid mixture, which comprises: 微生物 growing microorganisms in a nutrient medium to grow * wherein all carbon sources used as protein biosynthetic substrates are 13 C; (b > by The protein was recovered from this microbial culture liquid; (0 in the presence of sulfhydryl-based selective agent, K • _, non-oxidative conditions hydrolyze the protein * K to produce an amino acid mixture; @This unpurified amino group The acid mixture is added to the cation exchange resin to produce a partially purified amino acid mixture; and then the partially deactivated amino acid mixture is added to the anion exchange resin to produce a purified amino acid mixture; (f > Human foot. Amount of 13C-labeled cysteine into the purified amino acid mixture, so that foot κ can be supplied to mammalian and insect cells for protein production. The above method can also be used to produce, 15M-double labeled Amino acid mixtures, or 2H, 13C, 15N-triple labeled amino acids, or printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs to produce 2H-labeled amino acid mixtures. It also provides a method for converting glutamic acid and aspartic acid to glutamine and aspartic acid, respectively, and provides an isotope-labeled mammalian cell culture medium, which contains a small amount of glutamic acid and a high amount of bran. Amidine, and it optionally contains very little or no aspartic acid and a high amount of aspartamine. In particular, the present invention provides a specific method, which can be bran-15-83. 3. 10,000 (Please read the notes on the back before filling in this page) This paper size applies to Chinese national standard (CNS LA4 specification (210X297 mm) A7

五、發明説明(/J) 經濟部中央標準局員工消費合作社印裝 胺酸由上述方法所產生的胺基酸混合物中除去,及κ化學 方法將麩_胺酸轉為麩醯胺。利用相同的步驟,可κ化學 方法由天門冬酸合成天門冬醢胺。此法不會因同位素標示. ,包括2H’而影梁其效率。 本發明更提供將經同位素標示的半胱胺酸,由經標示的 多胜呔及胺基酸混合物中分離的方法。此法可用來產生K ,1 3c及1 5N作任何姐合標示的半胱胺酸。其中 '也包括 加入經標示半胱齒酸的胺基酸混合物。 發明肉兹 本窺明提供測定由哺乳動物或昆蟲细胞所生產蛋白質之 三維結構的方法。由於將哺乳動物或昆蟲细胞作為重組 DNA的宿主,其可產生與其天然三維结構相似或相同的蛋 白質,本發明因此可提供技術,用K探討具生物活性蛋白 質*其結構-功能之相互關係。其步驟包括,將哺乳動物 綑胞株於營養性培養基中培養,其中所有的胺基酸均完全 地Μ —或多種具N MR活性的同位素所標示。本發明坷使蛋 白質被完全地K13C ,或或其二者,甚至M2H,13C 及1SH作三重標示。本發明更提供方法,使蛋白質僅被 作完全標示,使其不具NMR活性。後者尤其於探討複合 物分子结構時更為有效,如,激素-受體複合物。使複合 物中另一半不具活性,而針對其標示K 一或多種具 •NMR活性之同位素,則可研討其结構。 本發明之哺乳動物細胞株營養性培養基中,含有衍生自 微生物之羥同位素標示胺基酸。已知哺乳動物及昆蟲细胞 之營養性培養基。同時也了解細胞生長所需,因此合成培 -16- (請先閲讀背面之注意事項再填寫本頁) 訂 ίφ 本紙張尺度適用中國國家標準(CNS )/Α4規格(210Χ297公釐) 83. 3. 10,000 經濟部中央標準局員工消費合作社印製 A7 I 1 .__B7___— 五、發明説明(ί。 養基中可包拮可吸收的碳水化合物來源,必須礦物質及生 長因子:而上述均可購得。上述培養基中*有些更含有少 量的焦葡萄酸。若需要此類培養基,所加入的焦葡萄酸較 佳於經適當的標示狀態。可購得經同位素標示之焦葡萄酸 。亦可購得不含血清的培養基。本發明中》最好使用不含 血清的培養基*用Κ可獲得較純的經標示蛋白質作N MR分 析。將經標示蛋白質,由不含血清之哺乳動物或昆^细胞 培養基中純化的古法*其可利用任何已知的技術。見 Deutscher, H.P., Guide t. ο Ρ r ο t ft ί η Purfications. Η θ t h n d s in Rnzvmo丨〇gv. V ο I . 18 2 (19 9 0) ° 將蛋白質作完全標示,其可利用加入經標示的所有必須 胺基酸及其他任何用來作蛋白質合成的受質。如此處所用 ,蛋白質合成包括釀蛋白中碳水化合物支鏈的生合成。 本發明提供得到胺基酸混合物的簡易方法。此法簡單易 行,對使用者無害,同時可放大,尤其於加入大量經標示 培養基K得到足量的蛋白質作HMR分析時更重要。 產生經標示胺基酸混合物的方法,乃根據胺基酸為一組 --------同時具有正電荷及負電荷的化合物。其此可由中性化合 物,或僅具正雷荷或僅具負電荷的化合物中被分離出,其 可藉吸附,或由酸性及鹼性離子交換樹脂中沖提。 此處所指之蛋白質經”實質上標示”或”實質上所有”分子 中某一特別元素的原子為同位素態表示,此分子已被足量 的同位素所標示,由此可得到有意義的MMR光譜數據。對 具NMR活性的同位素而言,如及1SN足量的程度表示 可由NMR光譜數據中推演出其三維结構。一般而言,所給 _ - 17 - 本紙張尺度適用中國國家標準(CNS LA4規格(210X297公釐) 83. 3. 10,000 (請先閱讀背面之注意事項再填寫本頁)V. Description of the invention (/ J) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Amino acid is removed from the amino acid mixture produced by the above method, and the κ chemical method is used to convert glutamic acid to glutamine. Using the same procedure, aspartic acid can be synthesized from aspartic acid by the κ chemical method. This method will not affect its efficiency due to the isotope labeling, including 2H ’. The present invention further provides a method for isolating cysteine labeled with an isotope from a labeled docetaxel and an amino acid mixture. This method can be used to produce K, 1 3c and 1 5N cysteine as any sister label. This also includes the addition of amino acid mixtures labeled with cysteic acid. The invention provides a method for determining the three-dimensional structure of a protein produced by mammalian or insect cells. Since mammalian or insect cells are used as hosts for recombinant DNA, they can produce proteins that are similar to or the same as their natural three-dimensional structure. Therefore, the present invention can provide a technique to use K to explore the biological-active protein * structure-function relationship. The steps include culturing mammalian hermaphrodites in a nutrient medium, in which all amino acids are completely labeled with M—or multiple isotopes with NMR activity. In the present invention, the protein is triple-labeled with K13C, or both, even M2H, 13C and 1SH. The present invention further provides a method whereby the protein is only fully labeled, making it non-NMR active. The latter is particularly effective when exploring the molecular structure of complexes, such as hormone-receptor complexes. Make the other half of the complex inactive, and for K, one or more isotopes with NMR activity can be studied for its structure. The mammalian cell line nutrient medium of the present invention contains a hydroxyisotope-labeled amino acid derived from a microorganism. Nutrient media for mammalian and insect cells are known. At the same time, I also understand the requirements for cell growth, so synthetic culture-16- (Please read the notes on the back before filling in this page) Order φφ This paper size applies to Chinese National Standard (CNS) / Α4 (210 × 297 mm) 83.3 . 10,000 Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. Yes. Some of the above-mentioned culture mediums * contain a small amount of pyrograpeic acid. If such a culture medium is required, the pyrograpeic acid added is preferably in an appropriately labeled state. Isotope-labeled pyrograpeic acid is available. Can also be purchased In the present invention, a serum-free medium is best used. In the present invention, it is best to use a serum-free medium. * A relatively pure labeled protein can be obtained by K for N MR analysis. The labeled protein is obtained from a mammal or a serum-free mammal. The ancient method of purification in cell culture media * can use any known technique. See Deutscher, HP, Guide t. Ο Ρ r ο t ft ί η Purfications. Η θ thnds in Rnzvmo 丨 〇gv. V ο I. 18 2 (19 9 0) ° The protein is fully labeled, which can be used by adding all the labeled amino acids and any other substrates used for protein synthesis. As used herein, protein synthesis includes brewing protein Biosynthesis of carbohydrate branches. The present invention provides a simple method for obtaining amino acid mixtures. This method is simple and easy to do, harmless to the user, and can be scaled up, especially by adding a large amount of labeled medium K to obtain a sufficient amount of protein for HMR The analysis is even more important. The method of generating a labeled amino acid mixture is based on a group of amino acids that have both positive and negative charges. This can be neutral compounds, or only Compounds with a positive thunder charge or only a negative charge can be isolated, which can be extracted by adsorption, or extracted from acidic and basic ion exchange resins. The proteins referred to herein are "substantially marked" or "substantially all" "The atom of a particular element in the molecule is an isotope state, and the molecule has been labeled with a sufficient amount of isotopes, thereby obtaining meaningful MMR spectral data. For isotopes with NMR activity In general, if the degree of 1SN is sufficient, its three-dimensional structure can be deduced from the NMR spectral data. Generally speaking, the given paper size is applicable to the Chinese national standard (CNS LA4 specification (210X297 mm) 83 . 3. 10,000 (Please read the notes on the back before filling out this page)

經濟部中央標準局員工消費合作杜印製 Α7 Β7 五、發明説明(Μ ) 予的元素的95% Μ上的原子均可轉於所需的同位素態,較 佳的可高於98%。 對只有2Η而言,具足量程度則表示,經標示分子不產生 足Μ干擾與分析其相结合分子之NMR訊號。通常,其足量 程度高於約70%,較佳地,其高於約95%。 另外,2Η的足量程度亦包括加強/加強解析具NMR活性 之原子核,如1 Η,1 3 C及1 s Ν 。一般,此足量程度介於約,— 20% 至約 100 %。 胺基酸混合物起始物為經適當同位素標示之蛋白質水解 _ 物。根據本發明,起始蛋白質乃實質上M13C ,或13C及 15H ,或13C ,15N及至少部份2H,甚至只有2H所標示。 已有多種技術說明如何產生此蛋白質,包括將细菌經標示 之碳水化合物及鹽類中生長(Kay , et a 1 . , ajLEXsJ,將细 菌於蒲類水解物中生長(Chubb, R.T., et al·,Produced by the staff of the Central Bureau of Standards of the Ministry of Economic Affairs of the People's Republic of China. Α7 Β7 V. 95% of the elements given in the invention description (M) can be transferred to the required isotope state, and the better is more than 98%. For only 2%, a sufficient amount indicates that the labeled molecule does not generate sufficient NMR interference and analyze the NMR signal of the associated molecule. Usually, it is in a sufficient amount above about 70%, and preferably above about 95%. In addition, the sufficient amount of 2Η also includes strengthening / reinforcing the nucleus with NMR activity, such as 1Η, 1 3 C, and 1 s Ν. Generally, this level of sufficiency ranges from about 20% to about 100%. The amino acid mixture starting material is a proteolysate labeled with the appropriate isotope. According to the invention, the starting protein is essentially M13C, or 13C and 15H, or 13C, 15N and at least a portion of 2H, or even only 2H. A variety of techniques have been described to produce this protein, including growing bacteria in labeled carbohydrates and salts (Kay, et a1., AjLEXsJ, growing bacteria in hydroponics of pampas (Chubb, RT, et al · ,

Biochemistry. 30 . 7718 (1991))* 將酵母菌於藻類水解 物中生長(Powers, R., et ai., Biochemistry, 2J_, 43 34 (1992)),將细菌及酵母菌於經標示甲醇中生長(見 ------Moat, A.G.5, Foster, J . W . , Microbial Physiology. 2d Ed., John Wiley & Sons, Hew York (1988), p. 218),及將瞎光性藻類於經同位素標示之13C〇2及/或 1 5N 鹽中生長(CοX,J .,et a 1 .,$,.tg.b i e—_Isotopes in P ft d i a t r i η N n t r ί t. i η n a I and Metabolic Research.Biochemistry. 30. 7718 (1991)) * Growth of yeasts in algae hydrolysates (Powers, R., et ai., Biochemistry, 2J_, 43 34 (1992)), bacteria and yeasts in labeled methanol Growth (see ------ Moat, AG5, Foster, J.W., Microbial Physiology. 2d Ed., John Wiley & Sons, Hew York (1988), p. 218), and blindness Algae grow in 13C02 and / or 15N salts labeled with isotopes (CοX, J., et a 1., $, .Tg.bie—_Isotopes in P ft diatri η N ntr ί t. I η na I and Metabolic Research.

Chapman , T.E. et a 1 . , Eds . , Intercept Ltd .,Chapman, T.E. et a 1., Eds., Intercept Ltd.,

Andover House, England (1950), p. 165)。相似地’已 知多種水解蛋白質的方法,包括K氫氯酸,甲磺酸 -18 - 本紙張尺度適用中國國家標準(CNS ),4規格(21 〇 X 297公釐) 83. 3. 10,000 (請先閱讀背面之注意事項再填寫本頁) .•Μ:*.Andover House, England (1950), p. 165). Similarly, a variety of methods for hydrolyzing proteins are known, including K hydrochloric acid, methanesulfonic acid-18-this paper size applies the Chinese National Standard (CNS), 4 specifications (21 × 297 mm) 83. 3. 10,000 ( (Please read the notes on the back before filling out this page). • Μ: *.

------1Τ----—I 經濟部中央標準局員工消費合作社印繁 Α7 Β7 五、發明説明(frl) (LeMaster et a 1 . , s m R.r a )及酵素水解。若使用酵素水解 法,則易於酸化水解液。其可使酵素變性及沉澱酵素*再 Μ離心方式將其由水解液中去除。 本發明中,使用酸水解較好。較佳地使用無機強酸進行 酸水解,如,氫氯酸,硝酸或硫酸或磺酸,如ρ -甲苯磺酸 或甲磺酸,但*使用後者為佳。酸濃度根據蛋白質本質而 有不同,但一般均足Μ使完全水解。一般而言,酸濃度由 約1 Ν至約6 Ν,ΪΜ圭由約2 Ν至約4 Ν。酸水解於非氧化條 件下進行。其可由真空下進行反應,或加入惰性氣體,如 氮,氨,及其相似者。 欲水解蛋Θ質’其濃度為約〇.5g/l〇 ml至5g/l〇 ml,較 佳於約 lg/l〇 ml 至約2.3g/10 ml 。 水解反應進行的溫度及時間,需足M造成實質上有效的 完全水解,但需減少消旋性反應或不穩定胺基酸的流失。 水解反應的溫度範圍一般為約90至140 t,但,為了減少 胺基酸的消旋性反應,較佳為1 〇 〇至11 5 t:為最佳。水解 時間根據欲水解的蛋白質5可為24至72小時範圍。較佳的 一〜-水解時間為48小時。 易於由氧化而裂解的胺基酸更以堪原劑來保護。較佳地 ,使用強遨原劑*其含有硫氫基*如*乙硫醇酸 (Fasman , G . I). , Ed., Practical—Handbook Df Bioohftmistry a n..d. e o n I 9 r BJl〇 I_q a y , CRC , New York (19 8 9),p . 1 〇 6)。還原劑的目的不僅只用於保護易氧化 裂解的色胺酸及織胺酸。若使用乙硫醇酸*則可根據本發 明的方法輕易地將其去除。 -19 - (請先閱讀背面之注意事項再填寫本頁)------ 1Τ ----— I Staff and Consumer Cooperatives of the Central Bureau of Standards, Ministry of Economic Affairs, Yinfan Α7 Β7 V. Description of Invention (frl) (LeMaster et a 1., Sm R.r a) and enzyme hydrolysis. If the enzyme hydrolysis method is used, the hydrolysis solution is easily acidified. It can denature enzymes and precipitate enzymes * and remove them from the hydrolysate by centrifugation. In the present invention, acid hydrolysis is preferred. It is preferred to use a strong inorganic acid for acid hydrolysis, such as hydrochloric acid, nitric acid or sulfuric acid or a sulfonic acid, such as p-toluenesulfonic acid or methanesulfonic acid, but it is better to use the latter. The acid concentration varies depending on the nature of the protein, but is generally sufficient for complete hydrolysis. Generally speaking, the acid concentration is from about 1 N to about 6 N, and the pH is from about 2 N to about 4 N. Acid hydrolysis is performed under non-oxidizing conditions. It can be carried out under vacuum, or by adding an inert gas such as nitrogen, ammonia, and the like. The concentration of the to-be-hydrolyzed egg Θ is about 0.5 g / 10 ml to 5 g / 10 ml, preferably about lg / 10 ml to about 2.3 g / 10 ml. The temperature and time of the hydrolysis reaction should be sufficient to cause substantially effective complete hydrolysis, but it is necessary to reduce the racemic reaction or the loss of unstable amino acids. The temperature range of the hydrolysis reaction is generally about 90 to 140 t, but in order to reduce the racemic reaction of the amino acid, it is preferably 100 to 11 5 t: the most preferable. The hydrolysis time may range from 24 to 72 hours depending on the protein 5 to be hydrolyzed. The preferred one-to-hydrolysis time is 48 hours. Amino acids that are easily cleaved by oxidation are more protected with kanogens. Preferably, a strong rhenium agent is used * which contains a sulfhydryl group * such as * ethanethiol (Fasman, G. I)., Ed., Practical—Handbook Df Bioohftmistry a n..d. Eon I 9 r BJl 〇_q ay, CRC, New York (19 8 9), p. 10). The purpose of the reducing agent is not only to protect tryptophan and weaving acids, which are easily oxidized and cracked. If thioglycolic acid * is used, it can be easily removed according to the method of the present invention. -19-(Please read the notes on the back before filling this page)

本紙張尺度適用中國國家標準(CNS )._Λ4規格(210X297公釐) 83. 3. 10,000 A7 B7 的 濃 度 則 足 以 簧 質 上 對 乙 硫 醇 酵 而 言 &gt; 其 由 約 3 至 約 5¾ :V /V 陽 離 子 交 換 樹 脂 管 柱 則 上 &gt; 任 何 酸 性 樹 脂 簡 單 的 酸 性 樹 脂 9 如 使 用 的 陽 離 子 交 換 樹 Do W 化 學 公 司 * Midi 樹 脂 後 ♦ 利 用 酸 性 溶 原 則 上 &gt; 可 使 用 任 何 的 無 機 酸 &gt; 如 氫 氯 酸 數 胺 基 酸 的 pR a 值 &gt; 其 pH 值 介 於 約 1 至 約 去 除 所 有 酸 性 及 —- 般 提 即 足 夠 0 管 將 酸 液 去 除 〇 為 了 其 使 用 2-6X 管 柱 體 積 後 » 鹼 液 沖 提 陽 離 鹼 性 物 質 〇 原 則 上 f 單 純 的 鹼 液 9 如 5 氫 式 為 HR iR 2R 3 &gt; 其 中 烯 基 〇 此 含 氮 鹼 包 括 等 〇 鹼 液 中 和 了 酸 性 胺 基 酸 及 鹼 性 化 合 物 i 而 其 羧 基 則 帶 負 雷 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 五、發明説明( 遝原劑所使用 ,使免受破壞。 7¾ ν/ν,較佳的 將水解液加入 較佳為酸性。原 方便,較佳使用 等。本方法中可 50X8-400 ,可由 。將水解液加入 及酸性污染物。 ,較佳使用簡單 之pH值低於大多 旋性反應。一般 液的體積需足Μ 2-6Χ管柱體積沖 利用水洗樹脂 被去除*較佳, -…--於水洗去除酸 吸附於樹脂上的 ,但,較佳使用 或含氮鹼,其通 或C1-C4院基或 ’三乙胺水溶液 時沖提出吸附的 酸的胺基圼中性 保護色胺酸及織胺酸 濃度為介於約1至約 〇 中。陽離子交換樹脂 均可使用*但,為了 Η♦,吡啶基*甲鞍基 脂包括》Dowex and, Μ丨chigan 購得 液洗樹脂可去除中性 一種酸,但,為方便 ,硫酸等。酸性溶液 但,不低至可引發消 2 ,較佳為約2 。酸 性污染。通常Μ約 確保所有的污染物均 的水。 子樹脂*得胺基酸及 珂使用任何一種鹸液 氧化納,氫氧化鉀* f,R2及R3均為氫, ,氨水,甲胺水溶疲 陽離子交換樹脂,同 。鹼液的pH值使胺基 荷,鹼液的pH值較佳 -2 0 _ 83. 3. 10,000 本紙張尺度適用中國國家標準(CNS )&gt;4規格(210X297公釐) 經濟部中央標準扃員工消費合作社印裝 A7 B7 . 五、發明説明(〈y) 約高於10。為了避免胺基酸於強鹼條件下行消旋性反應* 其pH值應低於1 3,較佳介於約1 〇 -11 。驗液中和了酸性陽 離子交換樹脂,且同時沖提出吸附的胺基酸及鹼性化合物 〇 胺基酸可進一步再由陰離子交換樹脂純化。將由陽離子 交換樹脂所得到的沖提液加入鹼性陰離子交換樹脂。原則 上,可使.用任何鹼性樹脂,較佳地,使用單純鹼態、如氫 氧根。合宜的陰ΪΙ子交換樹脂包括,Dowex 1X8-100 ,可 由Dow化學公司,丨and, Michigan購得。胺基酸可吸 附於齡性離子交換樹脂,其原因為,當其胺基不帶正電荷 時,其羧基為負電荷。 K鹼液清洗去除鹼性及中性污染物。此步驟中所使用的 鹼液可為上述由陽離子交換樹脂管柱中將胺基酸沖提出的 任何鹼液。 K水沖提陰離子交換管柱以去除驗液。較佳的,沒有任 何輸液殘留與結合於樹脂上胺基酸相接觸,因此,以約 2-8X管柱體積,至少4X體積的水來清洗管柱為佳。 --------以酸將胺基酸由鹼性陰離子交換樹脂中沖提出。原則上 *可使用任何酸液,但,較佳的,使用易於去除的弱酸, 易揮發酸。最好為甲酸或乙酸。所使用的酸濃度,其册值 為約2 - 6 ,較佳的,介約3 _ 5 。由管柱中沖提出的經純化 胺基酸為淺白色溶液。本發明之另—個優點為,天門冬酸 為最後一個被沖提出之胺基酸。例如,除了天門冬酸,所 有的胺基酸I;; 〇·25 3; v/v乙酸水溶液下被沖提出。天門冬 酸則為2 · 5 S; v/v乙酸水溶液下沖提出。本發明因此可作 -21 - 本紙張尺度適用中國準(CNS ( 210X297公釐)~~' / · (請先閱讀背面之注意事硕再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 A7 , , B7_______ 五、發明説明(&gt;0) 為純化天門冬酸的簡易方法。如下述,此天門冬酸可為經 標示態’再轉為經標示天門冬醯胺,其可添加於經標示胺 基酸混合物中。 較佳的’上述沖提步驟為所謂”逐步梯度”沖提。同時, 較佳的*所使用的沖提酸濃度為直線,或另外的,為指數 梯度方式。根據所使用的梯度,可漸次地沖提出胺基酸, 不論Μ混物或單一胺基酸方式。本發明為純化胺基酸的^ ^ 簡易步驟*不論是單一或混合物型式。本發明同時發表所 分離的胺基酸,可改變整個胺基酸混合物中胺基酸分布。 本發明赤指出*所有的胺基酸混合物可符合所給予细胞株 的需要。 經分離之胺基酸可再以標準技術,如減壓揮發或冷凍乾 燥來分離。本發明之另一方面為所分離之胺基酸將於實質 上為純態,此因所使用沖提酸具高度揮發性。 本發明之另一優點乃關於精胺酸比其他胺基酸具有較高 的鹸性。因此*於陽離'子交換樹脂中,精肢酸為最後一個 被沖提出,甚至較所有污染物為晚。當冲提的pH值為 • - i〇-12時,精胺酸為電中性。此因其高鹼性胍基支鏈,於 rH值範圍為10-12時,將帶有正電荷,而中和了羧基的負 雷荷。與其他胺基酸不同*精胺酸將於污染物後才由陽離 子交換樹脂中冲提出,因此,其可經再分離及结晶,例, Μ標準方法與氫氯酸反應(Cox, G.J.,.1 . R i η 1 . Γ. h ft m .. :L8_,475 (1928))。本發明另一方面,因此為精胺酸的簡 易純化法。 較佳地,本發明於水解步驟中使用含硫氫基還原劑,使 -22 - I紙張尺度適用中國國家標準(CNS )._Λ4規格(210X297公釐) 83. 3. 10,000 (請先閱讀背面之注意事項再填寫本頁) 訂 1 &gt; A7 __^____B7 __ 五、發明説明( 純胺基酸混合物維持與起始水解物中相同的比率,僅有極 少量產率的改變。本發明之另一方面乃為簡易製備純胺基 酸混合物的方法,使其與起始蛋白質維持相同的比率。因 此,胺基酸的比率,可藉由選擇合適的起始蛋白質或蛋白 質混合物來控制。另外,根據本發明所製備的胺基酸混合 物’可再加入購得或合成的胺基酸或酸。 例如,^哺乳動物钿胞培養基而言,半胱胺酸為極重要 的胺基酸,但於士多數細菌,酵母菌或薄類蛋白質中,其 濃度卻不足以供應哺乳動物或昆蟲细胞之哺乳動物蛋白質 生合成。_ 已知合成半胱胺酸的酵素方法。例如,此處列為參考資 料之丨][.8.專利4,733,011給}^73113「3等人中提及利用硫化 氫’ Μ酵素反應將L-絲胺酸製為L-半胱胺酸的方法。此處 列人參考文獻之13卩丨\^1:3等人的1].$.專利4,782,021中提 及Κ絲胺酸羥基甲基轉化酶將離胺酸與甲醛反應,使產生 L-絲胺酸。經同位素標示半胱胺酸,包括i3C -半胱胺酸及 ,15Η-半胱胺酸,其製備利用可購得受質參與的步驟 —* --- 經濟部中央標準局員工消費合作社印製 上述利用酵素方法製備經同位素標示半胱胺酸並不利於 生產經三重標示2H,13C * 15Ν -半胱胺酸,其因無法取得 適當的三重標示起始物。即使可取得此受質,重氫化對酵 素動力反應有不利的影響。根據此,本發明也提供新穎的 '方法,用Μ進行同位素標示半胱胺酸,包括三重標示半胱 胺酸,及包含此同位素標示半胱胺酸之胺^酸混合物。 Μ同位素標示半胱胺酸的方法,包括經三重標示半胱胺 -23 - 83. 3. 10,000 (請先閱讀背面之注意事硕再填寫本頁) 本紙張尺度適用中國國家標準(CNS LA4規格(210Χ297公釐) I ) I ) 經濟部中央標隼局員工消費合作社印製 A7 __·___B7 五、發明説明(j) 純胺基酸混合物維持與起始水解物中相同的比率,僅有極 少量產率的改變。本發明之另一方面乃為簡易製備純胺基 酸混合物的方法,使其與起始蛋白質維持相同的比率。因 此’胺基酸的比率,可藉由選擇合適的起始蛋白質或蛋白 質混合物來控制。另外,根據本發明所製備的胺基酸混合 物*可再加入購得或合成的胺基酸或酸。 例如,對哺乳動物細胞培養基而言*半胱肢酸為極重要 的胺基酸,但於i多數细菌,酵母菌或藻類蛋白質中,其 •濃度卻不足Μ供應哺乳動物或昆蟲细胞之哺乳動物蛋白質 生合成。 Β知合成半胱胺酸的酵素方法。例如,此處列為參考資 料:^ U.S.專利4,733,01 1給Miyahara等人中提及利用硫化 氫’ W酵素反應將L-絲胺酸製為L-半胱胺酸的方法。此處 列人參考文獻之Ishiwata等人的IKS.專利4,782,021中提 及Μ ,絲胺酸羥基甲基轉化酶將離胺酸與甲醛反應,使產生 1/$_酸。經同位素標示半胱胺酸,包括1SC_半胱胺酸及 13C * 半胱胺酸,其製備利用可購得受質參與的步驟 i述利用酵素方法製備經同位素標示半胱胺酸並不利於 生產經三重標示2H,13C ,UK-半咣胲酸,其因無法取得 適當的Ξ重標示起始物。即使可取得此受質,重氫化對酵 素動力反應有不利的影響。根據此,本發明也提供新穎的 方法’用Μ進行同位素標示半胱胺酸,包括三重標示半胱 胺酸’及包含此同位素標示半胱胺酸之胺基酸混合物。 W同位素標示半胱胺酸的方法,包括經三重標示半胱胺 _ -23- 本.紙張尺度ϋ用中U4規格(21〇&gt;&lt;297公釐) ' 83.3. 10,000 (請先閱讀背面之注意事^再填寫本頁)This paper size applies the Chinese National Standard (CNS). _Λ4 size (210X297 mm) 83. 3. The concentration of 10,000 A7 B7 is sufficient for ethyl mercaptan fermentation on the sprouts &gt; It ranges from about 3 to about 5¾: V / V cation exchange resin column then> Any acidic resin Simple acidic resin 9 such as the cation exchange tree Do W Chemical Co. * Midi resin ♦ Use of acidic solution in principle &gt; Any inorganic acid can be used &gt; Hydrochloric acid pR a value of amino acid> Its pH value is from about 1 to about remove all acidity and --- generally enough is 0 tube to remove the acid solution 0 for its use 2-6X column volume » Alkaline extraction of alkaline substances 〇 In principle f simple lye 9 such as 5 hydrogen is HR iR 2R 3 &gt; where alkenyl 〇 This nitrogen-containing base includes etc. lye neutralizes acidic amino acids and Basic compound i and its carboxyl group with negative lightning Printed by the Consumer Cooperative (please read the precautions on the back before filling this page) 5. Description of the invention (the use of rhenium agent to prevent damage. 7¾ ν / ν, it is better to add the hydrolysis solution to the acid. It is convenient and convenient to use. It can be used in this method. It can be 50X8-400 in this method. It can be added with hydrolysate and acidic pollutants. It is better to use simple pH value lower than most of the spin reaction. The volume of the general solution needs to be sufficient M 2 -6 × column volume is washed with water to remove the resin. * Preferred, -...-- Washing to remove acid adsorbed on the resin, but it is better to use or nitrogen-containing alkali, which is either C1-C4 or basic. The concentration of the amino group of the adsorbed acid, the neutral protected tryptophan acid and the serine acid, is between about 1 and about 0 when the ethylamine aqueous solution is drawn out. Both cation exchange resins can be used * but, for Η ♦, pyridyl * Methyl saddlery lipids include "Dowex and, M. Chigan, commercially available liquid-washing resins that can remove a neutral acid, but, for convenience, sulfuric acid, etc. Acidic solutions, however, are not low enough to trigger consumption, preferably about 2." Acid pollution. Usually M about to ensure that all pollutants are Substances * get amino acids and ketones. Use any kind of mash solution. Sodium oxide, potassium hydroxide * f, R2 and R3 are hydrogen, hydration, ammonia water, methylamine water-soluble cation exchange resin, the same. The pH value of the lye makes the amine charge, and the pH of the lye is better -2 0 _ 83. 3. 10,000 This paper size applies the Chinese National Standard (CNS) &gt; 4 specifications (210X297 mm) Central Standard of the Ministry of Economic Affairs 扃Employees' Cooperatives printed A7 B7. 5. Description of invention (<y) is higher than 10. In order to avoid the racemic reaction of amino acids under strong base conditions, its pH value should be lower than 13 and preferably between about 10-11. The test solution neutralized the acidic cation exchange resin, and simultaneously extracted the adsorbed amino acid and basic compound. The amino acid can be further purified by the anion exchange resin. The eluent obtained from the cation exchange resin was added to a basic anion exchange resin. In principle, any basic resin can be used. Preferably, a purely basic state such as hydroxide is used. Suitable anion exchange resins include Dowex 1X8-100, which is commercially available from Dow Chemical Company, and, Michigan. Amino acids can be adsorbed to aging ion exchange resins because the carboxyl group is negatively charged when the amine group is not positively charged. K lye cleaning removes alkaline and neutral pollutants. The lye used in this step may be any of the lye extracted from the amino acid in the cation exchange resin column described above. K water was used to flush the anion exchange column to remove the test solution. Preferably, no infusion residue is in contact with the amino acid bound to the resin. Therefore, it is better to wash the column with about 2-8X column volume and at least 4X volume of water. -------- The amino acid is extracted from the basic anion exchange resin with an acid. In principle * Any acid solution can be used, but, preferably, a weak acid that is easily removed and a volatile acid is used. Most preferred is formic acid or acetic acid. The concentration of the acid to be used has a value of about 2 to 6 and preferably about 3 to 5. The purified amino acid extracted from the column was a pale white solution. Another advantage of the present invention is that aspartic acid is the last amino acid to be extracted. For example, with the exception of aspartic acid, all amino acids I; 0.253; v / v acetic acid aqueous solution was extracted. Aspartic acid was 2.5 S; v / v acetic acid aqueous solution was drawn down. The present invention can therefore be used as -21-This paper size is applicable to Chinese standards (CNS (210X297 mm) ~~ '/ (Please read the note on the back before filling out this page) Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Preparation of A7,, B7_______ 5. Description of the invention (&gt; 0) is a simple method for purifying aspartic acid. As described below, this aspartic acid can be labeled and then converted to labeled asparagine, which can be added to It is indicated in the amino acid mixture. The preferred 'the above-mentioned stripping step is a so-called "gradual gradient" stripping. At the same time, the preferred concentration of the stripping acid used is a straight line, or in addition, it is an exponential gradient method. According to the gradient used, amino acids can be gradually extracted, regardless of the M mixture or a single amino acid method. The present invention is a simple step for purifying amino acids ^ ^ simple or mixed type. The present invention is published at the same time The isolated amino acid can change the amino acid distribution in the entire amino acid mixture. The present invention indicates that * all amino acid mixtures can meet the needs of the given cell line. The isolated amino acids can be re-standardized technology, It is separated under reduced pressure or freeze-dried. Another aspect of the present invention is that the amino acid to be separated will be substantially pure, which is because the extracted acid is highly volatile. Another advantage of the present invention is related to Arginic acid is more alkaline than other amino acids. Therefore, in Yuyangli's exchange resin, sperm limb acid is the last one to be extracted, even later than all pollutants. When the pH value of the extraction When •-i〇-12, arginine is electrically neutral. Because of its overbased guanidino branch chain, when the rH value is in the range of 10-12, it will have a positive charge and neutralize the carboxyl group. Negative lightning charge. Unlike other amino acids, arginine will only be extracted from the cation exchange resin after contamination. Therefore, it can be re-isolated and crystallized. For example, the standard method of M reacts with hydrochloric acid (Cox , GJ, .1. R i η 1. Γ. H ft m ..: L8_, 475 (1928)). Another aspect of the present invention is therefore a simple purification method of arginine. Preferably, the present invention is In the hydrolysis step, a sulfur-containing hydrogen-based reducing agent is used to make the -22-I paper size applicable to the Chinese National Standard (CNS). _4 size (210X297 mm) 83. 3. 10,000 (Please read the notes on the back before filling this page) Order 1 &gt; A7 __ ^ ____ B7 __ 5. Description of the invention (Pure amino acid mixture maintains the same ratio as the initial hydrolysate, only Very small changes in yield. Another aspect of the present invention is a simple method for preparing a pure amino acid mixture to maintain the same ratio as the starting protein. Therefore, the ratio of the amino acid can be selected by selecting a suitable The starting protein or protein mixture is controlled. In addition, the amino acid mixture 'prepared according to the present invention may be further added with commercially available or synthesized amino acids or acids. For example, in mammalian cell culture medium, cysteine is an extremely important amino acid, but its concentration in most bacteria, yeasts or thin proteins is not sufficient to feed mammalian or insect cells. Animal protein biosynthesis. _ Known enzyme methods for synthesizing cysteine. For example, it is listed here as a reference material]]. [.8. Patent 4,733,011 to ^ 73113 "mentioned in 3 et al. Using hydrogen sulfide 'M enzyme reaction to produce L-serine into L-cysteine The method is listed here in the reference 13 卩 丨 ^ 1: 3 et al. 1]. $. Patent 4,782,021 mentions that K serine hydroxymethyl convertase reacts lysine with formaldehyde to produce L -Serine. Isotope-labeled cysteine, including i3C-cysteine and 15'-cysteine, its preparation uses commercially available substrates to participate in the steps-* --- Central Bureau of Standards, Ministry of Economic Affairs Employee Consumer Cooperatives printed the above-mentioned method using enzymes to prepare isotope-labeled cysteine is not conducive to the production of triple-labeled 2H, 13C * 15N -cysteine, because it is not possible to obtain a proper triple-labeled starting material. Even if it is available This substrate, dehydrogenation, adversely affects the kinetic reaction of the enzyme. According to this, the present invention also provides a novel 'method for the isotope labeling of cysteine with M, including the triple labeling of cysteine, and including this A mixture of amino acids of cysteine. The isotope indicates cysteine Method, including triple labeling of cysteamine-23-83. 3. 10,000 (Please read the cautions on the back before filling out this page) This paper size applies to Chinese national standards (CNS LA4 specification (210 × 297 mm) I) I) Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 __ · ___ B7 V. Description of the invention (j) The pure amino acid mixture maintains the same ratio as the starting hydrolysate, with only a small change in yield. Another aspect of the invention is a simple method for preparing a pure amino acid mixture to maintain the same ratio as the starting protein. Therefore, the ratio of the amino acid can be controlled by selecting an appropriate starting protein or protein mixture. In addition, the amino acid mixture * prepared according to the present invention may be further added with commercially available or synthesized amino acids or acids. For example, for mammalian cell culture media, * cysteic acid is an extremely important amino acid, However, in most bacteria, yeast, or algae proteins, the concentration is not enough to provide mammalian protein biosynthesis to mammalian or insect cells. B. The enzyme method for synthesizing cysteine. Example For example, it is listed here for reference: ^ US Patent 4,733,01 1 to Miyahara et al. Mentions a method for preparing L-serine to L-cysteine by hydrogen sulfide 'W enzyme reaction. Listed here Ishiwata et al.'S IKS. Patent Reference 4,782,021 refers to M. Serine hydroxymethyl converting enzyme reacts lysine with formaldehyde to produce 1 / $ _ acid. Cysteines are labeled by isotopes, including 1SC_cysteine and 13C * Cysteine, which is prepared using commercially available substrates. The use of enzyme methods to prepare isotope-labeled cysteine is not conducive to the production of triple-labeled 2H, 13C, UK. -Hemicarbic acid, which is unable to obtain a proper weight labeling starting material. Even if this substrate is available, dehydrogenation has an adverse effect on the kinetic reaction of the enzyme. Based on this, the present invention also provides a novel method 'Isotope-labeled cysteine, including triple-labeled cysteine' and an amino acid mixture comprising the isotope-labeled cysteine. Method for W isotope labeling of cysteine, including triple labeling of cysteamine_-23- gen. U4 specification in paper size (21〇 &gt; &lt; 297mm) '83.3. 10,000 (Please read the back first (Note ^ then fill out this page)

經濟部_夬標率局員工消費合作社印製 A7 B7 五、發明説明( 酸,乃將含經標示半肢胺酸之蛋白質M酸水解。已知半胱 胺酸於酸水解條件下並不穩定,因此本方法包括,η於蛋 白質水解時保護半胱胺酸’ ίί)分離被保護之半耽胺酸且 iii)去保護且分離經標示之半晄胺酸。 已知可K S-苯甲基醚對硫醇基行化學保護。(參見 G r e e π,T .及 Wats,P-G.M.,Pro'hfini'.i vp fi γ o u d Chemistry , 2nd Ed.* John Wiley &amp; Sons, Hew York (1991))。事實i,於化學合成胜肽時,即KS-苯甲·基保 護半胱胺酸。不過,此保護化合物於酸中並不穩定,同時 ,於水解蛋白質的條件下亦會被破壊。 已知硫醇基Μ如下式方式被保護為帶電荷之苯甲基硫酵 醚時,於可水解蛋白質的強,熱酸條件下仍為穩定狀態*Ministry of Economy _ Printed by A7 B7, Employees' Cooperatives of the Bureau of Standards and Labor. V. Description of the invention (Acid, hydrolyzes the protein M containing the labeled hemi limb amino acid. Cysteine is known to be unstable under acid hydrolysis conditions Therefore, the method includes, n protecting cysteine during proteolysis' ί) separating the protected hemicanine and iii) deprotecting and isolating the labeled hemicarine. K S-benzyl ether is known to chemically protect thiol groups. (See Gre e π, T. and Wats, P-G.M., Pro'hfini'.i vp fi γ o u d Chemistry, 2nd Ed. * John Wiley &amp; Sons, Hew York (1991)). Fact i: In the chemical synthesis of peptides, that is, KS-benzyl-protected cysteine. However, this protective compound is not stable in acid, and at the same time, it will be broken under the condition of hydrolyzing protein. It is known that when the thiol group M is protected as a charged benzyl thiolase in the following formula, it is stable under the conditions of strong hydrolyzable protein and hot acid conditions *

'⑴ -其中,Ri.為半胱胺酸,不論是單獨存在或屬於蛋白質分 子的一部份*且至少R2-Re之一為酸性基,如羧基* C2.-C4.羧基烷基或Cn-C^羧基烷氧基或為鹼基,如 二烷基氨基,C3-Ce二烷基氨基*烷基或C3-C0二烷基氦 基烷氧基,而其餘的R2-Rs ,則不論是單獨,或相組合* 則為氫,鹵素,Ci-Ce烷基或Ci-Ce烷氧基。較佳地* R«為酸基,如羧基,羧基甲基或羧基甲氧基,或鹼基,如 二甲基氨基*二甲基氨基甲基或二甲基氨基甲氧基*且其 -24 - 本紙張尺度適用中國國家標準(CNS丨/4規格(210X297公釐) 83. 3. 10,000 (請先閱讀背面之注意事項再填寫本頁) 衣— nn TJ n^i —ϋ I— I I m 11 · i- 0 i-j i 五、發明説明( &gt; A7 B7'⑴-where Ri. Is cysteine, either alone or part of a protein molecule * and at least one of R2-Re is an acidic group, such as a carboxyl * C2.-C4. Carboxyalkyl or Cn -C ^ carboxyalkoxy or a base such as dialkylamino, C3-Cedialkylamino * alkyl or C3-C0dialkylhelylalkoxy, and the remaining R2-Rs, regardless of Is alone or in combination * is hydrogen, halogen, Ci-Ce alkyl or Ci-Ce alkoxy. Preferably * R «is an acid group such as carboxy, carboxymethyl or carboxymethoxy, or a base such as dimethylamino * dimethylaminomethyl or dimethylaminomethoxy * and its- 24-This paper size applies to Chinese national standard (CNS 丨 / 4 size (210X297mm) 83. 3. 10,000 (Please read the precautions on the back before filling this page) Clothing — nn TJ n ^ i —ϋ I— II m 11 · i- 0 ij i 5. Description of the invention (&gt; A7 B7

餘的R 2 - R. ,則不論是單獨或相組合,則為氫,齒素, C:L-CS烷基或“-Ce烷氧基。 將半胱胺酸碲醇(II)與鹵化苯甲基化合物(III)反應 可製備高產率的化合物(I) X R^H (II)The remaining R 2-R., either alone or in combination, are hydrogen, dentine, C: L-CS alkyl or "-Ce alkoxy. Telluryl cysteate (II) is halogenated Reaction of benzyl compound (III) can produce compound (I) XR ^ H (II) in high yield

I—\II (請先閎讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印褽 其中X為鹵 於鹼性溶液 於(I)中 _的安定性 同時*使被 及其相似方 利用已知 HD * 如, 乙酵中。 於本發明 »甲基硫醚 素,較佳 中反應, 出璃帶電 ,因此》 保護分子 法,與其 技術,可 Μ鹼金屬 中,較佳 (IV)態保 為氯或溴,且如上所定義,其 如稀釋的氨,或氫氧化鈉水溶液。 荷的酸或鹼,可加強酸液中苯甲基硫 起始硫醇乃於熱酸性條件下被保護’ 可藉著不同的溶解度,離子交換樹脂 他分子種類分離。 將碕醇衍生物(I)再轉換為起始硫酵 與其反應*例如,以鈉溶於液態氧或 的,將半胱胺酸UII)以酸性p -羧基 護, V〇-RI R'-HN-CHI H,C-S-I— \ II (Please read the precautions on the back before filling out this page) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, where X is the stability of halogen in alkaline solution in (I). Its analogue uses known HD * eg in acetic acid. In the present invention »methyl thioether, the reaction is preferred, and the glass is charged, so the" protective molecular method, and its technology, can maintain the preferred (IV) state in the alkali metal as chlorine or bromine, and as defined above , Such as diluted ammonia, or aqueous sodium hydroxide solution. The charged acid or base can strengthen the benzyl sulfide in the acid solution. The starting thiol is protected under hot acidic conditions. ’It can be separated by other solubility, ion exchange resin and other molecular species. Convert the alcohol derivative (I) into the starting thiol and react with it * For example, dissolve sodium in liquid oxygen or sodium, cysteine UII) with acid p-carboxyl group, V〇-RI R'- HN-CHI H, CS-

、〇H 、νβ '(IV) 25 本紙張尺度適用中國國家標準(CNS )..A4規格(21 OX 297公釐) 83.3. 10,000 經濟部中央標準局員工消費合作社印製 A7 , , B7_____ 五、發明説明(〇 . 當反應起始物為自由態半胱胺酸*則其中R及R’為氣’或 是當反應起始物為多胜肽,則R及R’代表多胜肽中相鄰的 胺基酸。’ 將不論是自由態胺基酸或多胜肽中的胜肽單位之半胱胺 酸(11 ),與p -氯甲基苯甲酸於溫和的鹼性條件下反應’如 於經稀釋的蔡水或氫氧化納水溶液中,可製備高產率的化 合物(IV)。製備經同位素標示半胱胺酸*將經適當同位素 標示蛋白質於硫^醚生成條件下,於稀釋氨水或氫氧化納 水溶液中與(111)反應。可利用已知的適當蛋白質,但, 較佳使用衍生自紫硫菌的蛋自質,如Rhodopseudomonas 及oaosu lata ,及其他富含半胱胺酸有機體, 如 Leptot. hr ΐ y discophora 及 Schizophvl lum commune » 及經重組细菌,其用K生產富含半胱胺酸蛋白質,如 ATCC 31.448,及用Μ表現人類胰島素/\ _之大腸桿菌,可 將該有機體於合適的經標示之培養基中生長。 半胱胺酸衍生物(I V )於熱,強酸培養基中很穩定,但於 室溫下,則較不溶於酸中及中性培養基中。因此,化合物 ---XIV)可易於與蛋白質水解物之其他胺基酸分離,例如,過 濟'或離心冷卻的水解物。相對的,半胱胺酸衍生物(IV)於 輪性有機溶劑中具有高溶解度,如乙醇鉸,因此,利用鹼 性有機溶劑萃取方式,如乙醇銨水溶液化合物(丨V )可易於 與蛋白質水解物的其他組成份分離。 另外’半胱胺酸衍生物(I V )可利用上述胺基酸純化方法 的修正法,將其由蛋白質水解物中分離出。將蛋白質水解 液吸附於H +態之離子交換樹脂上,且Μ酸沖提除去污染物 -Λ __ - 26 - 本紙張尺度適用中( CNS )/4規格(21〇χ297公釐) &quot;~~~ ^3 (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作杜印製 A7 _;_____B7 五、發明説明(yT) 。於水洗後,將水解液之胺基酸,包括半胱胺酸衍生物 (IV)由1T樹脂上沖提出後,加入0H-樹脂中,且以氨水冲 提。水洗後* Μ稀釋的醋酸將胺基酸由0H-樹脂上冲提出 。不過*由於半胱胺酸衍生物(IV)之苯甲酸支鏈*使其酸 性較其他胺基酸為高,而造成化合物(IV)於所有胺基酸後 被沖提出,包括天門冬酸。半胱胺酸衍生物(IV)的分離乃 藉將適當分液乾燥或濃縮Η +樹脂後,Μ稀釋氨水冲提,再 使適當的分液揮^。 利用標準方法*半胱胺酸衍生物(IV)可易於再轉換為半 胱胺酸(II),較佳Μ溶於合宜溶劑中的鹼金屬來行反應, 例如,溶於液態氨或乙醇中之納。 半胱胺酸可利用上述方法生成不經標示,單一標示,雙 重標示或三重標示的型態。所需的含半胱胺酸蛋白質起始 物之同位素組成,可由控制生產蛋白質之營養性培養基的 組成來控制。 已知哺乳動物细胞培養基中,除了胺基酸及葡萄糖,尚 含有多種化合物,如維生素,脂肪酸,必須礦物質及生長 ---调子?本發明之另一方面乃是,由本發明所產生之纯經標 示胺基酸混合物,可將其加入任何细胞株所需的生長因子 混合物中,而藉此產生可用於哺乳動物或昆蟲细胞株之經 同位素標示之培養基。除了經同位素標示的胺基酸外,凡 其他受質可被细胞用來作蛋白質合成,均可Κ經標示態供 應。例如,碳水化合物*如葡萄糖,可K13c -標示態及/ 或電氫態。 同時已知蛋白質水解步驟將破壞胺基酸天門冬醯胺及麩 (請先閲靖背面之注意事項再填寫本頁) --'' ©--- 本紙張尺度適用中國國家標準(CNS )._Λ4規格(210X297公釐) 83. 3.10,000, 〇H, νβ '(IV) 25 This paper size applies to Chinese National Standard (CNS) .. A4 size (21 OX 297 mm) 83.3. 10,000 Printed by A7,, B7 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Description of the invention (0. When the reaction starting material is a free state cysteine *, then R and R 'are gas' or when the reaction starting material is a polypeptide, R and R' represent the middle phase of the polypeptide O Amino acid. 'Reaction of cysteine (11), whether in free form or in the peptide unit of the peptide, with p-chloromethylbenzoic acid under mild alkaline conditions' For example, in diluted Caishui or sodium hydroxide aqueous solution, high yield of compound (IV) can be prepared. Isotope-labeled cysteine * is prepared. An appropriate isotope-labeled protein is produced under the conditions of thioether formation in diluted ammonia. Or sodium hydroxide in aqueous solution to react with (111). Known suitable proteins can be used, but it is preferred to use egg prion derived from purple sulfur bacteria, such as Rhodopseudomonas and oaosu lata, and other cysteine-rich organisms , Such as Leptot. Hr ΐ y discophora and Schizophvl lum commu ne »and recombinant bacteria that use K to produce cysteine-rich proteins, such as ATCC 31.448, and E. coli expressing human insulin / \ _, can be used to grow the organism in suitable labeled media. Cysteine derivatives (IV) are stable in hot, strong acid medium, but are less soluble in acid and neutral medium at room temperature. Therefore, the compound --- XIV) can easily interact with protein hydrolysates Other amino acids are separated, for example, hydrolyzed or centrifuged. In contrast, cysteine derivatives (IV) have high solubility in rotatable organic solvents, such as ethanol hinges. Therefore, extraction with alkaline organic solvents, such as aqueous ethanol ammonium compounds (丨 V), can be easily hydrolyzed with proteins The other components of the product are separated. The 'cysteine derivative (IV) can be isolated from the protein hydrolysate by a modification of the aforementioned amino acid purification method. The protein hydrolysate was adsorbed on the ion exchange resin in H + state, and the M acid was extracted to remove the pollutants-Λ __-26-This paper is applicable to the standard (CNS) / 4 (21〇297297 mm) &quot; ~ ~~ ^ 3 (Please read the notes on the back before filling out this page) Order the consumer cooperation of the Central Bureau of Standards of the Ministry of Economy Du printed A7 _; _____ B7 V. Description of Invention (yT). After washing with water, the amino acid of the hydrolysate, including the cysteine derivative (IV), was extracted from the 1T resin, added to the 0H-resin, and extracted with ammonia. After washing with water, the diluted acetic acid stripped the amino acid from the 0H-resin. However * because the benzoic acid branch of the cysteine derivative (IV) * makes it more acidic than other amino acids, the compound (IV) is extracted after all amino acids, including aspartic acid. Isolation of the cysteine derivative (IV) is carried out by drying or concentrating the appropriate liquid separation, and then concentrating the resin, and then diluting it with diluted ammonia water, and then allowing the appropriate liquid separation to evaporate. It can be easily converted back to cysteine (II) by standard methods. The cysteine derivative (IV) can be easily converted to cysteine (II). It is preferred that the alkali metal be dissolved in a suitable solvent for reaction, for example, liquid ammonia or ethanol. The admiration. Cysteine can be generated by the above methods without labeling, single labeling, double labeling or triple labeling. The required isotopic composition of the cysteine-containing protein starting material can be controlled by controlling the composition of the nutrient medium used to produce the protein. It is known that mammalian cell culture medium, in addition to amino acids and glucose, still contains a variety of compounds, such as vitamins, fatty acids, must be minerals and growth --- toned? Another aspect of the present invention is that the purely labeled amino acid mixture produced by the present invention can be added to the growth factor mixture required by any cell line, thereby producing a mammalian or insect cell line. Isotopically labeled media. In addition to isotopically labeled amino acids, all other substrates can be used by cells for protein synthesis. For example, a carbohydrate * such as glucose may be in the K13c-labeled state and / or in the hydrogen state. At the same time, it is known that the proteolytic step will destroy the amino aspartame and bran (please read the precautions on the back of Jing before filling this page)-'' © --- This paper size applies to Chinese National Standards (CNS). _Λ4 specifications (210X297 mm) 83. 3.10,000

« I « I 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(/) 醯胺,且分別伴隨生成酸性胺基酸,天門冬酸及麩醯胺酸 。大多數哺乳動物培養基含有大量的麩醯胺。不過,對某 些晡乳動物细胞來說*將麩醯胺加入本發明所產生的胺基 酸混合物中,不影響其生長速率或重組蛋白質的生產率。 但是,對某些哺乳動物或昆蟲细胞株,麩醯胺的添加對其 生長表現極為重要。本發明的另一方面乃是,根據培養基 中所使用的細胞株的特性.,不一定要添加麩醯胺至本發明 所產生的胺基酸混合物中。同時發現,若使用本篇所描述 之較佳條件,並未發現任何消旋性反應。 已知再利用層析方法,可輕易地將麩醯胺酸與胺基酸混 合物分離,其後再κ化學或酵素方法將其轉為麩醯胺。再 將所產生的麩醯胺用來添加至所需的胺基酸混合物中。 於pH值為中性時》所有胺基酸混合物中僅有麩蘸胺酸帶 負電荷,此因其具有二個羧基而僅有一個氨基。其餘的胺. 基酸,於pH值為中性時,可為不帶電荷(e.g.甘胺酸)或正 電荷(e,g.離胺酸)。 因此*可於去除沖提酸液後,e.g. Μ冷凍乾燥方式,將 ——胺基酸混合物通過Μ弱酸製備的陰離子交換樹脂,而可具 專一性地將麩醯胺酸與胺基酸混合物分離。原則上,可使 用任何弱酸,但較佳地,使用醋酸鹽或甲酸鹽之陰離子交 換樹脂。 當其他中性或正電性胺基酸通過陰離子交換樹脂時,由 於麩醯胺酸帶有負電荷而可吸附於樹脂。當將胺基酸由樹 脂中沖提出後,Μ水清洗樹脂,且Κ適當的酸液將麩醯胺 酸由管柱中沖提出。可利用標準方法,如減壓蒸發或冷凍 -28 - 本紙張尺度適用中國國家標準(CNS ).&gt;4規格(210X297公釐) 83. 3. 10,000 (請先閲讀背面之注意事項再填寫本頁) .7「装· 、-* A7 B7 五 發明説明( 乾燥方式,將所分離的麩醯胺酸回復。 可利用已知的方法,如F e s ί k e t a 1所發表的酵素方法 ,將麩醜胺酸轉變為麩醯胺。不過,如上述》酵素方法並 不利於重氫化及三重標示受質。另外,根據本發明,可利 用下述流程1之新穎化學方法。 流稈 1«I« I Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (/) Amidoamine, which is accompanied by the production of acidic amino acids, aspartic acid and glutamic acid. Most mammalian media contain large amounts of glutamine. However, for some mammalian cells * the addition of glutamine to the amino acid mixture produced by the present invention does not affect its growth rate or the productivity of the recombinant protein. However, for some mammalian or insect cell lines, the addition of glutamine is extremely important for its growth performance. Another aspect of the present invention is that, according to the characteristics of the cell line used in the culture medium, it is not necessary to add the glutamine to the amino acid mixture produced by the present invention. It was also found that no racemic reaction was found using the better conditions described in this section. It is known that the glutamic acid and amino acid mixture can be easily separated by using a chromatography method, and then converted to glutamine by a κ chemical or enzyme method. The resulting glutamine is then used to add to the desired amino acid mixture. When the pH is neutral, only the glutamic acid is negatively charged in all amino acid mixtures, because it has two carboxyl groups and only one amino group. The remaining amine-based acids can be uncharged (e.g. glycine) or positively charged (e, g. Lysine) at neutral pH. Therefore * after removing the acid extraction solution, eg Μ freeze-drying, the amino acid mixture is passed through an anion exchange resin prepared by the weak acid, and the glutamic acid and the amino acid mixture can be specifically separated . In principle, any weak acid can be used, but preferably, an anion exchange resin of acetate or formate is used. When other neutral or positively charged amino acids pass through the anion exchange resin, the glutamic acid can be adsorbed on the resin because it has a negative charge. After the amino acid is washed out from the resin, the resin is washed with M water, and the glutamic acid is washed out from the column with an appropriate acid solution. Standard methods can be used, such as decompression evaporation or freezing-28-This paper size applies Chinese National Standard (CNS). &Gt; 4 specifications (210X297 mm) 83. 3. 10,000 (Please read the precautions on the back before filling in this Page) .7 "Packing ·-* A7 B7 Five invention description (drying method, recovery of the separated glutamic acid. The known method, such as the enzyme method published by Fes ί keta 1, can be used to convert the bran Uric acid is converted to glutamine. However, the enzymatic method as described above is not conducive to deuteration and triple labeling. In addition, according to the present invention, a novel chemical method of the following scheme 1 can be used. Flow stalk 1

Ho. y0Ho. Y0

X-HN-CHX-HN-CH

\ ? X-N-CH X-N-CH CH, 1 ch2 1 ch2 1 ch2 I ch2 1 ch2 I 1 . · 1 C\ hct、、〇 1 h2n^ ^ (VI) (VII) (VIII) '◊Ο X-HN-CHI CH, (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 人、 h2n 、〇 (IX) H。、〆I HjN -CHI ch2 ch2I c H2N〆、、0 (X) -29 - 本紙張尺度適用中國國家標準(CNS )__A4規格(2IOX297公釐) 83. 3. 10,000\? XN-CH XN-CH CH, 1 ch2 1 ch2 1 ch2 I ch2 1 ch2 I 1. -CHI CH, (Please read the notes on the back before filling out this page) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, h2n, 0 (IX) H. , 〆I HjN -CHI ch2 ch2I c H2N〆 ,, 0 (X) -29-This paper size applies to China National Standard (CNS) __ A4 specification (2IOX297 mm) 83. 3. 10,000

» I A7 _ _ B7 五、發明説明ρβ). 首先,將麩醯胺酸之氨基保護而得(VI)。已知許多合適 的保護基,包括.Fmoc, t-Boc及其相似者。 將N -經保護的麩醯胺酸環化以生成噚唑啶酮(V 11)。已 知此轉化方法’ e . g .參—見,Itoh (Cham. Ph^rm. Rull,_ 11_,1 (3 7 9, ( 1 9 6 9 ))。於11 o h方法中,於催化量的強酸存 在下,如苯甲磺酸,將化合物(VI)與三聚甲醛反應,而得 (VII),其可利用已知方法分離。以合宜的活化劑活化 (VII) 之自由羧&amp;基,如二環己基碳化二亞胺,二異丙基 碳化二亞胺,η -溴化丁二醯亞肢及其相似者。同時,已知 其他的活化基。 將經活化的噚唑啶_與氨氣反應而得環醯胺衍生物 (VIII) 。當製備-標示麩醯胺時,氨氣也需以15Ν標示 。與所有的物料相同,ΐ5Η-氨非常昂貴。更甚者*由 於其為氣體*因此難Μ被精確地控制及測量。因此,較佳 的,1 5 Ν -氨氣的產生,乃於另外的燒瓶中,加入15 Ν鹽類 溶液,如15Ν-氯化铵,硫酸銨等,再加人鹼液與其反 應,將所產生的氨氣與經活化的噚唑啶酮反應。合宜的溶 -------劑包括極性,加氫性有機溶劑,如二甲基亞5風及二甲基甲 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁} 醯胺,而合宜的鹼液包括,強或和鑀的強相互溶鹼液,如 四甲基胍及氫化納。 於合宜的溶劑中,將環醮胺衍生物(V 11 I) Μ弱鹼水溶液 水解,而得H -經保謂麩醯胺衍生物(I X)。可利用各種鹼液 *但,為簡單化,使用單純鹼液,如溶於乙醇水溶液中之 氫氧化鈉。為了減低造成醯胺的水解,較佳的僅使用1-5 當最的鹼液,更佳的,使用1-2當量。 __- 30 -__. 本紙張尺度適用中國國家榇準(CNS )夕4規格(210X297公釐) 83.3. 10,000 A7 B7 五、發明説明($) 根據所使用的保護基,利用 麩醯胺去保護基。(見Green, 釀胺(X) e · g . Μ结晶法或減壓 已知的層析方法。 已知上逑方法又可用於將天 本發明之另一方面是生產天門 將上述水解條件,加上製備 天門冬醯胺的方法,則可製備 合來標示之胺基酸混合物。本 明的方法可純化經任何同位素 僅關於胺基酸的氨基及羧基之 位素標示的胺基酸混合物可利 不論是否Κ同位素標示,所 哺乳動物或昆蟲細胞生長。因 得的哺乳動物或昆蟲细胞及其 的同位素混合物所完全標示。 本發明將由下例範例闌述, ------明範圍 已知方法將所得的Ν-經保護 e t a 1. f supra)。可分離變 蒸發,或將其純化,e · g · K 門冬酸轉變為天門冬醯胺° 冬醯胺的方法。 經標示半胱胺酸,麩醯 Μ 2 Η,1 3 C及1 s Η作任何組 發明的另一方面為利用本發 取代的瞭基酸。由於本發日月 氫離子化,因此,任何經同 用本發明來純化。 得的胺基酸混合物足Μ供應、 此,本發明的另一方邱為所 代謝產物,將與趄始物相同 其僅作閹述,並不限制本發 範例 經濟部中央標準局員工消費合作社印製 齙例 將由ChTnrft1a 培養基得到的藻類生物質量 用通過 Μ (水)稀釋至約10%黏稠吠,再將其置於冰上’利 . όίί彳暮0勺黏 微液化器(Microfluidizer)三次使細胞破裂。將W 、一,再將 稠液K 5,0 0 0 r p m ,5 t:離心1 5分。收集其上清柩 一 wr U&gt;半驟二次。 沉澱溶於水中後* Μ相同條件再離心。恵覆此步 31 83. 3. 1〇.°00 (請先閱讀背面之注意事項再填寫本頁)»I A7 _ _ B7 V. Description of the invention ρβ). First, the amino group of glutamic acid is protected to obtain (VI). Many suitable protecting groups are known, including .Fmoc, t-Boc and the like. N-protected glutamic acid is cyclized to form oxazolidinone (V 11). This conversion method is known 'e.g. See also, Itoh (Cham. Ph ^ rm. Rull, _ 11_, 1 (3 7 9 ((19 6 9))). In the 11 oh method, the catalytic amount In the presence of a strong acid such as benzylsulfonic acid, the compound (VI) is reacted with paraformaldehyde to obtain (VII), which can be separated by known methods. The free carboxylic acid of (VII) is activated with a suitable activator Groups, such as dicyclohexylcarbodiimide, diisopropylcarbodiimide, η-butadiene bromide limbs and the like. At the same time, other activating groups are known. Activated oxazolidine _Reaction with ammonia gas to obtain the cyclic amidine derivative (VIII). When preparing and labeling glutamine, ammonia gas must also be labeled with 15N. Like all materials, ΐ5ΐ-ammonia is very expensive. Even more * It is a gas * so it is difficult to be accurately controlled and measured. Therefore, it is preferred that 15 N-ammonia gas is generated in another flask by adding a 15 N salt solution, such as 15N-ammonium chloride, Ammonium sulfate, etc., together with human lye to react with it, the generated ammonia gas is reacted with activated oxazolidone. Suitable solvents --- --- the agent includes polarity, hydrogenation Organic solvents, such as those printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs of dimethyl chloroform and dimethyl formamide (please read the precautions on the back before filling out this page) hydrazine, and suitable lyes include, strong or The strong mutual soluble alkali solution of hydrazone, such as tetramethylguanidine and sodium hydride. In a suitable solvent, the cyclopentamine derivative (V 11 I) Μ weak alkaline aqueous solution is hydrolyzed to obtain H- Amine derivatives (IX). Various lyes can be used * However, for simplicity, a simple lye, such as sodium hydroxide dissolved in an aqueous ethanol solution, is used. In order to reduce the hydrolysis of amidine, it is preferred to use only 1- 5 When the most lye is better, use 1-2 equivalents. __- 30 -__. This paper size is applicable to China National Standard (CNS) Xi 4 specifications (210X297 mm) 83.3. 10,000 A7 B7 V. Invention Note ($) Use of glutamine for deprotection depending on the protecting group used. (See Green, Fermented amine (X) e · g. M Crystallization method or Chromatographic method known under reduced pressure. Known method of loading It can also be used for the above-mentioned hydrolysis conditions of another aspect of the invention, and the preparation of asparagus The method of amidine can prepare the labeled amino acid mixture. The method of the present invention can purify the amino acid mixture labeled by any isotope only about the amino group and carboxyl group of the amino acid. Labeled, all mammalian or insect cells grow. The mammalian or insect cells and their isotope mixtures are completely labeled. The present invention will be described by the following examples. N-protected eta 1. f supra). It can be separated, evaporated, or purified, and e · g · K aspartic acid can be converted to asparagine. Cysteine, glutamate M 2 Η, 1 3 C and 1 s Η are labeled as any group. Another aspect of the invention is the use of substituted base acids of the present invention. Since the sun and the moon are hydrogenated, any of them can be purified by applying the present invention together. The obtained amino acid mixture is sufficient to supply. Therefore, the other aspect of the present invention is a metabolite, which will be the same as the starting material. It will only be described, which does not limit the example of the development. Preparation Example The algae biomass obtained from ChTnrft1a medium was diluted to about 10% sticky bark by M (water), and then placed on ice. Όί Twilight 0 spoon viscous microliquefier (Microfluidizer) three times to make cells rupture. Set W, one, and thick solution K 5, 0 0 0 r p m, 5 t: Centrifuge for 15 minutes. Collect the supernatant 柩 wr U &gt; half a step twice. The precipitate was dissolved in water and centrifuged under the same conditions.恵 Repeat this step 31 83. 3. 1〇. ° 00 (Please read the precautions on the back before filling this page)

本紙張尺度適用中國國家標準(CNS ).&gt;4規格(210X297公釐) 經濟部中央標隼局員工消費合作社印製 A7 , __B7___ 五、發明説明( 將所有上清液混合,加入三氯醋酸(最終濃度5 3: v/v)後 ,置於5 ΐ;中保存過夜。 將所得的懸浮液於5,000 rpm * 5 t:離心30分。倒去上 清液,Κ等體積的丙_溶解沉源後,再將其於5,000 ppm * 5 C中離心15分。去除上清液,將沉澱溶於500 m 1的乙 醇/醚中*且於減壓下過濾收集。以乙醇/醚清洗沉澱後 *減壓乾燥。 — 將上述之7 g可溶性蛋白質分液*於真宜中與含有4 % v / v氫硫基醋酸鹽之3 Μ甲磺酸(7 0 m 1 )於1 0 0 t!中反應 48小時。待冷卻後,將所得水解物緩慢倒入水中(7 0 m 1 ) ,再於冰浴中冷卻且將所得的混合物停置約1 0分。把所得 的冷卻液離心(RC-3B,250 ml離心管,5,000 rpm ,10分 )。將上清液打入(36m! /min),於其基座備有FMI實驗室 QSY (FMI Lab Pump QSY)之 Dovex 50 X 8 離子交換樹脂 (H +態,500g)管柱中。 當所有的水解液均被打入管柱中後*接著打入經稀釋的 碲酸水溶液(PH2.0, 1.5L)及水(2L)(3(3ml/min)至管柱中 -----,由管柱底部收集分液(經標示H*,500ml)。 利用泵將H +管柱與D〇Wex 1X8-100離子交換樹脂管柱相 連(0H-態* 500g)。由H*管柱以泵將稀釋的氨水(1 % v/v, 9L)打入(36nil/.min),且使此沖提液流入0H-管柱 。由〇H_管柱底部收集分液(經標示oh- * 500ml)。 由 TLC 分析(Analtech Silica GS plates, n-BuOH:This paper size applies the Chinese National Standard (CNS). &Gt; 4 specifications (210X297 mm) printed by the Consumer Cooperatives of the Central Bureau of Standards, Ministry of Economic Affairs, A7, __B7___ 5. Description of the invention (Mix all the supernatants and add trichloroacetic acid (Final concentration 5 3: v / v), store overnight at 5 ° C; store the resulting suspension at 5,000 rpm * 5 t: centrifuge for 30 minutes. Pour off the supernatant, and dissolve an equal volume of propylene. After sinking, it was centrifuged for 15 minutes at 5,000 ppm * 5 C. The supernatant was removed, the precipitate was dissolved in 500 ml of ethanol / ether * and collected under reduced pressure. The precipitate was washed with ethanol / ether And then dried under reduced pressure. — Separate the above 7 g of soluble protein * in Zhenyi with 3 M methanesulfonic acid (70 m 1) containing 4% v / v hydrothioacetate at 100 t The reaction was allowed to proceed for 48 hours. After cooling, the obtained hydrolysate was slowly poured into water (70 m 1), then cooled in an ice bath and the resulting mixture was allowed to stand for about 10 minutes. The obtained cooling solution was centrifuged ( RC-3B, 250 ml centrifuge tube, 5,000 rpm, 10 minutes). The supernatant was injected (36m! / Min), and FMI laboratory QSY (FMI Lab Pump QSY) column of Dovex 50 X 8 ion exchange resin (H + state, 500g). After all the hydrolysate has been injected into the column * then the diluted telluric acid aqueous solution (PH2.0 , 1.5L) and water (2L) (3 (3ml / min) into the column -----, collect and separate the liquid from the bottom of the column (labeled H *, 500ml). Use a pump to connect the H + column with the D〇Wex 1X8-100 ion exchange resin column is connected (0H-state * 500g). The diluted ammonia water (1% v / v, 9L) is driven into the pump (36nil / .min) by the H * column with a pump, and The eluent was allowed to flow into a 0H-column. The liquid was collected from the bottom of the OH_column (labeled oh- * 500ml). Analyzed by TLC (Analtech Silica GS plates, n-BuOH:

AcOH:Ha 0(2:1:1 v/v)展開液:寧希德林 ninhydrin (1 Χ v/v 於 MeOH:Glac AcOH (97:3 v/v))顯示精胺酸於 •a -32 - 本紙張尺度適用中國國家標隼(CNS )&gt;4規格(210x297公釐) 83. 3. 10,000 (請先閲讀背面之注意事項再填寫本頁) • -^衣------訂-------β-- ill— - - · 經濟部中央標準局員工消費合作杜印製 A7 ______B7__ 五、發明説明〇l) 0H-13-18分液中出現。 待沖提出精胺酸分液,停止泵運作,且將其直接與0H-管柱相連。當再開始由0H-管柱收集分液(500 時, 即重新開啟泵。 當開始由管柱底部連續收集5〇〇 rol分液時,將經稀釋的 醋酸水溶液(0.25% v/v,1〇l)由0H-管柱打人。持績蓮轉 泵’直到於沖提液中不再出現寧希德林反應。 TLC 分析(Analtech Silica GS plates, n-BuOH: Ac0H:H20(2:l:l v/v)展開液:寧箱德林(1¾ v/v 於 MeObGladcOH (97:3 v/v))顯示胺基酸混合物(於分 液 OH-25-36) ° 分別將含精胺酸分液與胺基酸混合物分液以冷凍乾燥進 行乾燥及濃縮。將所得物溶於水中後,以〇.22Wm濾膜過 濾置於無菌瓶中後,再行冷凍乾燥。基本上,根據C〇x, .,ajiP.ra的步驟,將精胺酸分液結晶,使生成氫氯酸鹽 ,得0.31 g。將胺基酸混合物分液分離,得白黃色粉末, 4.6 g 〇 ——--範例2 由供應商處取得不含血清之CH0-SSFM-1培養基(Gibco) *其適用於CH0细胞,且B去除其中之胺基酸。二種培養 基樣本其製備如下: 於200 ml之不含胺基酸之CH0-SSFM-1分裝液中加人, 1 . 經混合之胺基酸 (3 4〇11^)+半胱胺酸(2〇1^)+經结晶胺酸(4〇1^) 2. 經混合之胺基酸 -33 - 本紙張尺度適用中國國家標準(CNS )&gt;4規格(210X297公釐) 83. 3. !0,〇〇〇 l·--1--;---^,J衣------、玎------ο (請先閱讀背面之注意事項再填寫本頁) A7 . , B7_'_' 五、發明説明(5V) (340mg)+半胱胺酸(2〇i«g) +經结晶胺酸(4〇mg)+鍵臨 胺(I20mg)。 利用Μ 〇 . 2 2 w滹膜濾使此溶液無菌,且將分装液 (2-3ml)中種入CHO細胞(起始濃度lxl〇5/rol)。相對於控 制姐CH0-SSFM-1培養基樣本’記錄细胞數及%存活细胞( % ) 。 . 48h_Z2h_96h_120h_144h 168h 控制組 2.4(99) 5·2(96&gt; 々.0(93) 7.0 (91) 5.6(83) 4.0(64) 1 1.6(99) 3.8(93) 5.1(97) 12.0(92) 8.2(84) 5.0(72) 2 2.2(99) 4.0(95) 5.5 (93) 7.2(95) 7.2(82) 7.0(69) 其結果顯示ί )由範例方法所得的胺基酸混合物’其生長 特性與控制組並無不同且丨1)麩醯胺的加入對细胞生長並 無必要。 節例3 : 實質上根據範例1之方法製備雙重標示的胺基酸,除了 其中藻類生物量乃取自分別M 13C〇z及K15N〇3作為唯一碳 源及氮源之r.b 1 or ft 1 a 培養液。13C ,15N_半胱胺酸乃 稂據上述酵素方法來製備。 經濟部中央標準局員工消費合作社印製 由供應商處取得CH0-SSFM-1培養基(G ibco),其中將胺 基酸,碳水化合物,中間代謝產物及蛋白質水解物去除。 對上述1公升的培養基中加入: 13C ,15N-經混合胺基酸(包括13C ,15N-链醯肢酸) :3 g 13C ,15tr-精胺酸-HC 1 : 240 mg ί% * 半胱胺酸:160 mg -34 - 83. 3. 10,000 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS )/A4規格,(210X 297公釐) 經濟部中央標準局員工消費合作社印製 A7 , , B7_______ 五、發明说明(3¾ 13C -丙酮酸納(Isotec +Inc.): 70 mg 13C-D-葡萄糖:3· 8 g K 0 . 22 μ濾膜將所得溶液過滹使無菌。於250m 1上述溶 液中加入CH0细胞,其經重組用K表現及分泌娀毛膜性腺 激素(hCG)至最终濃度為3xl〇e细胞/毫升。將此培養液 攪拌15 hrs後,Κ離心法分離细胞。將细胞沉澱溶於500 Hi 1如上述製備之1 3 C ,1 s N -經標示培養基至濃度為1 . 2 X .... ,ν, 1 〇β細胞/毫升,且將其攪拌7 3小時。根據相同的限制, 利用可購得的CH0-SSFM-1培養基作為控制組。 利用抗-hCG抗體,M RIA來訂定所得的13C及15Ν-標示 hCG濃度。於73小時,13C ,1SN -標示hCG之濃度為90 pntole/ml ’其相對於控制組於88 hr., 100 pmole/ro]之未 經標示h C G的濃度。 節例4 : 半胱胺酸-S-4 -甲基苯甲酸銨的製備 將半胱胺酸(2.42 g, 20tnmol)及4-氯甲基苯甲酸 (3.74g,20mmol)溶於水中(90 ml) *且Μ濃縮氨水與其 反應。於室溫下*攪拌所得溶液1 hr。利用揮發方式去除 -·-約5 0 ffl1的溶劑,而得沉澱。逐滴加入濃縮氨水至沉澱溶 解。再Μ揮發方式去除溶劑直沉澱再出現。逐滴加入無水 經蒸餾乙酵,而得白色晶體之半胱胺酸-S-4-甲基苯甲酸 銨(賁際值:C, 49.0: Η, 5.8; Ν, 9·3; S, 11·6 ,理論值C,58.5 Η,5·9; H,10.3; S, 11.8);產率 4.9g (90S;), Rf (2Π:1 ν/ν/ν n-Bu0H:H20:Ac0H)9.73。 Delta Η (D2〇, 300 Mhz) 7.76 (2H, d, J 8Hz), 7.37 (2H, d, J 8Hz), 3.78 (2H,AcOH: Ha 0 (2: 1: 1 v / v) developing solution: Ninhydrin (1 χ v / v in MeOH: Glac AcOH (97: 3 v / v)) shows spermine at a- 32-This paper size applies to China National Standards (CNS) &gt; 4 specifications (210x297 mm) 83. 3. 10,000 (Please read the precautions on the back before filling this page) •-^ 衣 ------ Order ------- β-- ill----· Consumption cooperation between employees of the Central Bureau of Standards, Ministry of Economic Affairs, printed A7 ______B7__ V. Description of the invention 〇l) 0H-13-18 appeared in the liquid separation. Wait for the arginine solution to come out, stop the pump, and connect it directly to the 0H-column. When the separation and collection by the 0H-column (500) was started again, the pump was restarted. When the 500rol separation was continuously collected from the bottom of the column, the diluted acetic acid aqueous solution (0.25% v / v, 1 〇l) Hit by a 0H-column. The performance lotus pump was used until the Ningdling reaction no longer appeared in the eluent. TLC analysis (Analtech Silica GS plates, n-BuOH: Ac0H: H20 (2: l: lv / v) developing solution: Ning box delin (1¾ v / v in MeObGladcOH (97: 3 v / v)) shows amino acid mixture (in liquid OH-25-36) ° will contain spermine The acid separation and amino acid mixture were separated for freeze-drying for drying and concentration. After the solution was dissolved in water, it was filtered through a 0.22 Wm filter membrane into a sterile bottle, and then freeze-dried. Basically, according to C 〇x,., AjiP.ra steps, the arginine acid was separated and crystallized to produce hydrochloride to obtain 0.31 g. The amino acid mixture was separated and separated to obtain a white-yellow powder, 4.6 g 〇 ——- -Example 2 Obtain serum-free CH0-SSFM-1 medium (Gibco) from the supplier * It is suitable for CH0 cells, and B removes the amino acids from it. Prepare as follows: Add 200 ml of CH0-SSFM-1 aliquots without amino acid, and add 1. A mixed amino acid (3 4011 ^) + cysteine (2〇1 ^ ) + Crystalline amino acid (4〇1 ^) 2. Mixed amino acid-33-This paper size applies Chinese National Standard (CNS) &gt; 4 specification (210X297 mm) 83. 3.! 0, 〇 〇〇l · --1--; --- ^, J clothing ------, 玎 ------ ο (Please read the precautions on the back before filling this page) A7., B7_ ' _ 'V. Description of the invention (5V) (340mg) + Cysteine acid (20i «g) + Crystalline amino acid (40mg) + Bonded amine (I20mg). Use M 0.22 w 2 Membrane filtration made this solution sterile, and the aliquots (2-3ml) were seeded into CHO cells (initial concentration lx105 / rol). The cell number and% were recorded relative to the control CH0-SSFM-1 medium sample Viable cells (%): 48h_Z2h_96h_120h_144h 168h Control group 2.4 (99) 5 · 2 (96 &gt; 々.0 (93) 7.0 (91) 5.6 (83) 4.0 (64) 1 1.6 (99) 3.8 (93) 5.1 ( 97) 12.0 (92) 8.2 (84) 5.0 (72) 2 2.2 (99) 4.0 (95) 5.5 (93) 7.2 (95) 7.2 (82) 7.0 (69) The results show) amines obtained by the example method Base acid mixture 'its growth characteristics and control The control group is not different and 1) the addition of glutamine is not necessary for cell growth. Example 3: A double-labeled amino acid was prepared essentially according to the method of Example 1, except that the algae biomass was taken from rb 1 or ft 1 a as the sole carbon source and nitrogen source, respectively M 13 Coz and K15N〇3. Medium. 13C, 15N-cysteine is prepared according to the above-mentioned enzyme method. Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. Obtain CH0-SSFM-1 medium (G ibco) from the supplier, which removes amino acids, carbohydrates, intermediate metabolites and protein hydrolysates. To the above 1 liter of medium: 13C, 15N-mixed amino acids (including 13C, 15N-streptane acid): 3 g of 13C, 15tr-arginine-HC1: 240 mg ί% * Cysteine Amino acid: 160 mg -34-83. 3. 10,000 (Please read the notes on the back before filling out this page) This paper size applies to China National Standard (CNS) / A4 specifications, (210X 297 mm) Central Standard of the Ministry of Economic Affairs A7,, B7 _____ printed by the Bureau's Consumer Cooperatives V. Description of the invention (3¾ 13C -Sodium pyruvate (Isotec + Inc.): 70 mg 13C-D-glucose: 3. 8 g K 0. 22 μ Sterilize by sterilization. CH0 cells are added to the above solution at 250ml, and they are expressed by K and reconstituted with human chorionic gonadotropin (hCG) to a final concentration of 3 × 10e cells / ml. After stirring this culture solution for 15 hrs The cells were separated by centrifugation. The cell pellet was dissolved in 500 Hi 1 as prepared above. 1 3 C, 1 s N-labeled culture medium to a concentration of 1.2 X ...., ν, 10 β cells / ml And stirred for 7 3 hours. According to the same limitation, a commercially available CH0-SSFM-1 medium was used as the control group. Anti-hCG antibody was used The concentration of 13C and 15N-labeled hCG obtained by M RIA was determined. At 73 hours, the concentration of 13C and 1SN-labeled hCG was 90 pntole / ml ', which was 88 hr., 100 pmole / ro compared to the control group. The concentration of h CG is not stated. Example 4: Preparation of Cysteine-S-4 -Methylbenzoate Ammonium Cysteine (2.42 g, 20tnmol) and 4-chloromethylbenzoic acid (3.74g (20 mmol) was dissolved in water (90 ml) *, and concentrated ammonia water was reacted with it. The resulting solution was stirred at room temperature * for 1 hr. The solvent was removed by evaporation-about -50 ffl1 to obtain a precipitate. Dropwise addition Concentrate the ammonia water until the precipitate is dissolved. Then remove the solvent in the volatile mode and the precipitate will reappear. Add anhydrous anhydrous distillate to obtain the white crystals of cysteine-S-4-methylammonium benzoate (intermediate value: C, 49.0: Η, 5.8; Ν, 9 · 3; S, 11 · 6, theoretical value C, 58.5 Η, 5.9; H, 10.3; S, 11.8); yield 4.9 g (90S;), Rf (2Π: 1 ν / ν / ν n-Bu0H: H20: Ac0H) 9.73. Delta Η (D2〇, 300 Mhz) 7.76 (2H, d, J 8Hz), 7.37 (2H, d, J 8Hz), 3.78 ( 2H,

A -35 - l紙張尺度適用中國國家標準(CNS )&gt;4規格(210X297公釐) glTllO^ (請先閱讀背面之注意事項再填寫本頁) 訂----------- 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明. S), 3.73 (1H, dd, J2, 5 Hz), 2.90 (2H, m), Delta C (D20, 75 Mhz) 175.30, 172.89, 141.18, 135.43, 129.34, 128.86, 53.60, 35.178, 31.78, 28.16〇 範-例5 : 半胱胺酸-S-4-甲基苯甲酸銨對酸水解條件的穩 定性 於Schlenk試管中加人半胱胺酸-S-4-甲基苯甲酸銨 (lg)於經冷凍甲磺酸(3M)及硫氫基醋酸(4 %)水溶k中。 利用真空泵去除士氣,密封管口,且將其加熱至100 Ό, 48 hrs。使其冷卻後,Μ離心方式分離半胱胺酸-S-4-甲 基笼甲酸銨,且Μ定量方式Μ水洗(3x50π&gt;1 )。 iOU.: 由半胱胺酸-S-4-甲基苯申酸銨分離半胱胺酸 將半胱胺酸-S-4-甲基笨甲酸铵(200 mg, 0.76 mmol) 加人雙頸梨形瓶中.。將此燒瓶於乾冰/丙嗣中冷卻且K氨 氣沖洗。約1 0 m丨的氨液被濃縮後,每隔1分鐘加入納金 屬(約50 mg)至靛青色永久出現。儘速加入乾冰(約 ntg),使生成白色沉澱。使氨揮發,再Μ乾冰與殘餘物反 應。當所有氨均已揮發,加入水(1 0 m 1 ),且小心加入濃A -35-l The paper size applies the Chinese National Standard (CNS) &gt; 4 specifications (210X297 mm) glTllO ^ (Please read the precautions on the back before filling this page) Order ----------- Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Invention Description. S), 3.73 (1H, dd, J2, 5 Hz), 2.90 (2H, m), Delta C (D20, 75 Mhz) 175.30, 172.89 , 141.18, 135.43, 129.34, 128.86, 53.60, 35.178, 31.78, 28.16. Example 5: The stability of cysteine-S-4-methylbenzoic acid to acid hydrolysis conditions was added to the Schlenk test tube. Cysteine-S-4-methylbenzoic acid ammonium (lg) was dissolved in water with frozen methanesulfonic acid (3M) and thiohydroacetic acid (4%). Use a vacuum pump to remove morale, seal the nozzle, and heat it to 100 Torr, 48 hrs. After it was allowed to cool, cysteine-S-4-methylcrate ammonium formate was separated by centrifugation, and water was washed with quantification method M (3x50π &gt; 1). iOU .: Separation of cysteine from cysteine-S-4-methylbenzoate ammonium Cysteine-S-4-methylammonium benzate (200 mg, 0.76 mmol) was added to both necks Pear-shaped bottle ... The flask was cooled in dry ice / propane and flushed with K ammonia. After about 10 m of ammonia was concentrated, nanometal (about 50 mg) was added every 1 minute until indigo appeared permanently. Add dry ice (approximately ntg) as soon as possible to produce a white precipitate. The ammonia was evaporated and the dry ice was reacted with the residue. When all ammonia has evaporated, add water (10 m 1) and carefully add concentrated

------鹽酸,調整pH值至約8 。使混合物產生24小時氣體,再K 濃鹽酸調整pH值至約5後,搅拌此懸浮液。Μ過濾收集所 得的沉澱,將其溶於除氣水中(約10 ml) ’再加入 cMthiothreitol(114 fflg),並使其於氮氣下’ 5〇ΐ!中攪拌 2小時。將所得懸浮液M W h a t m a η Η 〇 .〗澳紙過滤’且經揮 發得膠狀物.。滴加無水經蒸餾乙醇得2群白色结晶半胱胺 酸,產率為30 mg 。 節例7 由溶菌酶中分離半胱胺酸 本紙張尺度適用中國國家標準(CNS )/4規格(2丨〇&gt;&lt;297公釐) 83.3. 10,000 (請先閲讀背面之注意事項再填寫本頁)------ hydrochloric acid, adjust the pH value to about 8. The mixture was allowed to generate gas for 24 hours, and the pH was adjusted to about 5 with K concentrated hydrochloric acid, and then the suspension was stirred. The resulting precipitate was collected by filtration, dissolved in degassed water (approximately 10 ml), and cMthiothreitol (114 fflg) was added thereto, followed by stirring under nitrogen for 5 hours. The resulting suspension, M W h a t m a η 〇 〇 .Australia was filtered 'and volatilized to give a gum. Two groups of white crystalline cysteine were obtained by dropwise addition of anhydrous distilled ethanol, and the yield was 30 mg. Example 7 Isolation of cysteine from lysozyme The size of the paper is applicable to the Chinese National Standard (CNS) / 4 (2 丨 〇 &gt; &lt; 297 mm) 83.3. 10,000 (Please read the notes on the back before filling (This page)

A 7 , , __ B7 __ 五、發明説明(. 將溶菌酶(10g)溶於水中(1L),再加入三氯醋酸(50 g ),且於4 t儲放過夜。利用離心方法分離所得的沉澱, K丙酮清洗(300 ml,x3)後乾燥。產率為9. 95 g。 於氮氣下,將經變性的溶菌酶溶於除氣水中,再加入 dithiothreitol(2.14 g)。將所得混合物於室溫下震盪過 夜。 加入無水經蒸餾乙酵(200 ml),且K5k下離心1〇分。將 沉澱物再溶於乙中(200 m ])後,再離心。重覆最後的操 作步驟。 將4-氯甲基苯甲酸(1.54 g)溶於除氣水(42 ml )及濃縮 氨水(7 in 1)。將所得溶液加入上述分離之沉澱中,且於氮 氣下,室溫中震盪過夜。 加入無水經蒸餾乙醇(2 00 m 1 ),且K 5k離心10分。再將 沈澱物溶於乙醇(200 ml)後,再離心。重覆最後的操作步 驟。於乾燥箱中,將所分離的沉澱物分離。 K乙醇清洗上述所得,發現其含有似蛋白物質。因此* 混合上述之上清液,於5 k離心10分後*分離其沉澱物。再 一加人去氣水及dithiothi-eitol,且於氮氣中,室溫下震邋 過夜。再加入丙酮(10 ml),且將於5k中離心10分。 經濟部中央橾準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 將沉澱物於去氣水(125 ml)中溶解,且與溶於水(21 ml)之4-氯甲基苯甲酸(0.77 g)及濃縮氨水(4 ml)反應。 再於氮氣中,室溫下震盪過夜。再加入丙酮(100 ml),且 將於5k中離心1 0分。將所得沉澱物於乾燥箱中乾燥後*與 先前得到的沉澱物相混。其總產率為9 . 5 g ,( 87 %,根 據溶菌酶胺基酸序列)。 -37 - 本紙張尺度適用中國國家標準(CNS )_A4規格(210X297公釐) 83. 3. 10,000 經濟部中央標準局員工消費合作社印裝 A7 . . _B7 _____ 五、發明説明(多0 將所得的蛋白質分液(9.5 S)於含有4X v/v氫硫基醋酸 之3M甲磺酸(95 ml)中,於真空下* 100 t,加熱48小時 。待冷卻後,將水解物與水相混(9 5 m 1) *且將所得的混 合物打入(50 ml/min)於其底座装備有FM1實驗室泵QSY 之Dowex 1X2-400離子交換樹脂管柱中態’ 250 g) ° 當所有的水解物K.泵打入管柱後’將經稀釋 (pH2,0 1L)及水(1.25 L)打入管柱中(50 mi/min)。利用 泵,將H*管柱與Dowex 5(^8-100離子交換樹脂管柱(01^態 1 2 5 0 g )相連。將經稀釋的氨水(2 3: v / v,6 L ) K泵打入 H +管柱(50 ml/min),且將沖提液打人〇H_管柱中。由 〇H_管柱底部收集分液(2L)。 T L C 分析(A n a 11 e c h S ί 1 i c a G S p 1 a t e s,η - B u 0 Η : /\c0H:H20(2:l:l v/v)展開液:寧希德林(1¾ v/v 於 MeOH:(Hac AcOH (97:3 v/v))顯示精胺酸於分液2及3中 出現。 將精胺酸分液沖提出後,停止泵的運作,且將其與0H--…-管柱相連,K水沖提(2L)。當持續由0H-管柱收集分液時 (2L) *再重新開啟泵。 當持續由管柱底部收集50〇 分液時,由泵再打入經稀 釋酷酸水溶液(0.25¾ v/v,〗〇L)。持續泵的蓮作,直到於 沖提液中不再有寧希德林出現。 tSTLC 分析(Analtech Si l.ica GS plates, n-BuOH: v/v)展開液寧希德林(U v/v於 MeOHUac AcOH (97:3 v/v))顯示胺基酸混合物的出現( - 3 8 ~ 本紙張尺舰财S國家標準(21〇&gt;&lt;297公着1 (請先閲讀背面之注意事項再填寫本頁)A 7,, __ B7 __ V. Description of the invention (. Dissolve lysozyme (10 g) in water (1 L), add trichloroacetic acid (50 g), and store at 4 t overnight. Isolate the obtained by centrifugation The precipitate was washed with K acetone (300 ml, x3) and dried. The yield was 9.95 g. Under nitrogen, the denatured lysozyme was dissolved in degassed water, and then dithiothreitol (2.14 g) was added. Shake overnight at room temperature. Add anhydrous distilled acetic acid (200 ml) and centrifuge at K5k for 10 minutes. Re-dissolve the precipitate in B (200 m) and centrifuge again. Repeat the last procedure. 4-Chloromethylbenzoic acid (1.54 g) was dissolved in degassed water (42 ml) and concentrated ammonia (7 in 1). The resulting solution was added to the separated precipitate and shaken overnight at room temperature under nitrogen. Add anhydrous distilled ethanol (200 m 1), and centrifuge at 5 K for 10 minutes. Dissolve the precipitate in ethanol (200 ml) and centrifuge again. Repeat the last operation step. In a dry box, place all The separated precipitate was separated. K was washed with ethanol and found to contain a protein-like substance. So * mix the above The supernatant was centrifuged at 5 k for 10 minutes * to separate the precipitate. Add degassed water and dithiothi-eitol, and shake overnight at room temperature under nitrogen. Add acetone (10 ml), and It will be centrifuged for 10 minutes in 5k. Printed by the Consumer Cooperatives of the Central Bureau of Quasi-Staff of the Ministry of Economic Affairs (please read the precautions on the back before filling this page). Dissolve the precipitate in degassed water (125 ml) and dissolve it in Water (21 ml) of 4-chloromethylbenzoic acid (0.77 g) and concentrated ammonia (4 ml) were reacted. Then under nitrogen, shake at room temperature overnight. Add acetone (100 ml), and it will be in 5k Centrifuge for 10 minutes. After drying the obtained precipitate in a drying cabinet *, mix it with the previously obtained precipitate. Its total yield is 9.5 g (87%, according to the lysozyme amino acid sequence). -37 -This paper size is in accordance with Chinese National Standard (CNS) _A4 (210X297 mm) 83. 3. 10,000 Printed A7 by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (more than 0 will divide the obtained protein into Solution (9.5 S) in 3M methanesulfonic acid (95 ml) containing 4X v / v hydrothioacetic acid under vacuum * 100 t Heat for 48 hours. After cooling, mix the hydrolysate with water (9 5 m 1) * and pour the resulting mixture (50 ml / min) on its base. Dowex 1X2-400 equipped with FM1 laboratory pump QSY The state of the ion exchange resin column '250 g) ° When all the hydrolysates K. pump into the column' diluted (pH2, 0 1L) and water (1.25 L) into the column (50 mi / min). Using a pump, connect the H * column to Dowex 5 (^ 8-100 ion exchange resin column (01 ^ state 1250 g). Dilute ammonia (2 3: v / v, 6 L) K Pump into H + column (50 ml / min), and punch the eluent into oH_ column. Collect the liquid separation (2L) from the bottom of oH_ column. TLC analysis (A na 11 ech S ί 1 ica GS p 1 ates, η-B u 0 Η: / \ c0H: H20 (2: l: lv / v) Developing solution: Ning Xidering (1¾ v / v in MeOH: (Hac AcOH (97: 3 v / v)) shows that spermic acid appears in the liquids 2 and 3. After the spermine liquid is flushed out, stop the pump operation, and connect it to the 0H --...- tube column, K water flush (2L). When the liquid is continuously collected and separated by the 0H-column (2L) * The pump is turned on again. When the 50ml liquid is continuously collected from the bottom of the column, the pump is charged into the diluted aqueous solution of acid (0.25 ¾ v / v, 〖〇L). Continue pumping until no more Ningdrin appears in the eluent. TSTLC analysis (Analtech Si l.ica GS plates, n-BuOH: v / v) The developing solution Ning Xidering (U v / v in MeOHUac AcOH (97: 3 v / v)) showed the emergence of the amino acid mixture (-3 8 ~ this paper ruler S National Standards (21〇 &gt; &lt; 297 Publication 1 (Please read the precautions on the back before filling this page)

經濟部中央標準局員工消費合作社印裝 A7 ‘ , B7 五、發明説明(&gt;7). 於分液11,1 2及1 3)。 當由管柱底部收集1L分液時,將經稀釋醋酸水溶液 (2.5¾ v/v, 12L)由泵打入0H-管柱。持續泵的運作,直 到於冲提液中不再偵測到寧希德林。 由 T L C 分析(A n a 11 e c h S Π i c a G S p 1 a t e s,η - B u Ο Η : Ac0H:H20(2:l:l v/v)展開液寧希德林(u v/v於 MeOH:G]ac AcOH (97:3 v/v))顯示天門冬酸(於分液 15-18 )及半胱&amp;酸-S-4-甲基苯甲酸(分液18-25)之出 現。 將含有半胱胺酸-S-4-甲基苯甲酸的分液相琨,且Μ稀 釋的硫酸調整pH值至2 。將所得溶液Κ25 ml/min通過 D〇wex lX2-400離子交換樹脂(H*態,250 g)。當所有的 水解物被打入管柱中後,接著再打入經稀釋的硫酸水溶液 (fH2.0,500 ml)及水(500 ml)。 將經稀釋的氨水(2% v/v, XXL)打人管柱中(25 ml/inin)。再由0H-管柱底部回收分液(約15(}1111)。 TLC 分析(Anaitech silica GS plates, n-BuOH: —— —ftC〇H:H2〇(2:l*.l v/v)展開液寧希德林(1;K v/v於Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 ‘, B7 V. Description of the invention (&gt; 7). In liquid separation 11, 12 and 1 3). When 1 L of liquid was collected from the bottom of the column, the diluted acetic acid aqueous solution (2.5¾ v / v, 12 L) was pumped into the 0H-column by a pump. The pump continued to operate until Ningdrin was no longer detected in the eluent. Analysis by TLC (A na 11 ech S Π ica GS p 1 ates, η-B u 〇 Η: Ac0H: H20 (2: l: lv / v) developing solution Ning Xiedlin (uv / v in MeOH: G) ac AcOH (97: 3 v / v)) shows the presence of aspartic acid (on liquid separation 15-18) and cyste &amp; acid-S-4-methylbenzoic acid (on liquid separation 18-25). Will contain The separation phase of cysteine-S-4-methylbenzoic acid, and the pH value adjusted by 2 diluted sulfuric acid to 2. The resulting solution K25 ml / min was passed through Dowex 1X2-400 ion exchange resin (H * State, 250 g). After all the hydrolysate has been charged into the column, then the diluted sulfuric acid aqueous solution (fH2.0, 500 ml) and water (500 ml) are charged. The diluted ammonia water (2 % v / v, XXL) into a column (25 ml / inin). The liquid was recovered from the bottom of the 0H-column (approximately 15 (} 1111). TLC analysis (Anaitech silica GS plates, n-BuOH: — — —FtC〇H: H2〇 (2: l * .lv / v) developing solution Ning Xidlin (1; K v / v at

MeOH:Giac Ac〇H (97:3 v/v))顯示了半胱胺酸-S-(4-甲基 苯甲酸)铵於分液12中出現,經揮發後得白色粉末之半胱 胺酸-S- U-甲基苯甲酸)銨,產率為0.47 g, (3296,根 據衍生的溶菌酶)。 範:分離(50%2H,13C* 15M -經標示半胱胺酸) -S-4-甲基苯甲酸銨MeOH: Giac AcOH (97: 3 v / v)) showed the appearance of cysteine-S- (4-methylbenzoate) ammonium in separation 12, and the cysteamine was obtained as a white powder after volatilization. Acid-S-U-methylbenzoate) ammonium, yield 0.47 g (3296, based on lysozyme derived). Fan: Separation (50% 2H, 13C * 15M-labeled cysteine)-S-4-methylammonium benzoate

將1〇 g含有麩醯胺酸(如範例9中製備)之50妬2H,13C -39 -10 g of 50 g containing glutamic acid (as prepared in Example 9) 2H, 13C -39-

度適用中國( CNS X 297公董〉 83. 3. 10,000 (請先閱讀背面之注意事項再填寫本頁) 衣丨 _ n _ - - - II - m L- i - - -1 I m n^— ------I— I -1 I-- 經濟部中央標準局員工消費合作杜印製 A7 B7 五、發明説明(Μ) * -經標不胺基酸混合物溶於436.2 ml水中及436.2 ml 重氫水(D2〇)中,其含有 (8 g),Na(:1(5 *碟酸鹽緩衝液(cH7,100 ml) ,TK-M金屬鹽(20 ml), 氯化鈣(濃縮液,4 ml),维生素混合液(1.4 mn,核黃素 (2 ml)* P -氨基苯甲酸(0.2 ml)。將所得的溶液過滅使無 菌’且均分於·—個500 ml震蓮三角瓶中。種植ATCC 31 448 (―種經重姐工程化使表現人類胰島素a鏈之大腸 桿爾)至溶液中,且於37¾中震盪24小時。 將此培養液離心,將所分離得的细胞沉澱經冷凍乾燥後 ,得約l.lg乾燥物料。 再Mdithiothleitol及4-氯甲基苯甲酸與细胞沉澱反應 ,且利用根據範例7的方法進行水解。除了使用2 5 g之Applicable to China (CNS X 297 Public Director) 83. 3. 10,000 (Please read the precautions on the back before filling out this page) Clothing 丨 _ n _---II-m L- i---1 I mn ^ — ------ I— I -1 I-- Consumption cooperation by employees of the Central Bureau of Standards, Ministry of Economic Affairs, Du printed A7 B7 V. Description of the invention (M) *-The standard amino acid mixture is dissolved in 436.2 ml of water and 436.2 In ml of deuterated water (D2〇), it contains (8 g), Na (: 1 (5 * disc buffer (cH7,100 ml), TK-M metal salt (20 ml), calcium chloride ( Concentrated solution, 4 ml), vitamin mixed solution (1.4 mn, riboflavin (2 ml) * P-aminobenzoic acid (0.2 ml). The resulting solution was sterilized to make it sterile and evenly divided into 500 ml. In the Zhenlian triangle flask, plant ATCC 31 448 (―a large intestine rod that expresses human insulin a chain engineered by heavy sister engineering) into the solution, and shake in 37¾ for 24 hours. Centrifuge the culture solution and separate the The obtained cell pellet was freeze-dried to obtain about 1.1 g of dried material. Then Mdithiothleitol and 4-chloromethylbenzoic acid were reacted with the cell pellet and hydrolyzed by the method according to Example 7. Except using 2 5 g of

Dowex 1X2-400 離子交換樹脂(H +態)及 D〇wex 50X8-100 離 子交換樹脂(0 Η -態)之外,乃根據範例7的方法純化所得 的生物質量。將冲提液中含有(50%2H,13C ,1SN -經標 示半胱胺酸)-S-4 -甲基苯甲酸銨之分液相混,且以經稀釋 硫酸將cH值調整至2 。將所得的溶液Kl〇mi/min通過 &amp;〇wex 1X2-4 00離子交換樹脂(H+態,5 g)。當所有的水 解液被打入管柱中,接著再打入稀釋硫酸水溶液(出2.0, 200 ml)及水(100 ml)。 把經稀釋的氨水(2¾ v/v, 1L)打入(10 ml/min)管柱中 。由0H-管柱底部收集分液(約15 ml)°TLC分析 (Analtech Silica GS plates, n-BuOH:Except for Dowex 1X2-400 ion exchange resin (H + state) and Dowex 50X8-100 ion exchange resin (0 Η-state), the biomass obtained was purified according to the method of Example 7. The eluate contains (50% 2H, 13C, 1SN-labeled cysteine)-S-4-ammonium methylbenzoate, and the cH value is adjusted to 2 with diluted sulfuric acid. The resulting solution K10mi / min was passed through &amp; 0wex 1X2-4 00 ion exchange resin (H + state, 5 g). When all the hydrolysate has been pumped into the column, then dilute the sulfuric acid solution (2.0, 200 ml) and water (100 ml). Pour diluted ammonia (2¾ v / v, 1L) into the (10 ml / min) column. Collect and separate the liquid (about 15 ml) from the bottom of the 0H-column °° C analysis (Analtech Silica GS plates, n-BuOH:

AcOH:H2〇(2:l:l v/v)展開液寧希德林(1¾ v/vm MeOH:Glaq AcOH (97:3 v/v))顯示其出現一種姐成份,其 -4 0 &quot; 本紙張尺度適用中國國家標準(CNS ),4規格(210X297公釐) 83. 3. 10,000 (請先閱讀背面之注意事項再填寫本頁) 、-0 S. 經濟部中央標隼局員工消費合作社印製. A7 , , B7 五、發明説明(今^/) “值與範例1中製備的半胱胺酸-S-(4-甲基苯甲酸)銨相 同。將適當分液揮發得(50%2H,13C ,15N -經標示半胱 胺酸)-S-4-甲基苯甲酸銨為白色粉末,產率為30mg 。. SLJO- 將 f:h lorel la sp培養液於分別 Μ &gt;98% 1 3C02及 &gt;98% 為主要碳源及氮源之1:1 v/v水/重氫水中生長 。將所得的藻類生物質量(約500 g) Μ (水)稀釋至約10% 〜.V., 黏稠狀後,使置&amp;冰上,再通過均質機三次使細胞破裂。 把所得的黏稠物於5,000 rpm,5¾中離心25分。收集上清 液,再將沉澱物重新溶於水中*再於相同條件下離心。重 覆此步驟二次。將上清液相混,與三氯醋酸(最終濃度為 5¾ v/v)反應後,使於5勺中儲存過夜。 將所得懸浮液於5 , 000 r pm,5 t:中雛心30分。倒除上清 液,Μ等體積丙酮溶解沉澱,再於5, 〇〇〇 rpm,中離心 15分。將沉澱於500 ml之乙醇/乙醚中溶解,且於減壓中 乾燥。 將所得的52 g之50%2H* 13C ,15H-經標示蛋白質於真 --------空中,Μ含有4¾ v/v之氫硫基醋酸之3M甲碼酸(520 ml)中 加熱至1 0 0 t:,4 8小時。待冷卻後,緩慢地將水解物倒入 水中(5 2 0 m 1 ),且於冰浴中冷卻,且將所得的混合物於冰 浴中置放約10分。將所得經冷卻溶液離心(RC-3B,250 m i離心管,5 k * 1 0分)。將上清液Μ泵打入(2 〇 〇 rol/πι丨n) Dowex 1X2-400離子.父換樹脂官柱中(Η +態’ 2.5 kg) *其於底座装備有FM1實驗室泉模型QD。 當所有的水解物均被打入管柱中•接著打人(2 00 -41 - 本紙張適用中國國家標準(CNS )_.A4規格(210X297公釐) 83. 3. 10,000 I---_---„--衣-- - · ” /L (請先閲讀背面之注意事項再填寫本買) 、va 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(以) 經稀釋的硫酸水溶液(pH2.0,7.5L)及水(11L) 至管柱中。 將H*管柱經泵與Dowex 50X8-100離子交換樹脂(0H-態, 2.5 kg)管柱相連。由H +管柱打入200 ml/rain經稀釋氨水 (2¾ v/v,50L) »且其沖提液亦通過0H_管柱。由0H-管 柱底部收集分液(2L)。 TLC 分析’(Analtech Silica GS plates, n-BuOH: Ac〇H:H20(2:l:l v/v),展開液寧希德林(1¾ v/v於AcOH: H2〇 (2: 1: lv / v) developing liquid Ning Xidering (1¾ v / vm MeOH: Glaq AcOH (97: 3 v / v)) showed that it appeared a sister component, which -4 0 &quot; This paper size applies to Chinese National Standards (CNS), 4 specifications (210X297 mm) 83. 3. 10,000 (Please read the notes on the back before filling out this page), -0 S. Employee Consumer Cooperatives, Central Bureau of Standards, Ministry of Economic Affairs Printed. A7,, B7 V. Description of the invention (today ^ /) "The value is the same as the cysteine-S- (4-methylbenzoic acid) ammonium prepared in Example 1. The appropriate liquid separation is evaporated to give (50 % 2H, 13C, 15N-labeled with cysteine) -S-4-methylbenzoic acid ammonium as white powder, yield 30mg .. SLJO- f: h lorel la sp culture solution in each M &gt; 98% 1 3C02 and &gt; 98% are the main carbon and nitrogen sources in 1: 1 v / v water / dehydrogen water. Dilute the resulting algal biomass (about 500 g) M (water) to about 10% ~ .V. After being viscous, place on &amp; ice, and then break the cells three times with a homogenizer. Centrifuge the obtained viscous substance at 5,000 rpm, 5¾ for 25 minutes. Collect the supernatant and re-precipitate Soluble in water * under the same conditions Centrifuge. Repeat this step twice. Mix the supernatant and react with trichloroacetic acid (final concentration: 5¾ v / v) and store in 5 scoops overnight. Store the resulting suspension at 5,000 r pm 5 t: 30 minutes in the middle heart. The supernatant was removed, the equal volume of acetone was used to dissolve the precipitate, and the mixture was centrifuged at 5,000 rpm for 15 minutes. The precipitate was dissolved in 500 ml of ethanol / ether, and Dry under reduced pressure. The obtained 52 g of 50% 2H * 13C, 15H-labeled protein in the true air, M 3M code containing 4¾ v / v of hydrothioacetic acid Heat in acid (520 ml) to 100 t :, 4 8 hours. After cooling, slowly pour the hydrolysate into water (520 m 1), and cool in an ice bath, and the resulting mixture Place in an ice bath for about 10 minutes. Centrifuge the obtained cooled solution (RC-3B, 250 mi centrifuge tube, 5 k * 10 minutes). Pump the supernatant M into (200 rol / πι 丨n) Dowex 1X2-400 ion. In the parent resin column (Η + state '2.5 kg) * It is equipped with FM1 laboratory spring model QD on the base. When all the hydrolysate is driven into the column • then People (2 00 -41-paper Zhang applies Chinese National Standard (CNS) _.A4 specification (210X297 mm) 83. 3. 10,000 I --------------'' / L (Please read the precautions on the back before (Fill in this purchase), va printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (in) Diluted sulfuric acid aqueous solution (pH 2.0, 7.5L) and water (11L) into the column. The H * column was pumped to a Dowex 50X8-100 ion exchange resin (0H-state, 2.5 kg) column. Inject 200 ml / rain of diluted ammonia (2¾ v / v, 50L) »from the H + column and the eluent also passed through the 0H_ column. The liquid was collected from the bottom of the 0H-column (2L). TLC analysis ’(Analtech Silica GS plates, n-BuOH: Ac〇H: H20 (2: l: l v / v), developing solution Ning Xidering (1¾ v / v in

Me〇H:Glac AcOH (97:3 v/v))顯示 50%2H, 13C , 1SH-經 標示精胺酸於分液11 -24中出現。 於冲提精胺酸分液後,停止泵的蓮作,且將其與0H-管 柱直接連接。重新開啟,將水(14 L)打人0H-管柱。繼纘 收集分液(2 L )。 當持續由管柱底部收集2L分液時,將經稀釋的醋酸水溶 液(0. 25¾ v/v)打入0H-管柱中。持續運作泵*直到於沖 提液中測不到寧希德林反應。 T L C 分析(A n a 11 e c h S i 1 i c a G S p 1 a t e s,η - B u 0 Η : 〜— AcOH:H2〇(2:l:l v/v),展開液寧希德林(1% v/v於Me〇H: Glac AcOH (97: 3 v / v)) showed 50% 2H, 13C, 1SH- labeled Arginine appeared in separations 11-24. After extracting the arginine solution, stop the pump of the pump and connect it directly to the 0H-column. Turn it back on and punch water (14 L) into the 0H-column. Follow up and collect the liquid (2 L). When the 2L separation was continuously collected from the bottom of the column, the diluted aqueous acetic acid solution (0.2525 v / v) was driven into the 0H-column. Continue to run the pump * until no Ningdrin reaction is detected in the eluent. TLC analysis (A na 11 ech S i 1 ica GS p 1 ates, η-B u 0 Η: ~ — AcOH: H2〇 (2: l: lv / v), developing solution Ning Xidlin (1% v / v in

MeOH:Giac AcOH (97:3 v/v))顯示50%2H, 13C , 15N-經 標示混合胺基酸(包括50%2H,13C ,15H-標示麩等胺酸 )於46-58分液中出規。利用冷凍乾燥分離50% 2H,13C ,15N-經混合胺基酸為淡黃色粉末。 將上述分離之50%2H,13C * 1SH-經標示混合胺基酸溶 於水中(8L),.且从泵打人(50ml/min)Dowex 50X8-100離子 交換樹脂(醋酸根態* 500 g)管柱中。收集分液(2L)。當 -4 2 ~ •l·I—I——-1—Q! (請先閱讀背面之注意事項再填寫本頁〕 訂 --Θ--- 本紙張尺度適用中國國家標準(〇^)/4規格(2丨0父297公釐) 83. 3. 10,000 A7 ^ _________._B7 ___:_ 五、發明説明(+/) 所有混合胺基酸溶液均被加入管柱中,κ泵將水打入管柱 中,直到所有的胺基酸被冲提出。 TLC 分析(Analtech Silica GS plates, n-BuOH: Ac0H:H20(2:l:l v/v),展開液寧希德林(1¾ v/v 於 MeOH:Glac AcOH (97:3 v/v))顯示了 50%2H,13C , 15H-經標示混合胺基酸(不含50%2H,13C ,15N-標示麩 醯胺酸)於分液卜6中出現,其以冷凍乾燥分離為淡黃色 粉末,產率20.63 g。 Μ稀釋醋酸(3 %,6L)清洗管柱*於分液7-8中50% 2H* 13C ,15Ν -標示趣醯胺酸為唯一的胺基酸組成份,其 經冷凍乾燥分離為白色粉末。產率2.9 g 。由於13C , 15N 及 2H耦合於 4.19, 3_97, 3.72, 3.48, 3.11, 2.68, 2.26,2.07及 1.83而造成 DeltaH (D20,300 MHz)廣泛多 變性。Delta C (D2〇, 75 MHz) 177.30(d), 173.92(q), 54.20 (d),53.49(d),51.58-50.37 (m), 35.50-34.28 U), 30.36 (d), 29.64 (d),及 25.92-24.99(m)。 -------於去除50% 2H ’ 13C ,1SN-標示麩醯胺酸前後,分別以 HPLC檢驗50%2H,13C ,15N-經標示胺基酸混合物(胺基 經濟部中夬標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 酸衍生為鄰笨二甲醛衍生物,SUpelC0Sil LC-Ιδ, 15x4.6mm管柱*非直線梯度由1〇〇 %四氫呋喃Π〇%): O2PCU(0.1M):K0Ac (0.2M)至 100 % 甲醇(80%):醋酸 (0.1N* 2 0%)超過55分)。除了於通過醋酸樹脂後,可完 全去除相對應的麩醯胺酸峰之外,其HP LC層析圖譜實際上 完全枏同。 -43 - I紙張尺度適用中國國家標準(CNS M4規格(2丨0X297公釐&quot;Ϊ : 83. 3. 10,000 經濟部中央標隼局員工消費合作社印製 A7 , l B7___ 五、發明説明(〇) 節例1 0 將9-舞基甲基氯甲酸鹽(3δ8 g, η „〇1)及1羥基丁二 藤亞胺(1·73 g,5mniol)溶於1,4 -二氧陸圜中(20 ml)且 Μ三乙胺反應(2.09 ml, 15 mmol)。將所得懸浮液攪拌 15分。 將,15N-經標示麩醯胺酸(188 g, Η mmo丨)與無水碳酸鈉(2· 54 g,20 mmol)溶於水中,且將 所得溶液加入上▲所製備的9 -葬基甲基-H-羥基丁二醯基 甲酸.鹽懸浮液中。把所得的懸浮液於室溫中攪拌過夜。 使溶液經蒸發乾燥,且使其於氯仿(約200 ml)與水中( 約200 ml)分層。以濃鹽酸酸化水層,使其出值為約2 , 再Μ乙酸乙酯萃取。使其有機層乾燥(無水硫酸鎂),且於 減壓下乾燥,而得推定為H-葬基甲基50%2H,13C , 15N -經標示麩醯胺酸衍生物為粉末狀。 將三聚甲醛(2.70 g, 30 mmol)及p-苯甲磺酸(少量)加 入如上述所得的粉末中,且將其溶於甲苯,使其迴流過夜 。使此溶液冷卻,且於減壓下使揮發得膠狀物。此殘餘物 --------於乙酸乙酯(約200 ml)及水(約200 m 1)中分層*使水層乾 燥(無水硫酸鎂),且於減壓下使揮發乾燥而得粉末狀鸣嗖 唾_ 0 把所得粉末溶於無水四氫呋喃(50 m 1)及二異丙基碳化 二亞胺(2.06 ml , 13.1 mmol)中,於K乾冰/丙_浴冷卻 前,使其於室溫下攪拌30分。 另外,將15N-氯化銨(2.86 g, 52.5 mmol)加入 Schlenk試管中,且將其溶於二甲基亞磾(25 ml)中。密 λ -4 4 ~ 本紙張尺度適用中國國家標準(CNS )._Λ4規格(210X297公釐) HWo (請先閲讀背面之注意事項再填寫本瓦)MeOH: Giac AcOH (97: 3 v / v)) shows 50% 2H, 13C, 15N- labeled mixed amino acids (including 50% 2H, 13C, 15H-labeled bran and other amino acids) at 46-58 Creampie regulations. 50% 2H, 13C, 15N-mixed amino acids were separated into light yellow powder by freeze-drying. The 50% 2H, 13C * 1SH-labeled mixed amino acid was dissolved in water (8L), and Dowex 50X8-100 ion exchange resin (acetate state * 500 g) was pumped (50ml / min) from the pump. ) In the column. Collect the liquid (2L).当 -4 2 ~ • l · I—I ——- 1—Q! (Please read the precautions on the back before filling out this page) Order --Θ --- This paper size applies Chinese National Standards (〇 ^) / 4 specifications (2 丨 0 parent 297 mm) 83. 3. 10,000 A7 ^ _________._ B7 ___: _ 5. Description of the invention (+ /) All mixed amino acid solutions are added to the column, and the κ pump beats the water Into the column until all the amino acids have been washed out. TLC analysis (Analtech Silica GS plates, n-BuOH: Ac0H: H20 (2: l: lv / v), developing solution Ningdlin (1¾ v / v in MeOH: Glac AcOH (97: 3 v / v)) shows 50% 2H, 13C, 15H-labeled mixed amino acids (excluding 50% 2H, 13C, 15N-labeled glutamic acid) Appeared in liquid solution 6, which was separated into light yellow powder by freeze drying with a yield of 20.63 g. Μ diluted acetic acid (3%, 6L) to clean the column * 50% 2H * 13C in the separation 7-8, 15N-labeled Trisamino acid is the only amino acid component, which is freeze-dried and separated into white powder. Yield: 2.9 g. Since 13C, 15N and 2H are coupled to 4.19, 3_97, 3.72, 3.48, 3.11, 2.68, 2.26, 2.07 And 1.83 caused DeltaH (D20, 300 MH z) Broad variability. Delta C (D2O, 75 MHz) 177.30 (d), 173.92 (q), 54.20 (d), 53.49 (d), 51.58-50.37 (m), 35.50-34.28 U), 30.36 ( d), 29.64 (d), and 25.92-24.99 (m). ------- Before and after removing 50% 2H '13C, 1SN-labeled glutamic acid, check HPLC for 50% 2H, 13C, respectively, 15N-labeled amino acid mixture (printed by the Consumer Cooperative of the China Standards Bureau of the Ministry of Amine Economy (please read the precautions on the back before filling this page). The acid is derived from o-benzaldehyde derivative, SUpelC0Sil LC-Ιδ, 15x4.6mm column * non-linear gradient from 100% tetrahydrofuran (10%): O2PCU (0.1M): K0Ac (0.2M) to 100% methanol (80%): acetic acid (0.1N * 2 0%) 55 points). Except that the corresponding glutamic acid peak can be completely removed after passing through the acetate resin, its HP LC chromatogram is actually completely different. -43-I Paper size applies Chinese national standard (CNS M4 specification (2 丨 0X297 mm &quot; Ϊ: 83. 3. 10,000 printed by A7, l B7___, Consumer Cooperatives of the Central Bureau of Standards, Ministry of Economic Affairs) 5. Description of the invention (〇 ) Example 10 0 9-Methylmethylchloroformate (3δ8 g, η „〇1) and 1-hydroxysuccinimide (1.73 g, 5mniol) were dissolved in 1,4-dioxolane Rhenium (20 ml) and M triethylamine (2.09 ml, 15 mmol). The resulting suspension was stirred for 15 minutes. 15N-labeled glutamic acid (188 g, Η mmo 丨) and anhydrous sodium carbonate were stirred. (2.54 g, 20 mmol) was dissolved in water, and the resulting solution was added to the 9-pentylmethyl-H-hydroxysuccinyl formic acid. Salt suspension prepared above. The resulting suspension was placed in Stir overnight at room temperature. Allow the solution to evaporate to dry and separate the layer in chloroform (about 200 ml) and water (about 200 ml). Acidify the aqueous layer with concentrated hydrochloric acid to give a value of about 2, then acetic acid Ethyl acetate extraction. The organic layer was dried (anhydrous magnesium sulfate) and dried under reduced pressure to obtain a presumed H-carbomethyl 50% 2H, 13C, 15N-labeled glutamic acid derivative as powder Add paraformaldehyde (2.70 g, 30 mmol) and p-benzylsulfonic acid (a small amount) to the powder obtained as described above, and dissolve it in toluene and allow it to reflux overnight. Allow the solution to cool and place on The residue was reduced to a gum under reduced pressure. This residue -------- layered in ethyl acetate (about 200 ml) and water (about 200 m 1) * The aqueous layer was dried (anhydrous magnesium sulfate ), And evaporated to dryness under reduced pressure to obtain a powdered salamander saliva_ 0 The obtained powder was dissolved in anhydrous tetrahydrofuran (50 m 1) and diisopropylcarbodiimide (2.06 ml, 13.1 mmol), and Before the K dry ice / propane bath was cooled, it was stirred at room temperature for 30 minutes. In addition, 15N-ammonium chloride (2.86 g, 52.5 mmol) was added to a Schlenk test tube, and it was dissolved in dimethylsulfinium ( 25 ml) Medium. Lambda -4 4 ~ This paper size applies Chinese National Standard (CNS). _Λ4 size (210X297 mm) HWo (Please read the precautions on the back before filling in this tile)

-QI I、訂— — .A ! I - —^n -I -- - - - I ! . 經濟部令夬標李局員工消費合作社印製 A7 B7 五、發明説明((^) 封管蓋’將此溶液浸泡於乾冰/丙嗣浴中使冷凍。打開管 蓋’加入氫化納(2. 1 g,60%分布於油中,52.5 mmol , 先Μ己焼清洗再與氮氣中乾燥)至管中。立即封閉試管, 且將其支臂與含有嗶唑啶酮衍生物之冷凝三角瓶中氣泡生 成管相連。 使Sc h 1 e n k試管中的二甲基亞颯溶液解凍,其中所產生 的1 5N -氨於啤唑啶溶液中冷凝。待所有的i 5 N _氨均經蒸餾 * Μ夾子扣住產氣管使其關閉。於室溫下使晖唑啶酮溶液 回溫過夜。 將水(2 m丨)加入所得溶液中,且攪拌30分。於減壓下使 溶液揮發乾燥。 使殘餘物於乙醇(5 0 m丨)及水(1 〇 ^ 1 )中溶解。Μ氫氧 化納(1Μ, 10.5 ml)與此溶掖反應*且迴流2.5小時,而 得Η-經保護麩醯胺衍生物。待冷卻後,以六氫吡啶(1 . 04 ml, 10.5 mmol)與溶液反應,且於室溫中攢拌過夜。 將所得溶液於減壓下揮發乾燥,且於氯仿(約100 ml)及 水(約100 ml)中分層。K二乙酸(約100 ffll)萃取水層,再 ·- -- Μ冰醋酸調整pH值至約7 。將所得溶液通過Dowex 1X2-400離子交換樹脂(NH+態,20 g)管柱,且揮發使乾 燥。Μ水(約100 ml)將其乾燥物溶解,且使其通過Do wex 50X8-100離子交換樹脂(醋酸態* 10 g) *使所得溶液於減 壓下揮發乾燥。因此,所得的50% 2H,13C ,15N-經標示 麩醯胺並未结晶。 將部份所得瑢於至少為5:1.5:1 v/v/v異丙醇:水:冰 醋酸,將其加入EM分離Lichroprep DU1管柱中(50x2.5 -45™ 本紙張尺度適用中國國家標準(CNS )&gt;4規格(210x 297公慶) 83. 3. 10,000 (讀先閱讀背面之注意事項再填寫本頁) ---訂 經濟部中央標準局員工消費合作杜印製 A7 B7 五、發明説明(C^C/) c m s )且Μ 5 : 1 V / V / V異丙醇:冰醋酸來沖提。將適當的分 液相混後,使減壓揮發得50% 2H,13C ,15Η-麩醯胺為膠 吠物。 一 4 6 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 83. 3. 10,000 (請先聞讀背面之注意事項再填寫本頁)-QI I 、 Order—— — .A! I-— ^ n -I----I!. Order printed by the Ministry of Economic Affairs and the Li Bureau Staff Consumer Cooperative A7 B7 V. Description of the invention ((^) Sealing cap 'Immerse this solution in a dry ice / propane bath to freeze. Open the tube cover.' Add sodium hydride (2.1 g, 60% in oil, 52.5 mmol, rinse with hexane and dry with nitrogen) to Tube. Immediately close the test tube, and connect its arm to the bubble generating tube in a condensing conical flask containing a blazolidone derivative. Thaw the dimethylsulfine solution in the Sc h 1 enk test tube, and the resulting 1 5N-ammonia is condensed in the pyrazolidine solution. Wait until all i 5 N _ ammonia is distilled * M clip to close the gas generating tube to close it. Warm the fenazolidone solution at room temperature overnight. Water (2 m 丨) was added to the resulting solution and stirred for 30 minutes. The solution was evaporated to dryness under reduced pressure. The residue was dissolved in ethanol (50 m) and water (100%). M sodium hydroxide (1M, 10.5 ml) reacted with this solvent * and refluxed for 2.5 hours to obtain a hydrazone-protected glutamine derivative. After cooling, hexahydropyridine (1.04 m (1, 10.5 mmol) was reacted with the solution and stirred overnight at room temperature. The resulting solution was evaporated to dryness under reduced pressure, and the layers were separated in chloroform (about 100 ml) and water (about 100 ml). K diacetic acid (Approximately 100 ffll) extract the aqueous layer, and then adjust the pH value to about 7 with glacial acetic acid. Pass the resulting solution through a Dowex 1X2-400 ion exchange resin (NH + state, 20 g) column, and volatilize to dry. M water (approximately 100 ml) was used to dissolve the dried product, and passed it through Do wex 50X8-100 ion exchange resin (acetic acid state * 10 g) * The resulting solution was evaporated to dryness under reduced pressure. Therefore, the obtained 50% 2H , 13C, 15N-Branamine is not crystallized. Part of the obtained amidine is at least 5: 1.5: 1 v / v / v isopropanol: water: glacial acetic acid, which is added to the EM separation Lichroprep DU1 column. Medium (50x2.5 -45 ™ This paper size applies the Chinese National Standard (CNS) &gt; 4 specifications (210x 297 public holidays) 83. 3. 10,000 (read the precautions on the back before filling this page) --- Order The consumer cooperation of the Central Bureau of Standards of the Ministry of Economic Affairs printed A7 B7 V. Description of the invention (C ^ C /) cms) and M 5: 1 V / V / V isopropanol: glacial acetic acid for extraction After mixing the appropriate liquid and liquid phases, the pressure is reduced to 50% 2H, 13C, 15Η-glutamine as the rubber bark. 4.6-This paper size is applicable to Chinese National Standard (CNS) A4 specification (210 × 297) 83) 3. 10,000 (Please read the notes on the back before filling in this page)

Claims (1)

A8 B8 C8 D8A8 B8 C8 D8 第83102456號專利申請案 中文申請專利範圍修正本(88年9月) 1. 一種測定蛋白質三維结構資料的方法,其包括下列步驟 (請先閣讀背面之注意事項再填寫本頁) ,如於蛋白質產生的條件下,將可產生欲探討蛋白質之 哺乳動物或昆蟲細胞培養物於營養性培養基中生長培養 ,此培養基中包含了所有细胞生長必須之胺基酸及可吸 收的碳水化合物源 &gt; 必須礦物質及生畏因子,其中該營 養性培養基中之胺基酸之所有碳原子實質上為UC及該 營養性培養基中之胺基酸之所有氮原子實質上為; to由營養性培養基中分離實質上為經標示態之蛋白質及 ⑵將此蛋白質K N M R光譜分析以測定其三維结構。 2. 根據申請專利範圍第1項的方法,其中該營養性培養基 中有足夠量的胺基酸之氫原子為2Η,使其與非重氫化之 經標示蛋白質,於N M R光譜分析中所產生的訊息相比較 下,可加強其於NMR光譜分析中產生的訊息解析度。 3. 根.據申請專利範圍第2項的方法,其中該營養性培養基. 中胺基酸之氫原子由20%至1〇〇 %為2H。 4. 根據申請專利範圍第2項的方法,其中實質上碳水化合 物源的所有碳原子均為1 3 C ,且於碳水化合物源中的氫 原子由20%至100 %為2H。 經濟部中央標準局員工消費合作社印製 5. 一種測定分子三維結構資料的方法,其中該第一種分子 與第二種分子生成複合物,且其中至少一種分子為蛋白 質,其包括步驟⑸產生實質上呈以穩定*具NMR活性之 同位素標示之第一種分子;扣使第一種分子與第二種分 子生成複合物,且⑵將此複合物以N MR光譜分析’ W測 定第一種分子的三維结構。 6. 根據申請專利範圍第5項的方法,於步驟(b)之前更包括 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) A8 B8 C8 D8Revised Chinese Patent Application No. 83102456 (September 88) 1. A method for determining the three-dimensional structure information of proteins, which includes the following steps (please read the precautions on the back before filling this page), as in Under the conditions of protein production, mammalian or insect cell cultures that produce the desired protein are grown in a nutrient medium, which contains all the amino acids and absorbable carbohydrate sources necessary for cell growth> Essential minerals and growth factors, wherein all carbon atoms of amino acids in the nutrient medium are substantially UC and all nitrogen atoms of amino acids in the nutrient medium are substantially; Isolate a substantially labeled protein and analyze the protein by KNMR spectroscopy to determine its three-dimensional structure. 2. The method according to item 1 of the scope of patent application, wherein the nutrient medium has a sufficient amount of amino acids with a hydrogen atom of 2Η, which is generated by non-deuterated labeled protein in NMR spectroscopic analysis. Compared with the information, the resolution of the information generated in the NMR spectrum analysis can be enhanced. 3. The method according to item 2 of the scope of patent application, wherein the nutrient medium has a hydrogen atom of amino acid from 20% to 100% as 2H. 4. The method according to item 2 of the scope of patent application, wherein substantially all carbon atoms of the carbohydrate source are 1 3 C, and hydrogen atoms in the carbohydrate source are from 20% to 100% to 2H. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. A method for determining three-dimensional structure information of a molecule, wherein the first molecule forms a complex with the second molecule, and at least one of the molecules is a protein, which includes steps ⑸ to generate a substance The first molecule labeled with stable isotope with NMR activity is shown on the top; the first molecule is made into a complex with the second molecule, and the complex is analyzed by N MR spectroscopy 'W to determine the first molecule Three-dimensional structure. 6. According to the method in the scope of patent application, item 5 is included before step (b). This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) A8 B8 C8 D8 第83102456號專利申請案 中文申請專利範圍修正本(88年9月) 1. 一種測定蛋白質三維结構資料的方法,其包括下列步驟 (請先閣讀背面之注意事項再填寫本頁) ,如於蛋白質產生的條件下,將可產生欲探討蛋白質之 哺乳動物或昆蟲細胞培養物於營養性培養基中生長培養 ,此培養基中包含了所有细胞生長必須之胺基酸及可吸 收的碳水化合物源 &gt; 必須礦物質及生畏因子,其中該營 養性培養基中之胺基酸之所有碳原子實質上為UC及該 營養性培養基中之胺基酸之所有氮原子實質上為; to由營養性培養基中分離實質上為經標示態之蛋白質及 ⑵將此蛋白質K N M R光譜分析以測定其三維结構。 2. 根據申請專利範圍第1項的方法,其中該營養性培養基 中有足夠量的胺基酸之氫原子為2Η,使其與非重氫化之 經標示蛋白質,於N M R光譜分析中所產生的訊息相比較 下,可加強其於NMR光譜分析中產生的訊息解析度。 3. 根.據申請專利範圍第2項的方法,其中該營養性培養基. 中胺基酸之氫原子由20%至1〇〇 %為2H。 4. 根據申請專利範圍第2項的方法,其中實質上碳水化合 物源的所有碳原子均為1 3 C ,且於碳水化合物源中的氫 原子由20%至100 %為2H。 經濟部中央標準局員工消費合作社印製 5. 一種測定分子三維結構資料的方法,其中該第一種分子 與第二種分子生成複合物,且其中至少一種分子為蛋白 質,其包括步驟⑸產生實質上呈以穩定*具NMR活性之 同位素標示之第一種分子;扣使第一種分子與第二種分 子生成複合物,且⑵將此複合物以N MR光譜分析’ W測 定第一種分子的三維结構。 6. 根據申請專利範圍第5項的方法,於步驟(b)之前更包括 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 A8 B8 C8 , D8 _ 六、申請專利範圍 ,實質上將第二種分子以重氫標示。 7. 根據申請專利範圍第5項的方法’其中第一種分子為蛋 白質,其可以下述方法生產,包括,(a&gt;於蛋白質生產條 件下,將可產生欲探討蛋白質之哺乳動物或昆蟲細胞培 養物於營養性培養基中生長,此培養基中包含了所有细 胞生長必須之胺基酸及可吸收的碳水化合物源’必須礦 物質及生長因子,其中胺基酸實質上K具NMR -活性之同 位素標示;且(b&gt;由營養性培養基中分離實質上為經標示 態之蛋白質。 8. 根據申請專利範圍第7項的方法’其中第二種分子為蛋 白質,可K下述方法生產,其步驟包括(a)於蛋白質產生 的條件下,將可產生欲探討蛋白質之哺乳動物或昆蟲细 胞於營養性培養基中生長,此培養基中包含了所有細胞 生長必須之胺基酸及可吸收的碳水化合物源,必須礦物 質及生長因子,其中實質上胺基酸均標示;且肚由 營養性培養基中分離實質上為經標示態之蛋白質。 9. 根據申請專利範圍第8項的方法,其中第一種分子為蛋 白質,可Μ下述方法生產,其步驟包括⑻於蛋白質產生 的條件下,將可產生欲探討蛋白質之哺乳動物或昆蟲细 胞於營養性培養基中生長,此培養基中包含了所有细胞 生長必須之胺基酸及可吸收的碳水化合物源,必須礦物 質及生長因子,其中,實質上,胺基酸以具NMR活性之 同位素標示;且&lt;bi由營養性培養基中分離實質上為經標 示態之蛋白質。 1 0 .根據申請專利範圍第5 , 6 , 7 , 8或9項之方法,其中具N M R 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) I ^裝------訂----- 經濟部中央標準局員工消費合作社印製 A8 B8 C8 D8 六、申請專利範圍 活性之同位素為1 3 C。 11 .根據申請專利範圍第5 , 6 , 7 , 8或9項之方法,其中第一種 分子以1 3 C及1 5 N作雙重標示。 12 .根據申請專利範圍第9項之方法,其中具NMR活性的同 位素為1 3C或是1 3C及1 5N ,且用於製備第一種分子之 營養性培養基中,有足量胺基酸之氫原子為2H’其用K 加強與非重氫化經標示蛋白質之NMR光譜訊號相較下, 其N MK光譜分析所產生的訊號解析度。 13 .根據申請專利範圍第1 2項之方法,其中用以製備第一種 分子之營養性培養基中的胺基酸,其由20%至100 %的 氫原子為2H。 1 4 . 一種可供應哺乳動物或毘蟲细胞生長的營養性培養基, 其中含有细胞生長所需的所有胺基酸,可吸收的碳水化 合物,及必須礦物質,生長因子,其中實質上凡细胞用 來行蛋白質合成之胺基酸及其他任何受質,均M 13C及 1 5 N來標示。 1 5 .根據申請專利範圍第1 4項之營養性培養基,其中實質上 碳水化合物來源K 1 3 C標示。 16.根據申請專利範圍第14或15項之營養性培養基*其中該 營養性培養基中之胺基酸的氫原子由20%至100 %為 2H 〇 17 .根據申請專利範圍第1 6項之營養性培養基,其中添加實 質上以1 3 C及1 5 N作標示的半胱胺酸,且其由2 0 %至 100 %的氫原子為2H。 1 8 ·根據申請專利範圍第1 6項之營養性培養基,其中添加實 本紙張尺度適用中國國家標準(CNS ) M規格(210χ297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 Α8 Β8 C8 D8 經濟部中央標準局員工消費合作社印製 六、申請專利範圍 質上K 13C及13N作標示的麩醯胺’且其由20%至100 %的氫原子為2 Η。 19 .根據申請專利範圍第1 6項之營養性培養基’其中添加實 質上K 1SC及15Ν作標示的天門冬醯胺,且其由20%至 100 %的氫原子為2Η。 20 .根據申請專利範圍第1 4項之營養性培養基’其中該胺基 酸實質上Κ 2 Η標示。 .21 .根據申請專利範圍第2 5項之營養性培養基’其中該碳水 化合物來源實質上Κ 2Η標示。 22 . —種產生實質上經同位素標示之胺基酸混合物之方法, 其中包括,⑶將微生物於營養性培養基中生長,其中凡 微生物用以行蛋白質生合成之任何受質的所有碳實質上 均為13C ,及凡微生物用以行蛋白質生合成之任何受質 的所有氮簧質上均為15N ,或凡微生物用Μ行蛋白質生 合成之任何受質的所有氫實質上均為2 Η ; (b)由培養液中 收集含蛋白質分液;®於硫氫基遷原劑存在下,以酸性 ,非氧化條件水解蛋白質Μ產生胺基酸混合物之粗產物 ;(d)將此胺基酸混合物的粗產物Κ陽離子交換樹脂色層 分析法純化,用K產生部份經純化的胺基酸混合物;(e) 將此經部份純化的胺基酸混合物K陰離子交換樹脂色層 分析法純化,Μ產生經純化的胺基酸混合物;且(f) Μ經 同位素標示的半胱胺酸添加至此涇纯化胺基酸棍合物中 ,且此同位素或同位素混合物與原存於營養性培養基者 相同,且其中半胱胺酸所添加的數量可足Κ供應哺乳動 物或昆蟲细胞的蛋白質產生。 (請先閎讀背面之注意事項再填寫本頁) b 裝. 訂· 本紙張尺度逋用中國國家標準(CNS ) A4規格(210X297公釐) ABCD b8iiv3 ττ、申請專利乾圍 23.根據申請專利範圍第22項之方法,其中之營養性培養基 及半胱胺酸K 13C標示。 2 4 .根據申請專利範圍第2 2項之方法,其中之營養性培養基 及半胱胺酸Μ 1 5 N標示。 25 ,根據申請專利範圍第2 2項之方法,其中之營養性培養基 及半胱胺酸Κ 標示。 26 .根據申請專利範圍第22項之方法,其中之營養性培養基 及半胱胺酸M13C及作雙重標示。 2 7 .根據申請專利範圍第2 6項之方法,其中之營養性培養基 及半胱胺酸更Μ 2Η標示,其中經純化之胺基酸混合物及 半胱胺酸之氫原子,其由20%至1〇〇 %為2Η。 28 .根據申請專利範圍第27項之方法,其中更包括將實質上 Μ 1 3 C及1 5 Ν標示之麩醯胺添加至經純化胺基酸混合物 中,且其中的氫原子由20%至1〇〇 %為2Η。 29. 根據申請專利範圍第28項之方法,其中更包括將實質上 Κ 1 3 C及1 5 Ν標示之天門冬醯胺添加至經純化胺基酸混 合物中,且其中該氫原子由20%至100 %為2Η。 30. 根據申請專利範圍第22項的方法,其中該微生物為微f桌 類,且於營養性培養基中所包含的碳源為經1 3 C -標示的 二氧化碳。 31. 根據申請專利範圍第22項的方法,其中該徽生物為微藻 類(m i c r 〇 a 1 g a 1),且於營養性培養基中所包含的為經 1 5 N -標示的無機氮源。 32 .根據申請專利範圍第22項的方法,其中該微生物為微藻 類,且於營養性培養基中所包含的碳源為經13C-標示的 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先聞讀背面之注意事項再填寫本頁) :--J--------------、玎— — :--- 經濟部中央標準局員工消費合作社印製 S8ii78 A8 B8 C8 D8 申請專利範圍 藻 微 為 .物 生。 徽20 該2H 中為 。 其均 源,水 氮法的 機方中 無的基' 的項養 示22培 標第性 N-圍養 15範營 經利上 及專質 碳請實 化申且 氧據, 二根類 子 隹 0 陽 的 用 使 所 中 其 法 方 的 項 2 2 第 圍。 範態 利H&quot; 專為 青 旨 --口 3» 申樹 據換 根交 子 離 陰 的 用 使 所 中 其 法 方 之 項 2 2 第 。 圍態 範 _ ϋ Η 禾 ο 專為. 請脂 申樹 據換 根交 其 法 方 之 項 利陽基 其由胺 ,物將 (d)染液 驟污溶 步性性 該中鹼 中及用 性利 酸且 的’ 物除 解去 水提 34質沖 第白中 圍蛋柱 範將管 利,脂 專液樹 請溶換 申性交 據酸子 根用離 。法 出方 提之 沖項 中36 柱第 管.圍 換範 交利 子專 離請 陽申 由據管 酸根換 其 (請先聞讀背面之注意事項再填寫本頁) 為 柱 (e) 驟 步 於 且 態 利 其 交蛋 子將 0 陰液 的溶 用性 使鹼 中用 沖中 中柱 柱管 管換 換交 交子 子離 離陰 陰由 由酸 物基 染胺 污將 性液 中溶 及性 性酸 鹼用 的利 物且 解’ 水除 質去 白提 括 包 其 法 方 之 酸 胺 胱 半 之 示 標 素 位 同 經 〇 備 出製 提種 冲一 經濟部中央標準局員工消費合作社印製 酸 胺 胱 半 之 中 肽 胜 多 為, 其應 t(反 酉衮 胱ί硫 半㈣護 的pa保 一不氯經' 標-I之 素SI4式 位㈣下 同}成 使位生 &lt;&amp;單从 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) ^81178 Α8 Β8 C8 D8 六、申請專利範圍Revised Chinese Patent Application No. 83102456 (September 88) 1. A method for determining the three-dimensional structure information of proteins, which includes the following steps (please read the precautions on the back before filling this page), as in Under the conditions of protein production, mammalian or insect cell cultures that produce the desired protein are grown in a nutrient medium, which contains all the amino acids and absorbable carbohydrate sources necessary for cell growth> Essential minerals and growth factors, wherein all carbon atoms of amino acids in the nutrient medium are substantially UC and all nitrogen atoms of amino acids in the nutrient medium are substantially; Isolate a substantially labeled protein and analyze the protein by KNMR spectroscopy to determine its three-dimensional structure. 2. The method according to item 1 of the scope of patent application, wherein the nutrient medium has a sufficient amount of amino acids with a hydrogen atom of 2Η, which is generated by non-deuterated labeled protein in NMR spectroscopic analysis. Compared with the information, the resolution of the information generated in the NMR spectrum analysis can be enhanced. 3. The method according to item 2 of the scope of patent application, wherein the nutrient medium has a hydrogen atom of amino acid from 20% to 100% as 2H. 4. The method according to item 2 of the scope of patent application, wherein substantially all carbon atoms of the carbohydrate source are 1 3 C, and hydrogen atoms in the carbohydrate source are from 20% to 100% to 2H. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. A method for determining three-dimensional structure information of a molecule, wherein the first molecule forms a complex with the second molecule, and at least one of the molecules is a protein, which includes steps ⑸ to generate a substance The first molecule labeled with stable isotope with NMR activity is shown on the top; the first molecule is made into a complex with the second molecule, and the complex is analyzed by N MR spectroscopy 'W to determine the first molecule Three-dimensional structure. 6. According to the method in the scope of the patent application, before step (b), this paper includes the standard of Chinese paper (CNS) A4 (210X 297 mm). The paper is printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. A8 B8 C8, D8 _ 6. The scope of patent application, essentially marking the second molecule as deuterium. 7. The method according to item 5 of the scope of the patent application, wherein the first molecule is a protein, which can be produced by the following methods, including, (a &gt; Under the conditions of protein production, mammalian or insect cells that are to be investigated for proteins will be produced The culture is grown in a nutrient medium, which contains all the amino acids and absorbable carbohydrate sources necessary for cell growth, 'essential minerals and growth factors, of which amino acids are essentially K isotope with NMR-active isotopes And (b &gt; Isolate a substantially labeled protein from a nutrient medium. 8. The method according to item 7 of the scope of the patent application, wherein the second molecule is a protein and can be produced by the following method, its steps Including (a) under the conditions of protein production, mammalian or insect cells that can produce the protein to be investigated are grown in a nutrient medium, which contains all the amino acids and absorbable carbohydrate sources necessary for cell growth , Must be minerals and growth factors, in which the amino acids are substantially marked; and the belly is separated from the nutrient medium The labeled protein is qualitative. 9. According to the method in the scope of patent application No. 8 wherein the first molecule is a protein, it can be produced by the following method. The steps include the following conditions: To explore the growth of mammalian or insect cells of proteins in a nutrient medium, this medium contains all the amino acids and absorbable carbohydrate sources necessary for cell growth, essential minerals and growth factors, of which, in essence, amines The basic acid is labeled with an NMR-active isotope; and &lt; bi separates the substantially labeled protein from the nutrient medium. 10. According to the method of item 5, 6, 7, 8 or 9 of the scope of patent application, Among them, the NMR paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page) I ^ -------- Order ----- Ministry of Economic Affairs Printed by the Consumer Standards Cooperative of the Central Bureau of Standards A8 B8 C8 D8 6. The isotope of the activity in the scope of patent application is 1 3 C. 11. The method according to item 5, 6, 7, 8 or 9 of the scope of patent application, of which The first molecule is double labeled with 1 3 C and 1 5 N. 12. According to the method of item 9 in the scope of the patent application, the isotope with NMR activity is 1 3C or 1 3C and 1 5N, and is used to prepare the first molecule. In a molecular nutrient medium, a sufficient amount of hydrogen atoms of the amino acid is 2H '. Compared with the NMR spectrum signal of the labeled protein, which is enhanced by K, it is analyzed by the NMK spectrum analysis signal. 13. The method according to item 12 of the scope of patent application, wherein the amino acid in the nutrient medium used to prepare the first molecule has a hydrogen atom of 2H from 20% to 100%. 14. A nutrient medium capable of supplying mammalian or migratory cells for growth, which contains all amino acids, absorbable carbohydrates, and essential minerals and growth factors required for cell growth. The amino acids and any other substrates used in protein synthesis are labeled with M 13C and 1 5 N. 15. The nutrient medium according to item 14 of the scope of the patent application, wherein the source of carbohydrate K 1 3 C is substantially indicated. 16. The nutrient medium according to item 14 or 15 of the scope of patent application *, wherein the hydrogen atom of the amino acid in the nutrient medium is from 20% to 100% is 2H 〇17. The nutrition according to item 16 of the scope of patent application In the culture medium, cysteine substantially labeled with 1 3 C and 15 N is added, and the hydrogen atom from 20% to 100% is 2H. 1 8 · Nutritional medium according to item 16 of the scope of the patent application, in which the actual paper size is added to the Chinese National Standard (CNS) M specification (210 × 297 mm) (Please read the precautions on the back before filling this page) Order Α8 Β8 C8 D8 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 6. The scope of patent application for glutamine is marked by K 13C and 13N, and its hydrogen atom from 20% to 100% is 2 Η. 19. The nutrient medium according to item 16 of the scope of the patent application, wherein aspartame is actually added with K 1SC and 15N as the label, and the hydrogen atom from 20% to 100% is 2%. 20. The nutrient medium according to item 14 of the scope of the patent application, wherein the amino acid is substantially labeled K 2 Η. .21. The nutrient medium according to item 25 of the scope of the patent application, wherein the source of the carbohydrate is substantially K 2Η. 22. A method for producing a substantially isotopically labeled amino acid mixture, including ⑶ growing microorganisms in a nutrient medium, wherein all carbons of any substrates used by microorganisms for protein biosynthesis are substantially 13C, and all nitrogens of any substrate used by microorganisms for protein biosynthesis are 15N in nature, or all hydrogen of any substrates used by microorganisms for protein biosynthesis is substantially 2 Η; ( b) collecting protein-containing liquid fractions from the culture broth; ® hydrolyzing the protein M in the presence of a thiohydrogen source agent under acidic, non-oxidizing conditions to produce a crude product of the amino acid mixture; (d) the amino acid mixture The crude product K was purified by cation exchange resin chromatography, and K was used to produce a partially purified amino acid mixture; (e) the partially purified amino acid mixture K was purified by anion exchange resin chromatography. M produces a purified amino acid mixture; and (f) M isotope-labeled cysteine is added to the purified amino acid stick compound, and the isotope or the isotope mixture and the original Medium were identical, and wherein the amount of cysteine added protein may be a sufficient supply Κ mammalian or insect cells is generated. (Please read the precautions on the back before filling out this page) b Binding. Binding · This paper size adopts Chinese National Standard (CNS) A4 specification (210X297 mm) ABCD b8iiv3 ττ, patent application and application 23. According to patent application The method according to item 22, wherein the nutrient medium and cysteine K 13C are labeled. 24. The method according to item 22 of the scope of patent application, wherein the nutrient medium and cysteine M 1 5 N are marked. 25. The method according to item 22 of the scope of patent application, wherein the nutrient medium and cysteine K are marked. 26. The method according to item 22 of the scope of patent application, wherein the nutrient medium and cysteine M13C are double labeled. 27. The method according to item 26 of the scope of patent application, wherein the nutrient medium and cysteine are marked with M 2Η, wherein the purified amino acid mixture and the hydrogen atom of cysteine are composed of 20% To 100% is 2%. 28. The method according to item 27 of the scope of patent application, which further comprises adding substantially glutamine labeled with M 1 3 C and 1 5 N to the purified amino acid mixture, and the hydrogen atom therein is from 20% to 100% is 2%. 29. The method according to item 28 of the scope of patent application, which further comprises adding asparagine substantially labeled K 1 3 C and 1 5 N to the purified amino acid mixture, and wherein the hydrogen atom is 20% To 100% is 2Η. 30. The method according to item 22 of the scope of patent application, wherein the microorganism is a microfamily, and the carbon source contained in the nutrient medium is carbon dioxide labeled 1 3 C-. 31. The method according to item 22 of the scope of the patent application, wherein the emblem organism is microalgae (m i c r 0 a 1 g a 1), and the nutritional medium contains a 15 N-labeled inorganic nitrogen source. 32. The method according to item 22 of the scope of patent application, wherein the microorganism is microalgae, and the carbon source contained in the nutrient medium is 13C-labeled. This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297). (Mm) (Please read the precautions on the back before filling out this page): --J --------------, 玎 — —:: --- Staff Consumption of Central Bureau of Standards, Ministry of Economic Affairs The cooperative printed S8ii78 A8 B8 C8 D8. The emblem 20 in the 2H is. Its homogeneous source, the basis of the water and nitrogen method is not the basis of the term of the cultivation of the 22nd standard N-culture 15 Fanying economic benefits and special carbon, please apply for application and oxygen data, two roots隹 0 Yang's use of the law's term 2 2 perimeter. Paradigm H &quot; Designed specifically for the purpose of youth-mouth 3 »Shen Shu according to the law in the use of the law to change the root of the cross to the yin 2 2 2. Circumstance Fan _ ϋ 禾 禾 ο Designed for. Please ask Zhishen Shu to change its roots to the law of the project Liyang base, which is made from amines, substances (d) The dyeing solution can be quickly stained and dissolved. Sexual acid and acid's removal of water and extraction of the 34th mass of the white perimeter egg column fan will control the tube, the lipid-specific liquid tree, please dissolve the exchange of acid roots. The 36th column tube in the red item mentioned by the French formulator. To change Fan Jiaolizi's special departure, please ask Yang Shen to replace it according to the tube acid (please read the precautions on the back before filling this page) for the column (e) Step Yu Qili crosses the egg and dissolves the solubility of 0 yin so that the alkali can be used in the middle of the column to change the cross tube to cross the yin and yin. The acid solution is dyed by amine to dissolve the sexual solution and sex. Acids and bases are beneficial and decontaminated. ”Water removal of quality and whitening include the standard amino acid and cysteine of the standard display unit. The same preparation and production of seeds are produced by the central government bureau of the Ministry of Economic Affairs and printed by the consumer cooperative. Most of the peptides in the amino acid cysteine have the following advantages, which should be the same as in the formula SI4 of the standard -I element 4 &amp; From this paper size, the Chinese National Standard (CNS) A4 specification (210 X 297 mm) is applicable ^ 81178 Α8 Β8 C8 D8 6. Scope of patent application CH2COOH 其中R及R ’各為氫; (bJ (i)將多胜肽水解,使生成含經保護硫醚之胺基酸混 合物且,(ii)利用離子交換管柱色層分析法,將經保護 硫醚由胺基酸混合物中分離Ϊ5 ;且 ⑵將經保護的硫_去保護,以產生經同位素標示的半胱 胺酸。 39 . —種經同位素標示之半胱胺酸的製劑,其中實質上所有 的碳原子為13C ,且實質上所有的氮原子為15N ,且由 20%至100 %的氫原子為2H。 40. —種製備經同位素標示麩醯胺或天門冬醯胺的方法’其 包括, .⑶將經同位素標示的麩醯胺酸或天門冬酸與N -荛基甲基 反應,Μ生成下式之N-經保護胺基酸 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印裝 I X-RN-CHI i CH,) c R〇y % 本紙張纽逋用+國國家橾準(CNS ) Λ4聽· ( 210X297公:t ) A8 B8 C8 D8 d8li78 申請專利範園 &lt;b)使N -經保護胺基酸與三聚甲醛在催化量之強酸存在下 反應Μ生成下式之腭唑啶酮, (°Υ° X-N-CH I (CHJn I 人、 ΉΟ Ο (〇於醯胺-生成條件下,將噚哩啶酮與氨反應,μ生成 如下式之環醯胺衍生物 (請先閱讀背面之注意事項再填寫本頁) 〇、 〇CH2COOH where R and R 'are each hydrogen; (bJ (i) hydrolysis of the polypeptide to produce an amino acid mixture containing a protected thioether; and (ii) using ion exchange column chromatography, Protected thioethers are separated from the amino acid mixture Ϊ5; and ⑵ deprotects the protected sulfide to produce isotope-labeled cysteine. 39.-a preparation of isotope-labeled cysteine, where Substantially all carbon atoms are 13C, and substantially all nitrogen atoms are 15N, and from 20% to 100% hydrogen atoms are 2H. 40. A method for preparing isotope-labeled glutamine or aspartamine 'It includes: (3) reacting isotope-labeled glutamic acid or aspartic acid with N-fluorenylmethyl to generate N-protected amino acids of the following formula (please read the precautions on the back before filling in This page) Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs I X-RN-CHI i CH,) c R〇y% This paper is used for New Zealand + National Standards (CNS) Λ4 Listening (210X297K: t) A8 B8 C8 D8 d8li78 Patent Application Park &lt; b) Make N-protected amino acid and paraformaldehyde in a catalytic amount In the presence of a strong acid, the reaction M produces oxazolidinone of the following formula, (° Υ ° XN-CH I (CHJn I human, Ή Ο Ο (〇) under hydrazine-forming conditions, the azrididone is reacted with ammonia, μ Cycloperamide derivatives of the following formula (please read the notes on the back before filling this page) 〇 、 〇 X-N-CH I ^Η,)η I .Η,Ν Ν0 經濟部t央標準局員工消費合作社印製 (d)將環醯胺衍生物水解,以生成下式之Ν -經保護胺基酸 H0W〇 c X-HN-CH I (严)π A Η〆V &lt;e)將Ν -經保護胺基酸去保護,Μ生成經同位素標示之挺 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) A8 B8 C8 D8 ^81178 六、申請專利範圍 醯胺成天門冬醯胺。 其中,ri為1或2 ,且X為胺保護基。 41. 一種麩醯胺的製劑,其中實質上所有的碳原子均為13C ,且實質上所有的氮原子均為,且由20%至100 % 的氫原子為2 Η。 42 . —種天門冬醯胺的製劑,其中實質上所有的碳原子均為 13C ,且實質上所有的氮原子均為。 43.根據申請專利範圍第42項的製劑,其中由20%至100 % 的氫原子為2H。 (請先閲讀背面之注意事項再填寫本頁)XN-CH I ^ Η,) η I .Η, N Ν0 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (d) Hydrolyze the cyclic amide derivative to form Ν-protected amino acid H0W 〇c X-HN-CH I (strict) π A Η〆V &lt; e) deprotect N- with a protected amino acid, and generate an isotope-labeled paper. The paper size applies Chinese National Standard (CNS) A4 specifications (210 X 297 mm) A8 B8 C8 D8 ^ 81178 6. The scope of patent application: Asparagine. Where ri is 1 or 2 and X is an amine protecting group. 41. A preparation of glutamine, wherein substantially all carbon atoms are 13C, and substantially all nitrogen atoms are, and the hydrogen atom from 20% to 100% is 2%. 42. A preparation of asparagine, wherein substantially all carbon atoms are 13C, and substantially all nitrogen atoms are. 43. The preparation according to item 42 of the scope of patent application, wherein the hydrogen atom from 20% to 100% is 2H. (Please read the notes on the back before filling this page) 經濟部中央標準局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs This paper is sized for the Chinese National Standard (CNS) A4 (210X297 mm)
TW083102456A 1993-02-05 1994-03-21 Compositions and methods for protein structural determinations TW381178B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/014,243 US5393669A (en) 1993-02-05 1993-02-05 Compositions and methods for protein structural determinations
PCT/US1994/001329 WO1994018339A1 (en) 1993-02-05 1994-02-07 Compositions and methods for protein structural determinations
ZA94815 1994-02-07

Publications (1)

Publication Number Publication Date
TW381178B true TW381178B (en) 2000-02-01

Family

ID=26685842

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083102456A TW381178B (en) 1993-02-05 1994-03-21 Compositions and methods for protein structural determinations

Country Status (1)

Country Link
TW (1) TW381178B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113125594A (en) * 2021-04-02 2021-07-16 宁波大学 Peptide chain hydrolysis reagent and preparation method and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113125594A (en) * 2021-04-02 2021-07-16 宁波大学 Peptide chain hydrolysis reagent and preparation method and application thereof
CN113125594B (en) * 2021-04-02 2022-06-24 安徽国肽生物科技有限公司 Peptide chain hydrolysis reagent and preparation method and application thereof

Similar Documents

Publication Publication Date Title
AU678446B2 (en) Compositions and methods for protein structural determinations
TW581772B (en) Methods and compositions for NMR structure determinations
Duff et al. Robust high-yield methodologies for 2H and 2H/15N/13C labeling of proteins for structural investigations using neutron scattering and NMR
Mosin et al. Biosynthesis of photochrome transmembrane protein bacteriorhodopsin of Halobacterium halobium labeled with deuterium at aromatic amino acids residues of 2, 3, 4, 5, 6-2H5] Phe,[3, 5-2H2] Tyr and [2, 4, 5, 6, 7-2H5] Trp
Suzuki et al. Methyl-selective isotope labeling using α-ketoisovalerate for the yeast Pichia pastoris recombinant protein expression system
Vuong et al. Synthesis of chiral spin-labeled amino acids
TW381178B (en) Compositions and methods for protein structural determinations
Yamasaki et al. RES-701-1, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701 II. Determination of the primary sequence
Fruton et al. The metabolism of peptides
US8193156B1 (en) Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof
Zhang et al. An improved protocol for amino acid type-selective isotope labeling in insect cells
Karnaukhova et al. 2 H-and 13 C-labeled amino acids generated by obligate methylotrophs Biosynthesis and MS monitoring
US20030124673A1 (en) Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
TWI283659B (en) Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
JP3166160B2 (en) New (1) and (3) C-labeled amino acids and their fermentative or enzymatic production
Mosin et al. The Development of Biosynthesis of 2Н-and 13С-labeled Amino acids and Proteins with Various Levels of Isotopic Enrichment Using Bacterial Objects
Špačková et al. Fast and cost-efficient approaches for 17O-isotopic labeling of carboxylic groups in biomolecules: from free amino acids to peptide chains
Lorkiewicz Effects of incorporation of iododeoxyuridine on Escherichia coli
Yamada et al. < Symposium I> A new imaging method of glucose transport in live cells
Kameda et al. Utilization of amino-acids during metabolism in Escherichia coli
Sheppard et al. Amino-acids
Connolly The stereoselective synthesis of nitrile amino acids using a chiral Schiff base complex.
鈴木里佳 et al. Methyl-selective isotope labeling using α-ketoisovalerate for the yeast Pichia pastoris recombinant protein expression system
Kay Alanine Probes of Supra-Molecular Structure and Dynamics
BE683574A (en)

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees